ASX Investment Opportunity - Change Financial Ltd (ASX:CCA)

Profit doesn’t arrive overnight in fintech, especially when you’re building the core infrastructure that other brands depend on. We’re joined by Tony Sheehan, CEO of Change Financial Limited, to break down the FY26 result and the operational choices that helped tip the company into profit after years of losses. We talk through the mechanics behind the numbers: sustained revenue growth, a stable fixed cost base, and why scaling card issuing volumes can materially lift margins as the platform matures.

We also get practical about where growth really comes from. Tony explains what Change Financial delivers across card processing, card issuing and payments testing, including support for digital wallets and white-label card programs. We unpack the drivers behind rising active card counts, how new fintech wins compare with existing customers scaling, and why investors should pay attention to the six to nine month lag between signing a client and seeing meaningful live-program revenue.

Then we zoom in on PaySim, the payments testing product that’s the default EFTPOS certification standard in Australia, yet still holds a tiny share of a massive global market. Tony shares what has held sales back, why modernising the interface matters as testing teams change, how a partner distribution model supports global expansion, and where agentic AI is already improving development speed and operational efficiency. We finish with a candid lesson from exiting the US: in payments, controlling your own destiny often comes down to licensing and regulatory leverage.

If you found this useful, please subscribe, share the episode with a mate, and leave us a review so more listeners can find ASX Briefs.

ASX Investment Opportunity - Nova Eye Medical Ltd (ASX:EYE)

One of the biggest surprises in eye health is how often cataracts and glaucoma overlap, and what that means for treatment choices. We’re joined by Tom Spurling, Managing Director of Nova Eye Medical, to unpack interventional glaucoma and the iTrack™ Advance platform, including why “treat earlier” can be a very different patient journey compared with years of glaucoma eye drops and the risks of waiting until the disease is severe.

We talk through how iTrack™ Advance can be performed during cataract surgery, the world’s most common operation, and why that channel matters so much for adoption in the US. Tom also explains Nova Eye Medical’s competitive stance in the minimally invasive glaucoma surgery (MIGS) market: a tissue-sparing, implant-free approach versus alternatives that cut tissue, bypass pathways, or leave an implant behind. It’s a clear lens on how clinicians make choices when patient safety, outcomes, and simplicity all compete for attention.

On the numbers, we cover FY26 sales growth, expanding gross margins, and what positive EBITDA signals about operating leverage as the business scales. We also look at the market runway in the US, the logic behind FY27 guidance, and where international growth could come from next, including Europe and the longer-term potential of China.

If you care about ASX healthcare stocks, medtech commercial execution, or the future of glaucoma treatment, hit subscribe, share the episode with a mate, and leave us a review so more people can find ASX Briefs.

ASX Investment Opportunity - Michael Hill International Ltd (ASX:MHJ)

Gold prices keep pushing higher, currencies swing, and consumer spending stays selective, yet Michael Hill International is finding ways to grow. We’re joined by CEO Jonathan Waecker to talk through why he calls FY26 the beginning of a turnaround, not the end, and what has to be true for the market to trust the next phase. We get specific on the levers behind the numbers: same store sales growth across markets, stronger EBIT, lower net debt, and the push for sustainable momentum rather than a single strong year. 

We also unpack how a jewellery retailer defends gross margin when precious metals hit repeated record highs, and why Jonathan believes customers will still pay when value is clear. From there, we go market by market: Canada’s record performance and the way stores and e-commerce reinforce each other, Australia’s ability to lift sales and margin without needless discounting, and New Zealand’s rebound driven by sharper value and the right range across key categories like bridal, solid gold, and diamond fashion. 

The conversation turns to execution and focus. Jonathan explains the Bevilles reset, the decision to simplify the brand portfolio so more energy goes into the core Michael Hill brand, and the size of the online opportunity with digital penetration still well below global peers. We finish on capital allocation, transparency between constant currency and AUD reporting, and the single metric he most wants to move over the next 12 months: EBIT. 

If you found this useful, subscribe to ASX Briefs, share the episode with a mate who follows retail and the ASX, and leave a review with your take on what makes a turnaround truly stick.

ASX Investment Opportunity - Culpeo Minerals Ltd (ASX:CPO)

Two fresh IP anomalies, a four-kilometre copper-bearing structure, and a drill rig on the move across Chile, this chat is packed with near-term catalysts. We’re joined by Geoff McNamara, co-founder and Non-Executive Chair of Culpeo Minerals (ASX: CPO), to break down how a copper-focused explorer chooses targets that can realistically become an open-pit mine, not just an interesting hole on a map.

We start with Culpeo’s core strategy in Chile’s coastal cordillera, where infrastructure like roads, power and water can change the economics of discovery. Geoff explains the company’s “sweet spot”: aiming for around 100 million tonnes at 0.7% copper equivalent (CuEq) or better, at scales a modest company can develop. From there, we get specific on Fortuna, where extending historical induced polarisation (IP) lines has delivered two strong, close-to-surface anomalies: El Quillay North and the new El Quillay West. We talk about how surface copper, structure, and geophysics fit together when you’re trying to vector back to the source of a mineralised system.

The conversation then shifts to current fieldwork and what’s next. Geoff outlines drilling at El Quillay South targeting structurally enhanced zones for potentially wider copper and gold mineralisation, plus the broader geochemical work that helps unify the project-scale picture. The biggest headline is Lana Corina and Vista Montana: access is back, the rig is set to move, and a maiden drilling program is about to kick off at a target the team believes extends a system that previously returned 454 metres at 0.96% CuEq from surface. We also cover Culpeo’s landholding expansion and a funding approach built around options and upcoming news flow.

If you’re following ASX copper exploration, Chilean drill results, IP survey targets, or the path from discovery to resource, hit play, subscribe, and share the episode with a mate. If you enjoy it, leave a review and tell us what milestone you’re watching most closely.

A demerged gold company can look like “just another explorer” on day one, but the real story is whether it can execute like a developer. We’re joined by Brendan Tritton, Managing Director and CEO of Valiant Gold Limited, to talk through what’s changed since the separation from Westgold and why Valiant believes its brownfields gold projects in Western Australia’s Murchison region can support a near term production pathway.

We dig into the Comet restart in plain language: why Mako Mining is on site for dewatering and underground rehabilitation, what it meant to successfully re enter the Comet Underground Mine, and how the unexpectedly solid underground conditions could accelerate timelines. We also unpack the practical mine engineering work underway to shape an initial life of mine plan, built from prior operating designs rather than waiting on a long, traditional study cycle.

On the growth side, we cover the Reedy project’s standout diamond drilling at depth, what a strong intercept well below the current mineral resource estimate suggests about the system, and how upcoming assays may help tighten confidence and support resource conversion from inferred to indicated. Plus, we look at why a second rig is heading to the Boomerang deposit, and how that resource could underpin an open pit start with longer term underground optionality.

We finish with funding and valuation: Valiant’s quarter end cash position, how management prioritizes parallel workstreams, and why Brendan thinks the market still underappreciates the shift from explorer to developer. If you enjoy these ASX mining updates, subscribe, share the episode with a mate, and leave a review so more investors can find it.

A drug’s name can sound like a footnote, but it can be the key that unlocks global trust. We sit down with Dr Liz Dallimore, Managing Director and CEO of Argenica Therapeutics, to explain why the World Health Organization’s recognition of xaranetide (ARG-007) is a meaningful step as the company scales clinical and commercial engagement in neuroprotection.

From there, we get practical about what comes next: Argenica is finalising a late-stage clinical trial protocol in moderate to severe acute ischaemic stroke, and the approach is sharper than before. Liz walks us through how Phase 2 results changed once AI was applied to stroke imaging, revealing stronger efficacy in patients with more severe strokes and larger visible brain injury. We talk precision medicine, why AI imaging diagnostics are now common in hospitals, and how selecting the right patients can give a trial its best chance of showing a real benefit.

We also cover the FDA pathway, including the hERG cardiac safety assay, TNK interaction testing with a clot-dissolving standard-of-care drug, and additional genotoxicity work, plus why trial design and clinical workflow matter just as much as the molecule. Finally, Liz shares landmark pre-clinical data in repeated mild traumatic brain injury and concussion, where a single low dose showed lasting neuroprotection out to 11 days, and we touch on cash runway, grant support and near-term milestones.

If you care about stroke treatment innovation, AI in clinical trials, and where Australian biotech is heading next, listen in, share it with a mate, and leave a review to help more people find the show.

If a braking system can prevent incidents, cut maintenance, and even reduce emissions, why wouldn’t every mine be looking at it harder? We sit down again with Andrew Booth, Managing Director and CEO of Advanced Braking Technology (ASX: ABV), to unpack what’s driving the company’s momentum and where mining safety technology is heading next.

We talk through ABT’s safety-critical braking solutions designed and manufactured out of Western Australia, including the BrakeSAFE range built on its patented Sealed Integrated Braking System (SIBS). Andrew explains why mines across Australia, North America, Africa and Asia are focused on the same pressure points: safety, reliability, automation readiness and lifecycle cost. We also dig into the FY26 performance highlights, including record quarterly revenue, stronger profitability, and what improving gross margins can signal as an industrial technology business scales.

A big part of the story is what happens after the first sale. We explore how ABT’s growing installed base supports recurring aftermarket revenue through spares, consumables and service, plus the role refurbishment can play in extending asset life and supporting sustainability targets. Then we shift to BRAKEiQ, ABT’s autonomous braking initiative, and why moving from warning-based collision avoidance to active vehicle intervention could be a major step-change for existing fleets that already run proximity detection systems.

If you found this useful, subscribe to ASX Briefs, share the episode with a mate in mining or industrial tech, and leave us a review so more listeners can find the show.

Supply chains are tightening, export rules are shifting, and suddenly the “hard” parts of critical minerals projects matter more than the hype. We’re joined by Allister Caird, Managing Director and CEO of Mount Ridley Mines Limited, to unpack what’s happening at the Grass Patch project near Esperance in Western Australia and why Mount Ridley is betting hard on metallurgy to unlock a full critical mineral basket.

We talk through Mount Ridley’s strategy at Grass Patch, including the exploration upside across a tenement package that is still largely untouched, plus the push to secure downstream and metallurgical pathways early. Alastair explains why many rare earth elements projects succeed or fail in the processing plant, not the drill core, and how the company is trying to de-risk that with a proprietary in-house leach method called the Selectro™ Process.

Then we get into the numbers that turned heads: strong recoveries across heavy rare earth elements, light rare earth elements, scandium, and especially gallium, where a hydrochloric acid baseline returned zero but Selectro™ delivered meaningful recovery. We also dig into what a closed loop, recyclable reagent design could mean for project economics and environmental footprint, and why simpler flowsheets can be a competitive edge in hydrometallurgy.

Zooming out, we look at geopolitics and western supply chains for heavy rare earths, scandium alloys, and gallium, and how Mount Ridley is positioning through partnerships including CSIRO and US national laboratories. If you care about Australian critical minerals, rare earth processing, and what catalysts actually move a project towards development, this one’s for you. Subscribe, share the episode, leave a review, and tell us: which critical mineral do you think becomes the biggest bottleneck next?

A manganese discovery that drills like a seam, sits near surface, and may produce a saleable concentrate with simple separation is the kind of story that can move fast on the ASX. We’re joined by Brendan Cummins, Managing Director of Black Canyon Limited, to break down what’s emerging at Wandanya in the Pilbara region of Western Australia and why the market is paying attention to this high-grade manganese and iron ore pairing. 

We talk through the drilling campaign and what a near-90% hit rate suggests about continuity, thickness, and mining confidence, plus what the next RC program is trying to prove on the northern and southern extensions. Brendan also explains the thinking behind a large gravity survey designed to look deeper, asking the bigger geological question: where did the manganese-rich fluids come from, and could there be a second concealed system below what’s already been found? 

On the processing and product side, we dig into metallurgy results, including density-based separation producing manganese oxide concentrates above 40% Mn with strong recoveries, and why that matters for capex and operating costs. We also unpack iron ore test work pointing to a durable lump product and the commercial meaning of “direct ship ore”, where simpler crushing and screening can translate into a cleaner development pathway. 

We finish with the roadmap: the maiden mineral resource estimate, scoping study inputs, funding runway, and the catalysts investors should watch across the next 12 months. If you want more clear, jargon-free updates on Australian mining, exploration and development, subscribe, share this episode, and leave us a review.

Hydrogen is already everywhere in modern industry, but the hard part is making it clean, affordable and scalable without waiting for perfect conditions. We sit down with Glenn Corrie, Managing Director of Hazer Group Limited, to unpack how the proprietary Hazer Process aims to do exactly that: convert natural gas and other methane-rich gases into low emissions hydrogen while producing a valuable co-product, high quality graphite. It’s a practical decarbonisation conversation built for steel, ammonia, refining, power and other hard to abate sectors that can’t simply electrify overnight.

We dig into a major commercial milestone with KBR: a completed process design package for a 30,000 TPA hydrogen facility. Glenn explains why a standardised engineering design changes the tone of customer engagement, enabling serious technoeconomic work and clearer decisions on deployment. We also explore where demand is strongest right now across Australia, Asia, the Middle East and North America, and why energy security and supply chain resilience are now accelerating industrial decarbonisation plans.

Graphite becomes the surprise centre piece. Glenn details why graphite monetisation can transform project economics, how partnerships in South Australia could create real offtake pathways, and what independent purification to 99.99% purity could mean for battery and electrical applications in a world worried about critical mineral concentration. We finish with Hazer’s move into low carbon liquid fuels like sustainable aviation fuel, the importance of patents in Japan, and how a capex-light licensing model supports the shift from technology development to commercial execution.

If you like deep dives on Australian climate tech, clean hydrogen, sustainable aviation fuel and critical minerals, subscribe, share this with a mate, and leave us a review. What’s the biggest barrier you think industry needs to clear to adopt low emissions hydrogen at scale?

A single assay can spark attention, but patterns are what build conviction. We sit down with Sean Delaney, Managing Director of Olympio Metals Limited, to unpack how the company has evolved into a high grade-focused explorer chasing gold and silver across North America, and why its two key assets are starting to look like complementary growth engines rather than side quests. 

We start in Quebec at the Bousquet Gold Project on the Cadillac Break near Val-d’Or, where Olympio has already earned 51% and is working towards 80% through a staged earn-in that balances flexibility with committed exploration spend. Sean explains what the Phase 3 drilling at Paquin is showing so far, why consistent gold across holes matters as much as the headline numbers, and how the team thinks about the moment a project begins to feel like resource definition rather than pure exploration. We also talk sequencing: pending assays, structural mapping, surface geochemistry, and the practical push to generate new drill targets while the weather window is open. 

Then we head to Idaho for the newly acquired Jacknife Silver Project, a high grade polymetallic opportunity with patented mining claims at its core. Sean shares why that detail can change the approvals and execution pathway, how an old pre-43-101 silver figure and historic underground development adds confidence, and why having a local partner with rigs and core facilities helps speed up the path to drilling. We close on the Dufay divestment uplift, what it does for the balance sheet, and the key catalysts to watch over the next 12 months, including the company’s view on silver price upside. 

Subscribe to ASX Briefs, share this chat with a mate who follows ASX explorers, and leave a review if you want more straight, timely company updates.

A rewards business turning into a payments and credit platform is not a small pivot, and that’s exactly what we unpack with Alex Gold, CEO of Klevo Rewards Limited. We talk through how Klevo has evolved beyond loyalty into digital wallets, stablecoin payments, and card issuing, and why the Fly Wallet acquisition matters when you’re aiming to operate across multiple jurisdictions with real payments capability.

We also dig into the recent 14-day commercial trial of Klevo’s stablecoin transaction platform, including the headline US$1.22 million in gross revenue and, more importantly, what the trial was designed to prove. Alex explains the focus on the full transaction cycle, cross-border flows, and the compliance framework required to move from a working beta into a reliable commercial launch. If you care about stablecoin payments in Australia, cross-border payments infrastructure, or how fintechs actually scale, this part is packed with practical detail.

From there, we shift to licensing and product strategy. Alex walks us through why Klevo acquired an Australian credit licence (rather than waiting 9–12 months for a new application) to support credit card issuing and future credit products. We explore what “crypto-linked credit” might look like for customers, including using credit to acquire crypto or collateralising digital assets like Bitcoin for real-world spending. We also touch on custody and wholesale capability through the ASFIN acquisition, plus what investors can watch as revenue and rollout milestones develop.

Since the interview was recorded, Klevo has announced revenue of $18.9 million for the month of July 2026 — with approximately $17.8 million attributable to the stablecoin platform now in commercial operation — alongside completion of two licence acquisitions and an Extraordinary General Meeting convened for 21 August 2026 to consider a proposed share consolidation and company name change to Klevo Group Limited.

Subscribe to ASX Briefs, share this with a mate who follows ASX fintech, and leave a review with the question you want us to ask next.

If you’ve ever wondered what a modern media business looks like when it’s built to sell outcomes, not just impressions, this chat with Josh Simons from Vinyl Group Limited (ASX: VNL) lays it out in plain language. We talk through how Vinyl is wiring together trusted cultural publishing brands with music technology platforms to “connect culture with commerce”, and why that strategy is changing the way advertisers and creators can work with a single network.

Josh breaks down the two halves of the business: Vinyl Media’s portfolio of recognizable mastheads across music, entertainment, lifestyle and youth culture, plus a platform division that includes Vampr’s creator network, vinyl.com e-commerce, and Serenade music collectibles. We also tackle the Q4 headline numbers and the real story underneath them: acquisitions that completed late in the quarter, 60-day billing cycles, operating costs that start immediately, and a $4.1 million surplus working capital position that helps explain why revenue and cash receipts temporarily disconnect.

From there we look ahead to the operating leverage plan for FY27: consolidating duplicated systems, integrating commercial teams, and embedding an AI first operating strategy that speeds up research, transcription, metadata, audience intelligence and campaign activation without replacing journalists. We also cover the centralised content management system rollout, why it improves site performance, SEO and security, and how new products like Vinyl Shelf and Workshop by Vampr aim to turn discovery into commerce. Guidance of more than $7 million in Q1 customer receipts and $38 to $40 million in FY27 revenue frames the target, but the focus stays on revenue quality and sustainable cash profitability.

Subscribe to ASX Briefs, share this episode with someone who follows Australian media and tech, and leave us a review with your biggest question about Vinyl’s path to profit.

$5 is enough to start investing, but the real question is what happens after that first deposit. We’re joined by Craig Keary, CEO of Raiz Invest Limited, to break down how an ASX listed micro investing pioneer is evolving into a broader wealth platform built for everyday Australians and the habits that make investing feel doable in real life, not just in theory.

We dig into the numbers behind the momentum: active customers growing to more than 350,000, ARPU lifting year on year, and average account balances pushing higher as markets rise and customers stay engaged. Craig walks us through the platform’s growing funds under management, including the standout performance of Jars portfolios and Kids accounts. It’s a sharp lens on what Australians are prioritising right now: goal-based saving and investing, and families helping younger people get started early, especially in a cost-of-living environment where every decision needs to count.

Superannuation also features as a core part of the proposition, with Raiz Invest Super earning strong recognition for performance and value. From there, we look forward to the FY27 product roadmap, including instant payments for live trading, access to US listed equities, and direct ASX trading through a single HIN. Craig also shares why the company is renewing its focus on acquisition, onboarding, conversion and activation, how AI capabilities and partnerships may support that push, and why “ambition” is the cultural anchor he wants driving disciplined execution.

If you’re interested in investing apps in Australia, wealth building, superannuation, and what to watch in ASX fintech, this conversation is packed with practical signals. Subscribe for more ASX Briefs, share this with a mate who’s trying to get on top of their money, and leave a review to help others find the show.

QuickFee is not trying to be everything to everyone. We’re talking about a focused ASX listed finance company that helps accounting and law firm clients pay fees on time, while giving those clients up to 12 months to repay. Founder and CEO Bruce Coombes joins us to explain how that simple working capital product translates into growth when distribution and partnerships click.

We dig into the quarter’s split story: strong momentum in Australia alongside a reset in the US. Bruce walks us through the lift in Australian finance total transaction value and the surge in legal disbursement funding, pointing to a sustained push into commercial law firms plus targeted efforts in the personal injury market that landed major new firms. If you follow specialty finance, fintech, or professional services payments, you’ll hear exactly what’s driving volumes rather than vague market talk.

On the US side, we cover the impact of exiting business units and the delayed embedding of QuickFee’s finance offering into Aiwyn’s payment solutions, now expected around December 2026. We also explore the potential upside once that integration goes live, given Aiwyn’s reach into top US CPA firms and the implied total addressable market. To round it out, we break down net interest margin, why pricing can be resilient, and how RBA, BBSW, and Fed rate moves can still shape the cost of funds.

If you want a clear view of QuickFee’s strategy, risks, and FY27 catalysts, hit play. Subscribe, share the episode with a mate who follows ASX growth stories, and leave us a review so more investors can find the show.

China pours more cement than any other country on earth and even a tiny share of that market can reshape a small materials company’s future. We sit down with Michael Bell, CEO of First Graphene, to unpack what it really takes to commercialise graphene at scale, not in a lab, but in customer products that ship, perform, and reorder.

We start with the fundamentals: what graphene is, why it behaves differently across suppliers, and why First Graphene’s early decision to build manufacturing capacity in Western Australia now pays off. With an established 100 tonne per year production platform, the conversation shifts to demand generation, customer conversion, and a pipeline that spans composites, polymers, conductive and thermal applications, and protective coatings.

Then we go deep on cement and concrete through PureGRAPH® CEM, where strength gains and durability improvements intersect with a decarbonisation story. Michael explains how lowering the clinker factor can cut CO2 emissions at scale, and why UK progress creates a springboard into bigger markets. That leads to the new MOU with Sixth Element, a major Chinese distributor in the 2D materials space, designed to validate and take PureGRAPH® CEM into the Chinese cement market with a partner-led approach.

We also cover the settled MITO® acquisition, what functionalised graphene oxide adds to the product portfolio, and why a real US footprint matters for aerospace and defence opportunities. If you care about advanced materials, construction innovation, and the practical path to revenue, this one is for you. Subscribe, share the episode with a mate, and leave a review so more people can find the show.

A single scientific insight can open up an entire pipeline, and that’s what makes this conversation with Noxopharm Limited so compelling. We’re joined by CEO Olivier Laczka to talk about Sofra™, the company’s RNA technology platform built on a breakthrough discovery about how the immune system triggers inflammation, developed alongside the Hudson Institute of Medical Research in Melbourne and published in a leading journal. If you care about where ASX biotech is heading, this is a clear look at how platform science turns into real drug programs.

We dig into SOF-SKN™, Noxopharm’s lead asset aimed at cutaneous lupus, a skin disease with a growing global market and no specific designed treatments. Olivier explains why a topical cream that blocks lupus-linked inflammation could be a meaningful shift for patients, and he shares the latest progress including a completed safety trial in healthy volunteers and the practical next step of moving into a trial with lupus patients. We also touch on how the same approach could expand into broader inflammatory skin diseases and chronic conditions where inflammation drives long-term damage.

Then we move into immuno-oncology, where Sofra™ isn’t used to dampen inflammation but to deliberately boost targeted immune activation for cancer treatment. Olivier walks us through newly released breakthrough data, including a 200-fold increase in immune activation when combined with a clinical stage TLR8 agonist in human skin biopsies ex vivo, plus supportive animal model results, and why IP protection and US patents matter when scaling a platform globally. Finally, we cover validation through an Australian Government MRFF grant linked to pelvic floor disorders and birth injury repair, and the key 6 to 12 month milestones investors watch: manufacturing, FDA engagement for IND preparation, cancer program progress, and growing international partnerships.

If you enjoyed this deep dive into RNA therapeutics, inflammation research, and clinical stage biotech execution, subscribe, share the episode with a mate, and leave a review to help more listeners find the show.

A lung scan can do more than show a shadow on an image. We sit down with Dr Andreas Fouras, MD, CEO and founder of 4DMedical, to talk about the shift from “how the lung looks” to “how the lung works” and why functional lung imaging is becoming a commercial reality across Australia, Europe and the United States.

We dig into the binding agreement to acquire Austria’s contextflow and why an established Vienna-based team with existing insurance reimbursement contracts in Germany can beat a slow greenfield build. Andreas explains the uncomfortable truth in medtech: FDA clearance and CE marking open doors, but reimbursement is what builds a durable business. We also explore how adding AI lung cancer screening and workflow tools complements CT:VQ™  and CT:VQ™ , creating a fuller clinical pathway from screening through to functional assessment and procedure planning.

Closer to home, we cover the TGA approval and ARTG inclusion for CT:VQ™   and why Australia’s high CT scanner density makes a software-only, non-contrast solution so compelling. From there we head to the US, looking at adoption at leading sites and the commercial meaning of the SimonMed Imaging agreement across 170 outpatient centres, including the value of health economics data for payer conversations. If you want a clear view of what to watch through 2026, we outline the practical metrics that matter: site wins, network progress and the scan volumes that drive SaaS revenue. Subscribe, share the episode with a mate, and leave a review to help more listeners find ASX Briefs.

Six times lower capture antibody usage and faster activation sounds like a marketing claim until you unpack what it does to cost, workflow, and test performance. We sit down with Merrill Gray, Managing Director and CEO of AnteoTech Limited (ASX: ADO), to explain how AnteoTech’s chemical and materials science platform improves molecule-to-surface bonding and why that matters in modern immunoassays and precision diagnostics.

We walk through AnteoTech’s move into CLIA diagnostics, including the successful completion of an initial stage in a collaborative CLIA development program with a large global life sciences company and the next stage already agreed. Merrill breaks down the practical value of superior antibody orientation on magnetic beads, and why reproducibility and sensitivity are the difference between a promising chemistry and a deployable in vitro diagnostics solution. We also discuss the upcoming ADLM 2026 launch of a ready-to-use CLIA kit that bundles magnetic beads, AnteoBind™ NXT , and optimised activation protocols, plus what “moving up the value chain” looks like when your customers range from vaccine R&D teams to pathology and research labs.

Then we pivot to advanced battery technology, where the same platform shows up as performance additives and materials choices that target real manufacturing constraints. You’ll hear how Anteo C progressed from 100 mL lab work to a 20-litre sample shipped for manufacturing scale trials in South Korea, why primer coatings on copper foil and aluminium foil matter for electrode performance, and how separator integrity links to safety and thermal runaway risk. We close on what to watch over the next six months, including regional go-to-market choices and progress on Ultranode™  high-silicon anode work aimed at high-power battery packs. If you find value here, subscribe, share the episode, and leave a review so more investors and builders can discover it.

We’re joined by Philippa Lewis, Chair and CEO of Imunexus Therapeutics, to break down a protein engineering platform that aims to “turbocharge” existing biologics like monoclonal antibodies, enzyme therapies, and even cell therapies. The idea is modular: attach small human protein components that can add new targeting, adjust immune activity, extend half-life, or enable multi-pathway action, while keeping the parent drug’s core function and manufacturability intact. For anyone tracking biotech innovation and the ASX biotech IPO pipeline, this is a clear look at how platform companies try to build repeatable value.

We also get into the business case hiding in plain sight: more than 100 FDA-approved monoclonal antibody drugs exist, and many are now off-patent. Imunexus argues that enhancing validated medicines can deliver differentiated next-generation biologics plus new intellectual property, giving pharma a way to refresh valuable assets as biosimilar competition grows. We talk partnering and licensing dynamics, why early preclinical deals can be meaningful, and what “capital-efficient” development looks like when you’re designing trials to generate fast, decision-grade data.

On the science side, the focus lands on IMX39 for multiple sclerosis, a market measured in the tens of billions of US dollars. Beyond relapse control, the discussion centres on progression, remyelination, and the possibility of repairing nerve damage, supported by preclinical results and a planned path to first-in-human studies in Australia under the TGA. We then zoom out to the wider pipeline, including IMX101 for small cell lung cancer, IMX113 for Gaucher disease with half-life extension, and a regenerative medicine angle for stem cell therapy enhancement.

If you found this useful, subscribe to ASX Briefs, share the episode with a mate who follows biotech, and leave a review with the one question you want answered next.

A single drill intercept can change the whole story, especially when it challenges the idea that a deposit should “pinch out” with depth. We’re joined by Tim Fraser, General Manager at Evergold Minerals Limited, to break down what’s happening at the Mount Monger gold project in Western Australia and why the latest result at Duchess of York (22 metres at 1.8 g/t gold) is such a meaningful confidence boost for the geological model and the next phase of drilling.

We talk through how Evergold’s understanding of Mount Monga has evolved after a full quarter of gravity surveys, soil geochemistry, and mapping. Tim explains why the team is now thinking beyond shallow resource potential, and how modern datasets like 3D gravity and drone magnetics can reveal a larger mineralised system hiding in plain sight. If you’re interested in ASX gold exploration, targeting strategy, and how technical work translates into investor catalysts, this is a clear look at the decision-making behind the scenes.

The conversation goes deeper on the Gladiator prospect and the sanukitoid intrusion model, described simply as the engine, the plumbing, and the trap. We unpack what that means in the field, why coincident soil anomalies and gravity features matter, and what the upcoming aircore drilling is designed to prove. We also cover Evergold’s growing Leonora Goldfields footprint, including the Randwick Tenements, and how the company is thinking about funding, discipline, and sequencing exploration alongside longer-term development goals like Craig’s Rest.

Subscribe to ASX Briefs, share this with a mate who follows WA gold, and leave a review if you want more straight-talking updates on drilling results, discovery models, and what to watch next.

A defence supply chain crunch is forcing a rethink: what if you could manufacture certified metal parts closer to the shipyard, the depot, or even the operational edge, instead of waiting on long, fragile supplier queues? We sit down with Sean Ebert, CEO of AML3D Limited, to unpack how large-scale additive manufacturing and 3D metal printing are being put to work right now, not as a prototype, but as an operational capability.

We explore what AML3D actually does, from combining arc welding, metallurgical science, and software to produce industrial grade parts using wire feedstock, through to why open-air, large-format printing can matter for defence, aerospace, and oil and gas. Sean explains the significance of  ARCEMY® systems becoming operational at Newport News Shipbuilding, one of the biggest players in US naval construction, and what it means to be embedded in a vessel’s supply chain over its life. We also talk about the promise of faster delivery, including the claim of parts produced up to 75% faster than traditional manufacturing, and where that speed genuinely changes outcomes.

From there we get practical about scaling: doubling the Ohio facility, expanding production capacity, and balancing system builds with parts manufacturing. We also dig into one of the most compelling “point of need” stories, a fully containerised  ARCEMY® system built into a 20-foot shipping container at the US Navy Additive Manufacturing Center of Excellence in Danville with Austal USA, plus the real-world constraints like post-print machining and non-destructive testing.

If AUKUS and advanced manufacturing are on your radar, you’ll hear why AML3D sees itself positioned across Australia, the UK, and the US for both new build and sustainment work. Subscribe for more ASX-focused interviews, share this with a mate who follows defence tech, and leave a review with your biggest question about additive manufacturing.

MSA is rare, relentless, and too often diagnosed only after the most obvious neurological symptoms arrive. We’re joined by David Stamler, Managing Director and CEO of Alterity Therapeutics, to explain what multiple system atrophy can look like from the first vague signs through to rapid loss of mobility, and why symptomatic treatments leave such a large unmet need. 

We talk through the phase two signal for ATH434, including what “48% slowing” on the MSA rating scale could translate to in everyday life, from walking and balance to tasks like dressing and eating, plus the importance of swallowing outcomes and orthostatic hypotension symptoms. David also shares how ATH434 is designed to work as an iron chaperone, why iron biology matters in neurodegenerative disease, and how new endpoints like digital biomarkers can track real-world walking with wearable sensors. 

A major focus is the regulatory path: Alterity’s alignment with the US FDA at the end of phase two meeting, why it de-risks the program, and what the agreed phase three clinical trial design looks like. We cover the practical steps still required before first patient enrolment, the expected timeline to results, what larger partners look for in a program like this, and how manufacturing and patent strategy support longer-term value. 

If you care about biotech, clinical trials, and the hunt for disease-modifying treatments in neurodegeneration, listen now and share this with someone following MSA research. Subscribe, leave a review, and tell us what question you want answered next.

Cement and steel making doesn't just burn fuel, CO₂ is also released as part of the process. That’s why industrial decarbonisation is so hard, and why a “just electrify it” slogan falls short once you get into kilns, furnaces, and process emissions. We’re joined by Phil Hodgson, Managing Director and CEO of Calix Limited, to break down an Australian-developed platform technology designed to change the way heavy industry heats and processes materials.

We talk through Calix’s core technology: an externally heated steel tube kiln that keeps combustion and process gases separate. For cement and lime, that matters because limestone is nearly half CO₂ by weight. By preventing gases from mixing, Leilac Technology can deliver a relatively pure CO₂ stream, making carbon capture simpler and helping chart a path to low emissions cement. Phil also explains why hybrid heating is central to commercial adoption, switching between renewable electricity, conventional fuels, or waste fuels to stay cost-effective even where carbon pricing and policy support are not available.

From there we dig into real-world strategy: the restructure of the PLS lithium midstream joint venture toward a capital-light licensing model, the major joint development agreement with Adani Group’s Ambuja Cements, and what India’s rapid cement expansion could unlock across Asia. We also look beyond cement to green iron and steel using hydrogen (Zesty), alumina progress with Norsk Hydro, and how Calix’s magnesia water treatment business helps fund broader growth.

If you care about climate technology, clean industry, carbon capture, electrified kilns, and how ASX-listed innovators try to scale in tough markets, this conversation is for you. Subscribe to ASX Briefs, share the episode with a mate in resources or climate, and leave a review with your biggest takeaway.

Silica dust does not care about good intentions, and neither do regulators. We sit down with Gabrielle O’Carroll, CEO of Sydney-based CleanSpace Holdings Ltd, to unpack how respiratory protection is evolving as workplaces face tighter exposure limits, stronger enforcement, and rising expectations across mining, construction, quarrying and manufacturing.

We start with the core problem: workers are exposed to hazardous airborne particles every day, yet traditional protection can be uncomfortable, awkward, and inconsistent in real-world use. Gabrielle explains why CleanSpace designs powered air purifying respirators (PAPR) that people actually want to wear, and how better comfort and fit can lift compliance and improve health outcomes over time. We also talk about the regulatory tailwinds in Australia, Europe and North America, including the impact of respirable crystalline silica limits and the public attention sparked by Australia’s engineered stone ban.

Then we get specific on CleanSpace Agile, described as the world’s first loose fitting PAPR with patented AirSensit® technology that senses breathing demand and adjusts airflow in real time. We explore why the form factor matters, how ditching hoods, belts and hoses can change day-to-day usability, and why loose fitting protection helps employers manage fit testing burdens and clean-shaven policies. Finally, we dig into EN 12941 certification for Europe, the fast follow ANZ certification, the distribution ramp, the R&D roadmap, and what milestones may signal commercial traction into FY27.

If you care about workplace safety tech, industrial PPE, or ASX-listed growth stories, listen now, then subscribe, share the episode with a mate, and leave a review so more people can find ASX Briefs.

A security monitoring business doesn’t grow a $63.2m secured installation pipeline by accident, so we sat down with Dennison Hambling, Managing Director of Intelligent Monitoring Group (IMG), to understand what’s really driving the momentum. We talk candidly about why large enterprises across Australia and New Zealand are increasingly choosing a single national provider for electronic security, fire protection, and monitoring, and how IMG is rebuilding that “one trusted partner” position as the industry stays highly fragmented.

We dig into the numbers behind the story, including operating cash flow and what Dennison calls improving earnings quality, plus the seasonality that can make quarter-to-quarter comparisons tricky. Dennison also shares how the company’s balance sheet journey and legacy tax losses influence capital allocation, and why he wants dividends to be sustainable when they arrive, not just symbolic.

A big segment focuses on the completed acquisition of Blue Sky Hold Co, including Wormald New Zealand (Tyco NZ) and Red Wolf Security. We unpack what these businesses do, how they strengthen IMG’s New Zealand footprint to more than 500 people across 12 locations, and why national coverage matters when serving government and large multi-site customers. We also explore why prior alignment within the Johnson Controls ecosystem can reduce integration risk and simplify the transition.

Then we zoom out to the technology shift: Video Guard and AI-powered video monitoring. Dennison explains how “threat assessment” changes the old alarm response model, why New Zealand is earlier in adoption than Australia, and how monitored video can expand the addressable market by competing with guarding and patrols while making real security more affordable.

If you care about security industry trends, ASX growth stories, or the practical realities of scaling a services business across Australasia, hit play now. Subscribe, share the episode with a mate, and leave a review so more people can find the show.

A marketplace can tell you more about the economy than a headline number, especially when thousands of everyday jobs are priced in real time. We sit down with Tim Fung to break down Airtasker’s Q3 performance and what’s really driving momentum in Australia: rising job volumes, strong completion rates, and an uplift in average task prices that reflects both demand and the cost-of-living squeeze pushing more people to earn on-platform. We also talk candidly about what’s next as consumer sentiment darkens and interest rate settings start to bite.

From there, we zoom out to the brand battle. Airtasker’s focus is simple: when a roof leaks, a tap drips, or IKEA furniture needs assembling, we want Airtasker to be the first name people think of. We unpack the strategic media partnership with Nine Entertainment and how it complements other channels to lift unprompted brand awareness, while also using the balance sheet in a disciplined way through delayed settlement structures.

Internationally, the story splits in two. The UK approaches a scale point where the marketplace can become cash generative quickly with low fixed costs, while the US remains in build mode, investing to strengthen network effects. We also cover the newer membership product, designed to lift frequency and create sticky recurring revenue through an annual fee and added credits. If you care about the gig economy, marketplace growth, ASX tech, and how pricing power shows up in the real world, this one is packed with signal. Subscribe, share it with a mate, and leave a review so more people can find the show.

“Recycled” sounds simple until you ask one awkward question: what exactly was recycled to make this product? We’re joined by Marie De Perthuis, CEO of MyEco Group Limited, to talk about how sustainable packaging earns trust when greenwashing is everywhere and shoppers are time-poor at the shelf.

We get a clear view of MyEco Group’s model: a Melbourne-based brand with manufacturing and R&D capability that supports traceability from resin to finished goods. Marie explains why third-party certification (including GRS for post-consumer recycled materials) is more than a logo. It’s how retailers and consumers separate credible recycled content from vague claims, and how a category lifts its standards without asking shoppers to do forensic research.

We also dive into growth drivers across two big channels. On the retail side, the new GRS certified post-consumer recycled bin liner range launching at Woolworths marks a major step beyond compostables and into a much larger market that directly competes with virgin plastic. On the council side, we unpack FOGO rollouts, tender wins, and why organics diversion, contamination reduction and landfill pressure are pushing councils to act sooner rather than later.

If you care about sustainable packaging in Australia, compostable caddy liners, soft plastic recycling, or what “real” recycled content looks like at scale, this conversation delivers practical detail and a straightforward checklist for cutting through the noise. Subscribe, share the episode with a mate, and leave a review, then tell us: what do you look for before you trust a sustainability claim?

A small ASX biotech can feel impossible to value until the data starts landing, and that’s exactly where Syntara is headed. We’re joined by CEO Gary Phillips to map out a tight run of clinical catalysts and the thinking behind a pipeline built around extracellular matrix dysfunction and amine oxidase chemistry, backed by specialist institutional investors and real in-house drug discovery.

We dig into Amsulostat, the lead program in myelofibrosis, and what positive FDA feedback actually means in practice: a clearer regulatory development pathway, a Phase 2B add-on design against placebo alongside JAK inhibitor standard of care, and stronger footing for potential partnering conversations in hematology and oncology. Gary also explains why safety and symptom score improvements matter so much at this stage, especially in diseases where current options can be hard to tolerate.

From there we switch gears into two more high-interest areas. In myelodysplastic syndrome (MDS), we cover the unmet need, the significance of grant-backed trials in Germany and Australia, and why indication expansion can materially lift an asset’s commercial upside. We also explore SNT 4728 in isolated REM sleep behavior disorder (IRBD), a sleep condition that can precede Parkinson’s disease, and how a placebo-controlled study funded by Parkinson’s UK uses brain imaging to look for reduced inflammation. Finally, we talk skin scarring, including hypertrophic and keloid scars, why function and mental health outcomes matter, and what a once-daily topical approach could mean if results stack up.

If you follow ASX biotech, clinical trials, FDA pathways, or early signals in Parkinson’s research, this chat is built for your watchlist. Subscribe, share the episode with a mate who tracks biotech's, and leave us a review so more people can find the show.

A medical device can be brilliantly engineered and still fail for one simple reason: it never makes it from regulatory clearance to routine use in hospitals. We talk with Paul Anderson, CEO and Managing Director of Orthocell Limited, about how his team is trying to close that gap with a collagen-based regenerative medicine platform designed to support repair of bone, nerve and tendon injuries, and why their nerve product Remplir is now the commercial focus. 

We unpack the growth story behind recent revenue momentum, starting with a successful Australian launch where Remplir is widely used and reimbursed, then moving into the US where the opportunity is huge and the work is relentless. Paul explains the hybrid commercial model, how surgeon training really happens, and why adoption often comes in waves as clinicians build confidence case by case. We also get specific about the unglamorous but decisive step in US market access: Value Analysis Committee approvals, and how building a pipeline of VAC submissions can turn a hospital “yes” into real purchasing and repeat use. 

Clinical proof sits at the centre of everything. We discuss the importance of real-world evidence, what a strong post-market dataset signals to surgeons and payers, and how that evidence supports upcoming EU and UK regulatory submissions. The conversation also explores the defence channel, including approvals across US military medical centres and what real-world use in complex trauma settings can do for credibility. If you care about ASX healthcare growth, medical device commercialisation, nerve repair innovation, and the practical realities of scaling in the US, UK and Europe, this one is for you. 

Subscribe for more ASX Briefs conversations, share the episode with a mate, and leave a review with the one question you still have after listening.

A kids smartwatch can be a solid business. A family safety platform that telcos can deploy to millions of customers is a very different ambition, and that’s what we explore with Simon Crowther, CEO and Managing Director of Spacetalk Limited (ASX: SPA).

We start with the core product that built the Spacetalk brand: a kids safety smartwatch that gives parents peace of mind through location features and a locked-down contact experience, without social media or a browser. Then we move into the real strategic shift, away from being device-led and towards being software-led and mobile-led, including a re-platforming to AWS designed to support scale in Australia and overseas.

Simon is candid about the November app launch and the data migration issues that followed, why the team chose a deliberate operational reset, and what “back on track” looks like in practice: falling support tickets, ongoing app updates, and new premium features on the way. We also unpack the metrics investors care about, including subscriber growth, mobile ARR, and how family safety features like content filtering can lift retention and extend customer lifetime value beyond the watch years into the first phone years.

From there, we dig into the commercial roadmap: cost savings, a push towards cash positive operations, and the opportunity in telco distribution. Simon explains the value proposition for partners like Vodafone and TPG, the idea of moving from a one-to-one telco customer relationship to a family dynamic, and why international interest is building across Europe and beyond alongside CY26 ARR guidance of $20m to $25m.

Subscribe for more ASX company insights, share this episode with a mate who follows small caps, and leave a review with your biggest takeaway. What part of Spacetalk’s pivot matters most to you: platform stability, family safety software, or telco scale?

The EV battery revolution isn’t just about who sells the most cars, it’s about who controls the materials that make batteries cheaper, safer, and easier to source. I’m joined by Ron Mitchell, CEO of Firebird Metals, to talk about a different kind of advantage: taking manganese concentrate and turning it into high value battery materials in a single integrated processing circuit, rather than shipping intermediates across a fragmented, multi-country supply chain. If you care about Australian critical minerals, battery materials, and the future of energy storage, this conversation is packed with practical detail.

We walk through Firebird’s “concentrate to cathode” approach, including high purity manganese sulphate production and why that product is such a strategic pinch point outside China. Ron explains why manganese is attracting serious attention as battery makers chase the holy grail of lower dollars per kilowatt hour, and how LMFP (lithium manganese iron phosphate) is emerging as a compelling evolution of LFP chemistry. We also dig into what “lithium manganese rich” (LMR) means, why it can reduce reliance on high nickel cathodes, and why Western OEMs are watching closely.

From there, we get into the moat-building pieces: Firebird’s exclusive LMFP patent licence through to May 2045, the commercialisation pathway that leans capital-light through partnering and licensing, and the importance of proving the technology in a Western setting via a demonstration plant near the Perth CBD. Ron also shares what it means to secure an ARENA Battery Breakthrough Initiative grant, and what shareholders should watch for across 2026 as equipment lands, commissioning ramps up, and new IP is lodged.

Subscribe for more conversations on ASX-listed innovators, share this with a mate who follows EVs and critical minerals, and leave a review to help others find the show. What do you think matters more right now: battery chemistry breakthroughs or supply chain sovereignty?

Mine sites are drowning in tasks that are repetitive, risky, and time-heavy, yet the real value sits on the other side of the work: clean data that helps people make faster calls. We chat with Chris Clark, Managing Director and CEO of RocketDNA Limited, about how AI-driven autonomous drones are taking on aerial surveying, security and surveillance, and asset inspection for Tier 1 mining customers across Australia and Africa and what that means when the output is trusted enough to drive day-to-day decisions.

We break down RocketDNA’s latest momentum, including revenue growth and the milestone of first positive operating cash flow, and why management keeps coming back to recurring revenue as the foundation for a scalable ASX microcap business. Chris explains how the xBot® solution brings together autonomous drone hardware, remote operations, and two key software layers: the SiteTube visualisation platform and Skylink®, RocketDNA’s proprietary operating system for managing autonomous drone fleets at enterprise level.

Skylink® is where the conversation gets practical: access control, scheduling, demand planning, maintenance oversight, and the jump from running a handful of drones to operating fleets across multiple sites. We also dig into the leading indicators that show whether a platform is becoming “sticky” including flight mission growth and active software users and why land-and-expand economics can beat constant greenfield chasing when customers keep ordering more units to meet demand.

If you care about autonomous drone technology, mining digitisation, and the shift from hardware projects to software-backed recurring revenue, this one is for you. Subscribe, share it with a mate in resources or tech, and leave us a review, then tell us: where do you think autonomous drones deliver the biggest productivity win first?

A fintech business can grow fast, but growing efficiently is the real test. We sit down with Mark Waller, Managing Director of One Click Group Limited, for a clear update on how One Click Life is scaling as a financial life admin app for Australians. Mark walks us through the company’s FY2025 performance, including record revenue of $6.1 million and its first underlying EBITDA profit, and why that profitability milestone changes what’s possible when it comes to funding marketing and expanding the product suite.

We also get practical about the operating model: how One Click keeps fixed operating costs largely steady while the user base climbs, and how a shift toward organic growth channels is lowering user acquisition costs. Mark explains what’s driving engagement outside the traditional tax season, and why adding more services creates multiple paths to market instead of relying on a single product cycle. If you follow ASX fintech stocks, unit economics, or scalable software platforms, there’s plenty here to consider.

From there we explore product expansion across online tax returns, wills, insurance, lending, and the Little Money cash advance product, designed to meet year round demand for short term liquidity. We also unpack One Click Super, built and awaiting trustee approval, with a focus on helping younger users consolidate and manage superannuation in one place. To finish, Mark shares what success looks like through 2026 from both a shareholder and customer lens, and how automation and API integration help deliver a smoother experience at scale.

If you found value here, subscribe, share the episode with a mate, and leave a review. What would you most want to manage in one app: tax, super, or day to day cash flow?

A thin, high-grade reef can be impressive on paper, but it can also be hard to mine at scale. That’s why we sit down with GreenTech Metals CEO James Rattenbury to talk about a different way to view the Munni Munni platinum group metals system in Western Australia’s West Pilbara: not just the reef, but the wider mineralised zones around it that bring copper and nickel into the story.

We walk through what Green Tech Metals is building across a dominant regional footprint, anchored by two projects only about 10 kilometres apart: Munni Munni (PGE with base metals potential) and Whundo (a high-grade copper-zinc VMS asset with overlooked gold). James explains why commodity prices, mining methods, and development benchmarks have shifted since earlier studies, and how that changes what “historic” data can be worth today. We also unpack the practical work underway, including drilling, resampling preserved legacy core, and QA/QC designed to support a JORC 2012 mineral resource estimate targeted for the June quarter.

From there, we look ahead to the 2026 catalyst timeline: Money Money’s re-estimated resource in late June, Whundo’s update by August, drilling news flow from June, and the metallurgical test work needed to confirm a simple concentrate pathway with meaningful PGE credits. If you follow ASX mining, critical minerals, platinum group metals, copper, nickel, and WA exploration, this conversation maps the milestones that could drive a re-rate.

Subscribe for more ASX Briefs, share this episode with a mate who follows resources, and leave a review so more listeners can find the show.

One obscure material is quietly doing heavy lifting across the modern economy: high purity alumina (HPA). From LED lighting to semiconductor manufacturing to the thermal management challenges inside fast-growing data centres, HPA shows up where heat and chemical stability can’t be left to chance. We sit down with Dr Mike Jones, Managing Director of Impact Minerals, to break down what HPA actually is, why it often becomes artificial sapphire, and why demand growth is catching investors’ attention.

We then move from the big picture to the execution plan at the Lake Hope HPA project in Western Australia. Mike explains the practical mining concept on a salt lake, the logistics of moving clay feedstock to Perth, and how the Alluminous processing technology changes the commercial timeline. With a pilot plant progressing from batch toward continuous operation, plus a specialised analytical lab to control impurities, the focus turns to throughput, product consistency, and what it takes to qualify HPA for battery and technology customers, including early test work with a US battery technology company.

There’s more optionality on the table too. We unpack a separate flowsheet that targets sulfate of potash (SOP) fertiliser and hydrochloric acid from lake clays around Salmon Gums, and why location matters for both agricultural demand and WA goldfields consumption. Finally, we hit the exploration leverage: high-grade gold and silver results at the Commonwealth VMS project with Kuniko’s drilling ramping up, plus Impact’s large Broken Hill ground position and a compelling magnetotelluric conductor target lined up for future drilling.

If you want clear, investor-focused context on Impact Minerals, Lake Hope, HPA processing, SOP fertiliser, Commonwealth drilling, and Broken Hill targeting, hit play, subscribe, share the episode with a mate, and leave a review so more people can find the show.

A rare earth project that aims to get to production without crushers, grinding circuits, or a high-cost processing maze gets our attention fast. We sit down again with Andrew Reid, Managing Director of Brazilian Critical Minerals (ASX: BCM), to unpack the Ema ionic adsorption clay deposit in Brazil and why in situ recovery (ISR) could be a genuine cost and schedule advantage for a new Western rare earth supply source.

We walk through the latest drilling at Ema and what it says about scale and consistency, alongside the updated mineral resource estimate that underpins the move toward a bankable feasibility study (BFS). Andrew explains the vertical profile many clay deposits show, including enrichment toward the base of the clay, and why Ema’s rare earth mix stands out. We also dig into the commercial reality of rare earths: buyers care about the basket, so discussions around neodymium praseodymium and the presence of heavies like dysprosium and terbium can shape offtake interest and downstream pathways.

From there, we get practical on execution risk. Andrew shares where the BFS work is focused now, why BCM is doing capital cost estimation in-country in Brazil, and how sourcing standard equipment locally can support credibility. We also cover BCM’s collaboration agreement with an established ISR operator and the strategic tailwinds Andrew is seeing in US-facing conversations about critical minerals and rare earth supply chain security.

If you’re tracking ASX rare earth stocks, Brazilian critical minerals, or the path from feasibility to financing, this is a grounded look at what matters next: BFS completion, permitting, offtake, and bankable project funding. Subscribe, share the episode with a mate who follows rare earths, and leave a review with the key risk or catalyst you think will decide the outcome.

A pen-sized microscope that can see living tissue in real time sounds like science fiction, but it’s exactly what Optiscan Imaging Limited is building. We welcome back Dr Camile Farah to talk through the company’s confocal laser endomicroscopy platform and why real-time digital pathology could change the way surgery, cancer care, and veterinary medicine make decisions at the point of care.

We dig into Optiscan’s latest regulatory milestone: the US FDA dossier submission for InSpecta®, a portable veterinary imaging device designed for clinic and field use. Camile explains why the US market matters so much, why veterinary is a smart entry point with a lower barrier than human healthcare, and how that step can de-risk the broader FDA pathway. If you’re tracking ASX medical device stories, this is a clear look at how regulatory strategy links directly to commercial readiness and revenue timing.

From there, we move to human health and a world-first in-human head and neck cancer imaging study at St John of God Murdoch Hospital, combining the InVue® precision surgery device with the InForm® Digital Pathology Platform. The core promise is simple and powerful: help surgeons and pathologists assess margins and tissue features in real time, cutting down the anxious wait for lab reports and reducing the risk of a second surgery. We also cover the partnership with Australian Clinical Labs and how telepathology streaming could enable fast expert reads across distance, much like teleradiology did for medical imaging.

If you want practical insight into real-time pathology, telepathology, FDA submissions, and the commercial triggers ahead, listen now. Subscribe to ASX Briefs, share the episode with a colleague, and leave a review with your biggest question about live microscopic imaging in theatre.

A product can be ready for the world and still be held back by one thing: how regulators choose to classify it. We sit down again with Dr Peter Molloy, Executive Chairman of Firebrick Pharma, to unpack the company’s shift from R&D to commercial execution and why a single regulatory milestone in Indonesia changes the scale of the Nasodine opportunity.

Peter walks us through the origin story that starts with Betadine and leads to Nasodine, a povidone-iodine nasal spray designed to target the viral cause of the common cold using a topical antiseptic approach. We dig into why povidone-iodine remains compelling after decades of use, how low concentrations can still be potent, and why the “no resistance” profile matters when consumers are surrounded by symptom-only OTC options. Just as importantly, we talk about the practical reality for ASX health companies: Australia’s TGA can treat products like Nasodine as a drug, while markets such as Singapore may treat it as an antiseptic, dramatically changing time, cost, and pathway to market.

From there, the conversation turns to growth: Indonesia’s approval and its 60 to 65 million middle and upper-middle class consumers, the Philippines as the next potential major approval, and plans to broaden the Nasodine product range. We also cover the business model behind the strategy, including licensing partnerships that reduce manufacturing and marketing burden, recent capital raising, cash burn, and what “runway” looks like in a tough funding environment. If you’re following Firebrick Pharma, Nasodine, or healthcare commercialisation in Southeast Asia, this is the roadmap and the reality check.

Subscribe for more ASX Briefs, share this with a mate who follows biotech, and leave a review with your biggest question about Nasodine’s path to global markets.

A scan that finds brain metastases earlier could change the whole treatment timeline, and that is exactly what we dig into with Riccardo Canevari, CEO and Managing Director of Radiopharm Theranostics. We walk through how a clinical-stage ASX biopharmaceutical company designs radiopharmaceuticals for oncology, and why “theranostics” is more than a buzzword when patients need faster, clearer answers. 

Riccardo breaks down the company’s two-platform approach: small molecules for imaging that can penetrate tissue and light up tiny tumours, and larger antibody-based therapies that stay in the body long enough to deliver a targeted radioactive payload. We talk about RAD 101 and its interim Phase 2B results in recurrent brain metastases, including strong concordance with MRI and the bigger goal of proving clinical value by detecting more disease earlier. Earlier detection can mean earlier treatment, which can ultimately mean better outcomes. 

We also cover the first patient dosed in the Phase 1 RAD 404 study for advanced prostate cancer, using a Terbium‑161 radio labelled antibody designed to damage cancer cell DNA. From there, we zoom out to the broader pipeline, including ongoing Australian studies such as RAD 202 and RAD 204 across lung and breast cancers, and how the team thinks about prioritisation when multiple trials are running at once. Finally, we look at next steps towards a pivotal Phase 3 program, FDA alignment, and what fast track designations could mean as the company moves towards late-stage registrational pathways. 

If you found this useful, subscribe for more ASX biotech conversations, share the episode with a mate, and leave a review so more people can find the show.

Five complete responses in advanced pancreatic cancer should make anyone in biotech sit up. We’re joined by Dr Chris Burns, CEO and Managing Director of Amplia Therapeutics, to unpack what the latest mature ACCENT trial data really says about narmafotinib when it’s added to standard chemotherapy with gemcitabine and Abraxane and why “making other drugs work better” is more than a slogan when patients are running out of time.

We talk through the headline numbers, including an 11.1 month median overall survival signal and what “complete response” means in practical clinical terms. Just as important, we dig into tolerability: the combination appears to keep the side effect burden largely in line with chemotherapy alone, which is critical for any add on cancer therapy hoping to move into larger, registration enabling studies. We also explore how the US FDA fast track designation helps shape timelines and strengthens discussions with potential partners watching the pancreatic cancer pipeline closely.

Not every combo is worth forcing, and are transparent about that. We cover the recruitment halt in the AMPLICITY trial pairing narmafotinib with the more aggressive FOLFIRINOX regimen, why the limiting toxicity was linked to the chemotherapy, and how the broader landscape is shifting toward targeted and personalised medicines, including emerging RAS inhibitors. We finish with the commercial foundations, from key patents extending protection to at least 2040 in major markets to the next 12 months of milestones across pancreatic and ovarian cancer.

If you want clear, investor friendly context on pancreatic cancer drug development, clinical trial readouts, FDA pathways, and partnering strategy, hit play. Subscribe, share this with someone following oncology breakthroughs, and leave us a review with the one result you’ll be watching next.

A junior explorer doesn’t often get the chance to step into prime ground that’s already been stress-tested by a major miner, right in the middle of a proven hard-rock lithium district. That’s why we sat down with Mitch Thomas, CEO of Solis Minerals, to unpack Solis’ strategic acquisition from Rio Tinto in Brazil’s Lithium Valley and what a 93,000 hectare land position can really mean when the targets are already defined and the plan is to drill.

We talk through the story behind the deal, including why this particular concession package is so compelling, how it sits in a region the team knows intimately, and how Solis’ history of building a lithium discovery next door shapes their technical approach today. Mitch explains what makes the early indicators worth chasing, from high lithium soil results to spodumene pseudomorphs, and why Rio Tinto’s extensive groundwork may give Solus a head start as it moves from surface work into scout drilling.

Lithium isn’t the only pillar. We also dig into Solis’ Peru copper portfolio, how the company thinks about copper porphyry exploration alongside lithium, and why operating across two in-demand energy metals can support more consistent market updates. Mitch also shares why Solis moved to an Australian-registered structure, what it means for ASX investors in terms of governance and liquidity, and the milestones to watch as the company targets drilling around mid-2026.

If you follow lithium exploration, Brazil mining projects, ASX resource stocks, or copper growth stories, hit subscribe, share this episode with a mate, and leave us a review so more investors can find the conversation.

Guinea supplies a huge share of the traded bauxite market and that concentration is forcing buyers and investors to rethink supply security. We sit down with Ryan De Franck, Managing Director of VBX Limited, to unpack why the Wuudagu Bauxite Project in Western Australia’s North Kimberley could stand out in the global bauxite landscape through a simple idea: pair high-grade, low-silica bauxite with logistics that are short, efficient, and built around real customer needs. 

We talk through what makes Wuudagu strategically significant, from its proximity to the coast and protected sea conditions for transshipment, to the shipping advantage of being closer to key end-user regions such as China, India, and the Middle East. Ryan also explains the impact of VBX’s 108% lift in Measured and Indicated Mineral Resource to 131.9 million tonnes, and how that larger, higher-confidence base supports a bigger development case as the Definitive Feasibility Study progresses. 

Metallurgy gets a spotlight too, with recent test work indicating a 23% increase in mass recovery versus prior assumptions, and what that can mean for operating costs, profit margins, and payback timing if it carries through at scale. We finish with the execution roadmap: the DFS timeline toward mid-2026, a pathway to first production in 2027, and the near-term milestones that matter most, including traditional owner agreements, approvals, and definitive off-take and funding work with strategic partners. 

If you follow ASX mining, bauxite projects, aluminium supply chains, or energy transition materials, this is a sharp update you’ll want in your queue. Subscribe to ASX Briefs, share this episode with a mate watching the sector, and leave a review telling us which milestone you think will be the biggest value driver.

A kid can’t learn well if the world sounds muffled, painful, or simply out of reach. We’re joined by Dr James Fielding, Managing Director and CEO of Audeara Limited, to talk through a pivotal stretch for this ASX-listed hearing health technology and audio technology company, following strong Q3 FY26 results and a growing global footprint.

We start with what Audeara actually builds: hearing health tech solutions sold as Audeara-branded hardware, plus the AUA Technology platform that can power other brands. James then explains the significance of an exclusive agreement with ShokzHear, the global leader in bone conduction listening devices. The goal is practical and urgent: create an optimised listening option for children dealing with chronic ear infections, particularly in regional and remote communities where in-ear devices can be uncomfortable or unusable. We also discuss just how widespread classroom listening issues can be and what better audio access could mean for learning outcomes.

From there we dig into the numbers investors care about, including back-to-back positive net operating cash flow and accelerating Australian wholesale revenue, supported by closer partner execution with audiology groups such as Amplifon. We finish with Audeara’s Auracast™ momentum, the Clinico partnership in Taiwan, and the BT-03 Audio Broadcaster rollout into environments like universities, hospitals, government buildings, and even sports bars where people can choose exactly what they want to hear.

If you’re tracking ASX small caps, medtech commercialisation, Auracast, bone conduction, or accessible audio, hit subscribe, share this with a mate, and leave a review to help more people find the show.

Electrification gets most of the headlines, but what happens when an industry needs constant high-temperature heat and the equipment is built for gas? That’s where biomethane and renewable gas infrastructure start to look less like a niche and more like a missing piece of Australia’s decarbonisation plan.

We’re joined by Joe Oliver, Managing Director of Delorean Corporation Limited, to explain how Delorean turns organic waste into renewable energy and why the company is shifting from being known for engineering into becoming a build-own-operate bioenergy infrastructure owner. Joe walks us through the NSW1 Horsley Park final investment decision, including the $30.5 million in non-dilutive grant funding, the 25-year lease and gas offtake agreement with Brickworks, and why the integrated behind-the-meter model can deliver de-risked, infrastructure-style contracted cash flow.

We also dig into the real-world “hard-to-abate” problem for sectors like brick and glass manufacturing and why biomethane is a practical substitute for natural gas that can work with existing infrastructure. With green gas demand rising fast due to corporate targets and regulatory pressure, Joe outlines the current supply-demand gap in Australia and what corporate and technical catalysts to watch over the next 12 months, from financial close through to construction milestones, first gas and first revenue, alongside progress on SA1 and the broader project pipeline.

If you found this useful, subscribe to ASX Briefs, share this episode with a colleague following renewable gas and bioenergy, and leave us a review. What’s the biggest barrier you see to scaling biomethane in Australia?

A copper story can sound simple until you ask the hard questions: can it be built, can it be funded without brutal dilution, and is there genuine upside left to find? We’re joined by Ivan Fairhall, Managing Director of Pivotal Metals Limited, to walk through how the company is tackling those questions with a dual-track strategy in Quebec, one of the world’s most supportive mining jurisdictions.

We start with the structural edge Quebec offers critical minerals explorers and developers: strong infrastructure, an experienced mining services ecosystem, and access to abundant low-cost hydro power that’s both green and commercially meaningful. Ivan also explains how flow-through shares can help fund exploration more efficiently, a concept many ASX investors haven’t encountered, and why these real-world advantages can change the risk profile of a junior company.

From there we get specific on the Hordern Lake Copper Project, including the existing 37Mt resource at about 1.1% copper equivalent, the appeal of shallow open-pittable mineralisation, and why metallurgy sits at the centre of any credible development plan. We then shift to the Belleterre Project, where Pivotal is drilling for the first time on a district-scale land package with historic high grades nearby and large areas that have barely been tested. Ivan breaks down the targeting approach using modern EM and other geophysics to hunt for new massive sulphide systems, plus what to expect from assay timing and ongoing fieldwork.

If you’re comparing ASX copper stocks, looking for Quebec mining exposure, or trying to understand what separates a “good resource” from a real development opportunity, this conversation gives you a clear framework. Subscribe, share the episode with a mate who follows copper, and leave a review telling us what topic you want us to tackle next.

Paying rent should be simple, but for millions of Australians it is anything but. Bonds can demand weeks of rent upfront, payment options are often rigid, and renters are left stitching together workarounds just to secure a home and stay on top of weekly costs. We sit down with Jan Ferreira, CEO of Rent.com.au Limited, to unpack how a renter-focused fintech platform can reduce that friction and build a more sustainable business at the same time.

Jan walks us through Rent.com.au’s shift from a rental search portal into a full-service renter platform, anchored by two flagship products. RentBond® is built to bridge the bond gap when renters need to stump up funds before they have even moved out of their current place, including a 21-day repayment window that can be fee-free. RentPay tackles the ongoing grind of rent payments by letting renters choose how and when they pay, across methods like bank transfer, direct debit, credit card, PayPal, and Alipay, while still delivering rent to agents in the way and timing they prefer.

We also dig into the size of the opportunity, with tens of billions in annual rent flows and rents rising sharply, and what that means for product adoption, partnerships, and repeat usage. Jan explains how expanded lending capacity and bringing loans in-house can lift revenue and profit, why recurring revenue changes predictability, and the milestones the team is targeting on the path to positive group EBITDA and cash flow before the end of 2026.

If you care about the future of renting in Australia, fintech in the property ecosystem, or how ASX-listed platforms grow recurring revenue, listen now. Subscribe, share this with a mate who rents, and leave a review, what feature would make renting less stressful for you?

Heavy rare earths sit at the centre of magnets, electrification, and the modern supply chain, but getting to a product customers will actually buy is the hard part. We’re joined again by Dr Mark Cooksey, Managing Director and CEO of ABx Group Limited, to hear what’s changed since our last chat and why ABx believes its Tasmanian Deep Leads project is moving into a more serious development phase.

We break down ABx’s second high purity mixed rare earth carbonate (MREC) sample and why it stands out: a higher proportion of heavy rare earths and even lower aluminium and iron impurities. Mark explains what MREC is used for, how separation plants think about feed quality, and why customer validation ultimately decides what “good” looks like. We also dig into processing choices for ionic clay rare earths, including what column leaching can tell you about heap leaching potential versus stirred tank leaching, and how that flexibility can shape capital cost, operating strategy, and approvals.

The conversation widens to the bigger Australian critical minerals ecosystem, including ABx’s involvement in the $240m Critical Metals for Critical Industries CRC and the push to accelerate practical R&D that supports real project decisions. We cover the Ucore Rare Metals MOU as a reminder that rare earths are a specification driven market, then switch gears to ABx’s ALCORE technology and the continuous pilot plant being built at Bell Bay to make industrial fluorine chemicals from aluminium smelter byproducts. We close with bauxite updates across Queensland, New South Wales, and Tasmania, and ABx’s priorities through 2026: engineering design, environmental approvals, customer deals, exploration upside, and getting the pilot plant running.

If you found this useful, subscribe to ASX Briefs, share the episode with a mate tracking critical minerals, and leave a review telling us what topic you want next.

Titanium sits inside some of the most important machines on the planet, yet supply chains are tightening and governments are treating critical minerals like strategy, not just commodities. That’s why we wanted to talk with Tom Langley, CEO of Fortuna Metals Limited, about what the company is uncovering in Malawi, an emerging rutile and graphite province that sits right beside Sovereign Metals’ world-class Kasiya deposit. 

We walk through Fortuna’s Mkanda discovery and what the numbers are hinting at so far, including high-grade rutile at surface and expanding core areas that point to serious scale. Tom explains the logic behind their rapid 0–2 metre sampling strategy, how it helps prioritise drill targets, and why confirming mineralisation at depth is the next value-defining step. We also dig into the deposit style, the role of weathering in concentrating heavy minerals, and why Malawi’s preserved profile can be such a powerful ingredient for rutile projects. 

From there, we zoom out to the bigger picture: why rutile is the highest-grade natural titanium feedstock, where titanium demand shows up in aerospace and defence, and how graphite credits could materially improve project economics. We touch on the market validation coming from next door at Kasiya, including strategic partners, funding interest and offtake agreements, then finish with what investors can watch for through 2026, from drilling programs and an exploration target to a maiden resource and metallurgical testwork. 

If you care about ASX resources, rutile, graphite, titanium supply chains and critical minerals policy, subscribe, share this with a mate, and leave us a review. What’s the single milestone that would most change your view on Fortuna Metals?

Ancient rocks may hold a faster, cheaper path to low‑carbon energy. We sit down with Dr Krista Davies, Managing Director of Prominence Energy, to unpack how the Gawler Craton’s hot granites, iron‑rich rocks, and deep crustal faults create multiple natural hydrogen “play types” across a massive 64,000 km² land position in South Australia. Krista brings three decades in oil and gas and a pioneering PhD in natural hydrogen to explain, in plain terms, why white hydrogen and helium could reshape heavy industry and unlock new export opportunities.

We walk through the exploration strategy from the ground up. First comes low‑impact soil gas and water bore sampling to detect subtle seepage signatures of hydrogen and helium, providing cost‑effective field validation across broad terrain. Then we integrate those anomalies with structural models to pick the smartest seismic lines, image reservoir and seal configurations, and rank traps before drilling. It’s a disciplined, geology‑led approach that turns a district‑scale thesis into drill‑ready targets while preserving capital and minimising surface disturbance.

Beyond the rocks, we map the market. Hydrogen demand today is big but emissions‑heavy; natural hydrogen offers a discovery‑and‑produce pathway that could lower costs and accelerate adoption for green steel, heavy transport, and industrial heat. Proximity to the Spencer Gulf, Whyalla’s industrial hub, and mining centres near Olympic Dam strengthens the case for local offtake and future export. We also dig into helium’s rising strategic value for MRI, semiconductors, and data centre cooling—an opportunity made sharper since Australia became a net helium importer. If exploration confirms accumulations of both gases, helium can enhance project economics and resilience.

We close with a clear 2026 roadmap: complete the geochemical survey on PEL 803, integrate insights to focus seismic in the second half, then advance a risk‑ranked portfolio toward drilling next year. If you care about energy transition, critical minerals, and practical paths to decarbonisation, this is a grounded, data‑driven look at what could be Australia’s next energy chapter. Follow the show, share it with a friend who follows ASX explorers, and leave a quick review to help others find these conversations.

A 149% revenue surge, first‑to‑market GMP MDMA in Australia, and a plan to scale faster than demand—Sam Watson, CEO of Bioxyne, joins us to unpack how a focused manufacturer turns emerging therapeutics into real‑world access. We dig into the mechanics behind record growth, the patient need driving MDMA and psilocybin uptake, and why replicable GMP capacity across Australia, the UK, and Europe is Bioxyne’s not‑so‑secret weapon.

Sam explains how medicinal cannabis remains the commercial engine while psychedelic therapeutics validate a long‑term bet on treatment‑resistant depression and PTSD. With authorised prescriber pathways opening and imports giving way to local GMP supply, clinics gain reliable access and patients get consistent, pharmacy‑grade dosing. We talk through the numbers—upgraded adjusted EBITDA guidance to 16–19 million—and the process upgrades that power it: automation, digitised quality systems, and operating leverage as volumes climb.

We also map the international play. Germany leads as a prescriber‑led, pharmacy‑dispensed market where cannabis flower dominates and Bioxyne targets five to ten tons over the next year through strong local partnerships. The UK mirrors Australia’s earlier stage, making it ripe for a copy‑and‑paste facility to relieve supply bottlenecks. Finally, Sam outlines how rapid clean room buildouts, short payback cycles, and white‑label reliability for 300+ brands create a durable moat: faster turnaround, fewer stockouts, and scalable quality at GMP standards.

If you’re tracking ASX‑listed growth stories, the evolution of medicinal cannabis, or the practical path for MDMA and psilocybin in regulated care, this conversation offers data, strategy, and on‑the‑ground execution. Follow and subscribe, share this with a friend who invests in healthcare, and leave a quick review to help others find the show.

When 77% of mortgages are written by brokers, the real power sits with the platform that connects lenders and customers. We sit down with David Bailey, CEO of Australian Finance Group, to unpack how AFG’s scale, data, and funding strategy power the broker-led mortgage market while delivering record results and resilient margins.

David explains AFG’s role as infrastructure for more than 4,300 brokers and 70+ lenders, detailing how the platform model converts volume growth into operating leverage. We explore the levers behind a 46% NPAT surge to $22.4 million, from the annuity strength of trail income to disciplined cost control and targeted investment in technology and compliance that speeds loan processing and reduces friction for busy brokers. The conversation also dives into AFG Securities’ margin expansion to 124 basis points, highlighting improved warehouse funding, portfolio optimisation, and the benefit of a highly liquid RMBS market. Strong credit selection and scale are central, translating into better spread management and a standout loss history across billions originated.

With consolidation reshaping the industry, David outlines how AFG’s size brings three structural advantages: stronger lender relationships, deeper data insights, and ongoing investment capacity. We discuss the company’s strategy of taking equity stakes in high-quality broker businesses to align incentives, support succession, and lift network productivity. Finally, we look ahead to FY29 aspirations, from growing faster than system to expanding the manufacturing segment with strict credit and margin discipline, all while maintaining capital discipline and sustainable dividends.

If you care about mortgage distribution, funding costs, RMBS dynamics, and the future of broker technology, this conversation lays out the roadmap. Subscribe, share this episode with a colleague, and leave a quick review to tell us what you want to hear next.

A small mineral with outsized impact takes centre stage as we explore how high-grade antimony, refined onshore, can reshape America’s critical minerals backbone. We sit down with Kerrie Matthews, Managing Director and CEO of Locksley Resources, to chart a clear path from drill bit to product: rigorous structural mapping, a data-driven maiden drill program at the Desert Antimony Mine, and a pilot plant designed around real metallurgy rather than wishful thinking. The stakes aren’t academic. With defence, flame retardants, and supply security on the line, the United States needs more than ore; it needs refining capacity, standards, and speed.

Kerrie breaks down how layered geophysics, geochemistry, and underground analysis improved the model before drilling kicked off, helping target above historic workings for faster, more meaningful results. We dive into batch sampling that returned weighted averages around 18% Sb and peaks above 25%, what that means for processing efficiency, and why high-grade feed can shrink plant footprint and operating costs. Then we zoom out to the policy landscape: the executive focus on downstream bottlenecks, a DPA Title III application to accelerate the pilot facility, and early engagement with funding channels that can bring refinery capacity back onshore.

Scale and diversification also come into play. The newly identified Beefeater shear, a 10 to 15 metre wide corridor that mirrors the Desert Antimony Mine structure, hints at a larger multi-vein system, with Hendricks offering further upside. On the rare earths front, El Campo’s proximity to MP Materials and strong surface TREO samples set the stage for a compelling follow-on drill program. We round it out with process innovation: advancing antimony purity targets, moving toward trioxide, and partnering with Rice University on Deepsolv™ pathways to inform a cleaner, smarter hydrometallurgical design.

If you care about resilient supply chains, practical project delivery, and the real work of turning geology into metals, this conversation brings clarity and momentum. Subscribe, share with a friend who follows critical minerals, and leave a review to tell us what you want to hear next.

Waves don’t just crash; they carry steady, reliable energy that can help power the grid. We sit down with Jonathan Fievez, CEO of Carnegie Clean Energy, to explore how CETO—a submerged, three‑belt buoy system—captures that motion and turns it into electricity. Jonathan walks us through the upcoming Phase 3 EuropeWave deployment at the Biscay Marine Energy Platform in the Basque Country, why that site accelerates learning with grid and environmental approvals in place, and how a successful launch becomes a defining moment for utilities evaluating wave energy at scale.

We dig into the engineering in clear terms: how the buoy stays a few metres below the surface, why drum-driven shafts and integrated tensioners matter for power quality, and how electricity is delivered ashore. Then we widen the lens. Carnegie’s MoorPower concept aims at diesel displacement for aquaculture barges, using the barge’s natural motion to generate energy and cut refueling risks. On the defence front, persistent sensing and surveillance need more power than batteries can offer; wave-driven systems can keep remote nodes online for longer with higher-fidelity data.

Control is where the cost curve bends. Backed by the EU-funded COIN program, Carnegie is advancing short-horizon wave prediction and AI-based reinforcement learning controls developed with Hewlett Packard Enterprise. The goal: survive brutal seas while extracting more energy from every set, and reduce costs via predictive maintenance. Jonathan also outlines the funding strategy—non‑dilutive grants and R&D tax credits in Australia and the Basque Country—and the near-term investor milestones: EuropeWave deployment, operational data, and progress toward a multi‑megawatt, full-scale project that aligns with Europe’s push for resilient, indigenous renewable energy.

If you’re curious about how ocean power can complement wind and solar with winter-peaking output and a compact footprint, this is a timely, practical dive into the next frontier of clean energy. Subscribe, share with a friend who loves climate tech, and leave a review with your top question about wave farms.

What if the backbone of smarter cities isn’t a shiny app, but a quiet layer that connects every meter, sensor and inverter into one brain? We sit down with X2M Connect CEO Mohan Jesudason to unpack how a device‑agnostic platform gathers data at scale, feeds AI, and then reaches back to control critical infrastructure without human intervention. From leak detection and automated billing to balancing renewable energy and boosting public safety, the story is about outcomes, not dashboards.

We dive into X2M’s expansion into Japan’s ageing water market, partnering with a leading local meter manufacturer to turn vast installed bases into high‑margin SaaS revenue. With more than 90% gross margins on recurring fees per device, even a small slice of Japan’s roughly 60 million meters becomes meaningful. Mohan shares how Korea’s utility market, where X2M is the incumbent, continues to accelerate through repeat orders and a broader product lineup, while channels strengthen in Australia, the UAE, and Taiwan’s renewable‑energy AI segment.

Financially, the company reports a 65% year‑on‑year Q2 revenue lift to $2.8 million, positive operating cash for the quarter, and a bolstered balance sheet aided by an R&D rebate and a $3 million capital raise. That capital is earmarked for growth and debt reduction as the business moves deeper into “horizon three” — scaling from a small enterprise to a substantial, cash‑generating operation. We also spotlight “Help Me,” a coin‑sized public safety device now rolling out in Seoul. Press it, and CCTV operators, police, and nominated contacts receive instant location and alerts, showing how smart city infrastructure can deliver real‑world safety in seconds.

Across 12 to 24 months, the focus is clear: harvest value from 88 enterprise and government customers, penetrate new markets, and scale three core products — utility monitoring, public safety, and hybrid AI for renewables. If data is the new infrastructure, the platforms that move it fast and act on it reliably will define the next decade of urban life. Enjoy the conversation, and if it resonates, follow the show, share this episode with a colleague, and leave a quick review to help others discover it.

Debt recovery rarely gets framed as a story of dignity, data, and disciplined growth—until you hear how Keith John runs Pioneer Credit. We sit down with the Managing Director to unpack a model that buys non‑performing loans from Australia’s big four banks, restores customer health through sustainable repayment plans, and turns empathy into durable cashflows.

Keith explains why banks prefer a partner that won’t extend the credit cycle or dabble in payday lending, and how that stance protects brands while securing steady forward flow agreements. We dig into the numbers: investing around $80 million at roughly 18–19 cents in the dollar, generating strong free cashflow, and driving down the cost of funds through real performance. A 315 bps margin cut on medium‑term notes and sharper pricing on a $272 million senior facility now at 435 bps over BBSW say as much about lender confidence as any earnings performance.

The heart of the advantage is operational. ESG metrics tied to customer outcomes triggered a further margin reduction sooner than expected, proving that fewer complaints and better arrangements are not just good ethics—they’re good economics. Data‑led segmentation improves cure rates, while cost to serve has fallen to around 32%, among the best globally. With newer vintages forecast to outperform older ones thanks to improved purchase dynamics and analytics, Pioneer is building a compounding flywheel: better outcomes lower funding costs, cheaper funding fuels selective portfolio growth, and efficiency expands margins.

We also tackle the macro picture. The key risk to watch is a sharp rise in unemployment, but current forecasts remain steady. Execution, not macro luck, will decide the next leg: disciplined purchasing, continued ESG delivery, and maintaining bank and lender trust. If you care about how ethical finance, strong data, and disciplined capital allocation can co‑exist—and outperform—this conversation offers a rare, clear playbook for sustainable returns in the Australian financial services market.

If this episode sparked new thinking, follow the show, share it with a mate, and leave a quick review so more listeners can find conversations like this.

A sprawling land package is only as valuable as the strategy behind it—and that’s where this conversation with James Wilson, CEO of Alchemy Resources, gets exciting. We dig into a data-led approach that targets big growth levers across WA and NSW: a standout 750-metre IP anomaly at Yellow Mountain, funded lithium drilling at Roe Hills beside the Manna project, and a de-risked iron ore path through a free-carried JV at Valley Bore.

We start with the portfolio: gold remains centre stage in the eastern goldfields near Kalgoorlie, where access and proximity to producing neighbours create practical advantages. From there, we unpack Yellow Mountain’s momentum—first-pass drilling returned 113 metres at 1.17% copper equivalent, and high-powered, 3D IP has now mapped three compelling targets, including a never-drilled eastern body that could represent the system’s heat source. James explains how modern assays and structural mapping tighten vectors that old imperial grids simply couldn’t resolve, and why careful fieldwork now will determine whether the area hosts one segmented system or two distinct domains.

Next, we turn to smart capital: iron ore is all about logistics, so Alchemy partnered with Newcam, an active miner with ports, storage, and customers in place. The 40% free-carried structure to decision to mine keeps upside alive while containing risk, and if the option is exercised, it could accelerate timelines on an existing mining lease. On lithium, Roe Hills benefits from aggressive JOGMEC funding, outcropping pegmatites, and clear LCT pathfinders, with a nine-hole RC program now chasing the right structural and thermal window near Global Lithium’s advancing Manna project.

We close with a crisp set of 2026 catalysts: drilling the large Yellow Mountain IP target to validate sulphides at scale, a possible option exercise at Valley Bore that would inject capital and operational muscle, and JV-driven news from Roe Hills and Briar alongside steady gold exploration near Carosue Dam. The through-line is deliberate: de-risk with partners where complexity is highest, and focus internal effort where discovery could be transformational. If you’re tracking ASX exploration stories with real leverage to discovery, logistics, and funding, this one belongs on your list.

Enjoyed the conversation? Follow the show, share it with a mate, and leave a quick review to help others find us.

WA’s grid is changing faster than most realise, and the evening peak is where the challenge bites. We sit down with Frontier Energy CEO Adam Kiley to explore how the Waroona Renewable Energy Project—120 MW of solar paired with a 6.9‑hour, 81.5 MW battery—aims to serve the 4 pm to 10 pm window that coal and gas used to cover. With a prime location only 500 metres from the Landwehr Terminal and a connection to 330 kV lines, Waroona is built on strong grid bones that support both Stage One delivery and future expansion.

Adam unpacks the numbers driving confidence: a guaranteed $32 million per annum from WA’s reserve capacity mechanism over the first five years, independent banker‑case models reflecting record‑high wholesale prices, and a clear pathway to 60–70% project debt. We dig into the macro: around 6.6 TWh per year of retiring coal and older gas, plus 3.5 TWh of new demand by 2031, creating an 11 TWh hole on a 22 TWh grid. Rather than waiting on long, costly transmission build‑outs, Frontier’s strategy co‑locates generation and storage at a strong node to shift midday sun into night-time supply when prices and reliability needs are highest.

We also talk execution: updated financials and technical expert reports for lenders, equipment contracting, and the timeline to final investment decision. Then we look at what’s next—an accelerated Stage Two study with similar scale, backed by 830 hectares of controlled land, approvals to amend, and a focus on replicable revenue certainty. If you care about clean baseload, peak-hour pricing, and practical solutions to the SWIS transition, this conversation lays out how firmed renewables can deliver.

Enjoyed the conversation? Follow the show, share it with a friend who tracks the energy transition, and leave a quick review so others can find it.

What if a beam of light could turn the tide against stubborn tumours and even wake the immune system? We sit down with Professor Thian Chew, Executive Chair and CEO of Invion Limited, to unpack how their photodynamic therapy zeroes in on cancer cells, stays inert until activated by a specific wavelength, and then triggers targeted oxidation that spares healthy tissue. The kicker: this same mechanism appears to amplify immune responses and shows promise against infectious agents like bacteria, fungi, and viruses.

We walk through concrete progress already underway. A non‑melanoma skin cancer study advances a topical application, while a forthcoming anogenital cancer trial with the Peter MacCallum Cancer Centre explores combining light‑activated therapy with established immunotherapies to convert “cold” tumours into “hot” responders. Backing from South Korea’s KDDF and partner Hanlim Pharma brings up to two million dollars in non‑dilutive support focused on oesophageal cancer and the development of an IV formulation. With both topical and IV routes, the platform can map to diverse clinical settings and multiple tumour types.

A major strategic shift came with Invion’s perpetual, exclusive global licence to the Photosoft™ platform. That move removes a long‑standing overhang, giving us the freedom to set indication priorities, simplify global partnerships, and negotiate clean commercial pathways. Under the hood, the science uses glucose conjugates to exploit the Warburg effect, letting sugar‑hungry tumours absorb the compound across a range of cancers. Beyond human oncology, our partnership with Protect Animal Health pushes a parallel pet oncology program that can reach companion animal trials faster, potentially generating earlier revenue and translational insights.

We close with a clear look at the next 12–18 months: continued recruitment and readouts in skin cancer, regulatory steps and initiation milestones with Peter Mac, preclinical efficacy and formulation updates in oesophageal cancer, and progress across companion animal studies. With recent capital raised and R&D facilities in place, plus non‑dilutive partner funding, the runway supports a steady cadence of data. If you’re tracking precision oncology, immune priming, and platform therapeutics, this is a roadmap worth following.

Enjoyed the conversation? Subscribe, share with a friend who follows biotech, and leave a quick review to tell us which upcoming catalyst you’re watching most.

A stubborn truth in healthcare is that the right treatment can still be the wrong format. We sit down with Damien Wood, CEO of EVE Health Group, to unpack how rethinking delivery—gummies for period pain and rapid oral films for ED—can remove friction, speed relief, and improve adherence across everyday conditions that carry massive personal and economic costs.

We start with Dyspro, a cannabinoid-based chewable designed for dysmenorrhea. It addresses a problem that drains billions from productivity and quality of life, yet is under-treated with options many find harsh or inconvenient. Then we dig into Libbo, an oral soluble vardenafil film that dissolves in seconds, works in about 15 minutes, and avoids first-pass metabolism. The result is a discreet, water-free option that fits real-world behaviour, supported by telehealth consultations, e-scripts, and home delivery through StiffIssue.com and partner clinics.

The conversation widens to strategy. We explore Australia-first launches, TGA pathways for export, and why alcohol-free formulations unlock the Middle East and North Africa, where cultural fit and regulation matter. With higher ED price points across MENA, partnerships and local distributors create a pragmatic route to scale. Damien also lifts the hood on Eve’s core capability: solubilising water-insoluble drugs to improve bioavailability and recast known actives into films, sprays, and topicals. As the patent cliff hits, this opens a pipeline where better formats can drive better adherence, particularly for older adults and anyone managing polypharmacy or swallowing issues.

By the end, you’ll see how delivery science, digital access, and cultural insight combine into a playbook for growth: expand adoption at home, target markets where differentiation matters, and licence where partners can move faster. If healthcare should feel simpler, faster, and more human, this is a roadmap worth watching. Enjoy the episode, then follow and share your thoughts—what format would make your own care easier? Subscribe and leave a quick review to help others find the show.

A newly listed small cap with a giant resource, a blue-chip funding partner, and a market hungry for reliable gas—this conversation with Equus Energy’s Will Barker gets right to the heart of how strategic timing can transform a project into a regional anchor. We unpack the Equus Gas Project on Western Australia’s Northwest Shelf, a mature, independently certified 2C contingent resource of 1.7 TCF of gas plus condensate, located alongside Gorgon, Io‑Jansz, Pluto and Scarborough. With over US$1.5 billion already invested in appraisal and studies, Equus now targets existing infrastructure to compress timelines and reduce development risk, aiming to supply both LNG backfill and domestic gas.

Will explains how Equus’s current valuation implies around 24 cents per barrel of oil equivalent—far below several offshore peers with smaller certified resources—setting up a potential re-rating if the team delivers milestones. A key driver is a landmark arrangement with Alcoa, Western Australia’s largest gas buyer, providing over US$30 million in staged funding to advance feasibility, commercial work, partner selection and offtakes. This is not debt or prepayment; it’s a strategic commitment that secures exclusivity over Equus’s domestic gas obligation and signals confidence from a major industrial customer at a time when WA faces a looming gas shortfall.

We also dive into the roadmap ahead: completing feasibility, updating economics, launching a structured partnering process, selling down at the project level to bring in an operator with balance sheet strength, and progressing gas offtake and infrastructure agreements. For listeners tracking ASX energy, LNG backfill, and domestic gas security, this is a clear, data-rich look at how a 100% owned resource can be transformed into long-term supply for Asia and Australia. If you value grounded strategy, real milestones, and market timing, you’ll find plenty to analyse here. Enjoy the conversation, then follow and subscribe—leave a quick review to tell us what milestone you’re watching next.

A pee-in-a-cup that can change urology care might sound too simple, but that’s exactly the point. We sit down with Dr Peter Meintjes, CEO of Pacific Edge, to explore how Cxbladder turns a urine sample into decisive signals that help rule out bladder cancer, reduce invasive cystoscopies, and save health systems money without cutting corners on accuracy.

We walk through how the test works, why choosing RNA from urine is such a technical leap, and how a stabilising buffer keeps samples viable at room temperature for up to 11 days. Then we dig into Cxbladder Triage Plus, a multimodal upgrade that blends RNA and DNA with advanced algorithms. With stronger performance and a US Medicare price of USD 1,328, Triage Plus is positioned to deliver real-world savings by avoiding unnecessary scopes and scans while giving clinicians clearer answers for patients with hematuria.

Reimbursement drives adoption, so we unpack the pathway with Novitas, the Medicare contractor, following inclusion in the American Urological Association guideline. Peter explains the evidence framework—analytical validation, clinical validation, and clinical utility—that underpins coverage decisions, and why a new local coverage determination could reset the company’s US strategy. We also cover capital discipline after coverage loss, the send-out testing model across Australia and Southeast Asia, and the longer-term plan to simplify the assay into an IVD kit that partner labs can run closer to patients.

We close with a practical look ahead: restoring Medicare coverage, charting a return to profitable operations, and fully resourcing high-priority projects. If you care about cancer diagnostics, health economics, and how evidence shapes access, this conversation offers a clear map of the science, the policy, and the commercial levers at play. Enjoy the episode, share it with a colleague, and subscribe to get the latest updates—then tell us what part of this strategy you want to hear more about next.

Critical minerals move fast when geology, chemistry and execution align. We sit down with Dr Mark Cooksey, Managing Director and CEO of ABx Group, to unpack how the company plans to bring heavy rare earths and clean fluorine chemicals to market while capturing value from proven bauxite assets.

First, we break down why ABx’s Tasmanian ionic clay resource matters: cleaner leaching, fewer process steps and a mixed rare earth carbonate with higher proportions of dysprosium and terbium, the workhorses behind high‑temperature permanent magnets. Mark explains how collaboration with ANSTO strengthens metallurgy from bench to larger test scales, and how a new exploration licence in northern Tasmania bridges existing leases, supports resource growth and deepens understanding of the geological controls behind the ionic clay system.

We then shift to fluorine. With fluorspar supply tightening and fluorine recognised as a critical input for semiconductors, fluoropolymers and refrigerants, ABx is developing a process to convert a surplus aluminium smelter byproduct into hydrogen fluoride. The pilot plant at Bell Bay, Tasmania, leased within a Rio Tinto facility, is designed for fast learning: build over the next six months, then run to generate performance data and samples for customers. Alongside, ABx advances bauxite projects through agreements with GII in Queensland and New South Wales, progressing environmental approvals and option studies, while a smaller Tasmanian bauxite operation targets early 2026.

Across the conversation, Mark lays out clear FY26 priorities: finalise metallurgy and engineering for a right‑sized rare earths start‑up, advance commercial talks for premium MREC, complete and operate the fluorine pilot, and drive bauxite approvals toward near‑term cash flow. If you care about heavy rare earths, fluorine supply chains, and practical, local execution in Australia, this is a timely look at where the market is heading and how ABx plans to lead.

If you enjoyed the conversation, follow the show, share it with a friend, and leave a quick review so more people can discover it.

A tiny dose that holds cancer at bay for a year, scans that turn solid tumours into “donuts,” and a bold trial where patients receive cell therapy before chemo—this conversation with Dr Rebecca McQualter, CEO of Chimeric Therapeutics, is packed with data and real-world impact. We dig into the CHM CDH17 CAR T program as it clears dose level two with clean safety and early signs of activity across colorectal, mid and hindgut neuroendocrine, and select pancreatic cancers. The durability story stands out: a patient on the lowest dose maintained stable disease for 12 months with detectable CAR T cells and no further treatment, trading chemo sessions for time with family and a long-postponed trip to the Redwoods.

We also unpack the CHM Core NK platform for blood cancers, an off-the-shelf approach with a unique frontline design at MD Anderson Cancer Center. By delivering engineered NK cells first and chemotherapy second in frail, high-risk AML patients, the study is seeing three complete responses and one partial response trending to complete, alongside stronger persistence signals. For clinicians and investors, this sequencing could reshape how frontline care is conceived when transplant isn’t an option, offering a path that prioritises efficacy while preserving patient resilience.

On strategy, we talk portfolio breadth and focus: four clinical-stage programs, yet concentrated execution on the first-in-class CHM CDH17 asset where unmet need and market potential intersect. With only five patients left to finish phase one, FDA-cleared phase one/two mechanics to accelerate, and active partnering underway for phase two, the near-term roadmap is clear. We close with how a lean team, refreshed board, and disciplined spend power complex cell therapy programs without losing sight of the person behind each data point. If you care about CAR T innovation, NK cell persistence, and rethinking cells-before-chemo in AML, this is your next listen. Subscribe, share with a friend who follows oncology, and leave a quick review to tell us what you want answered next.

A boom, a backlash, and a pivot with teeth—this conversation traces how Zoono Group turned a pandemic-era hygiene surge into a durable, data-backed strategy to cut food waste and boost supermarket margins. We unpack the science behind a dry-active antimicrobial coating that bonds to packaging, survives heat and storage, and delivers a mechanical kill through cell disruption. The result is a protective surface that prolongs freshness, reduces shrink, and moves retailers from cost-centre thinking to a measurable return on investment.

We walk through the road from lab to store shelf: multi-year regulatory and safety validation in the UK, proof-of-concept with Marks & Spencer across soft fruit categories, and the durability tests required for real-world packaging lines. Then come the commercial wins—Sharpak in the UK, Mpact in South Africa, and Multisteps in Australia—adding up to roughly $50 million in contracted sales over five years. The economics are striking: one extra day on 150 million punnets of raspberries can save an estimated £11 million, while coating those trays costs about £1 million. For packaging suppliers, the technology becomes a point of difference; for retailers, it’s a direct line to less waste and stronger margins.

We also touch on capital discipline—remaining debt-free, fully subscribed rights issues, and guidance to return to profit by year-end. Looking ahead, we explore growth in Asia and India, including trials on bananas and mangoes, and the network effects that could take the UK model into Europe at larger scale. If you care about food waste reduction, packaging innovation, or the business of fresh produce, this is a clear-eyed look at how a durable antimicrobial platform can create value across the supply chain.

Enjoyed the episode? Follow the show, share it with a colleague in retail or packaging, and leave a quick review so others can find it too.

Corrosion, costs, and clean energy collide as we sit down with Nick O’Loughlin, Managing Director of Sparc Technologies, to unpack a focused plan for real-world impact. We trace how a graphene-based additive called ecosparc® aims to make protective coatings tougher for critical steel assets, and why a pilot plant north of Adelaide could change the economics of green hydrogen by using light, not large amounts of electricity.

First, we dig into the coatings story. ecosparc® targets measurable gains in barrier performance, adhesion, and durability, designed to slot into existing formulations used on bridges, mining gear, and oil and gas infrastructure. Nick shares why trials with BHP Mitsubishi Alliance and the Cape Jaffa Lighthouse matter, and how recognition alongside Aramco at the Middle East Corrosion Conference signals technical credibility at the highest level. With a consolidated market of global coating manufacturers, Sparc is pursuing commercial agreements that could accelerate deployment once specifications are met. The goal: reach commercialisation by FY26 and scale through partners with worldwide reach.

Then we pivot to energy innovation through the Sparc Hydrogen joint venture with Fortescue and the University of Adelaide. The Roseworthy pilot is built and moving through commissioning to demonstrate photocatalytic water splitting—hydrogen production driven by light-activated catalysts with minimal electricity input. Nick explains how this approach addresses a core barrier in electrolysis economics, what success at pilot scale would mean for technology readiness, and how a strong data set could unlock global interest. Along the way, we talk about the complementary nature of these two bets: near-term revenue potential from coatings and a bold push in next-gen hydrogen.

If you’re tracking graphene in coatings, green hydrogen technologies, or ASX innovation stories, this conversation delivers clear milestones, partner validation, and timelines to watch. Subscribe, share with a colleague who lives in materials or energy, and leave a quick review with the question you want answered next.

A quiet revolution is happening in cancer screening: a simple blood draw is starting to find what used to hide in plain sight. We sit down with Shane Ryan, CEO of BCAL Diagnostics, to unpack how a Sydney-built breast cancer test is scaling nationwide and why a new exclusive partnership with ClearNote Health could change the game for ovarian and pancreatic detection across Australia and New Zealand.

Shane explains how thousands of donated samples and deep clinician engagement powered BCAL’s breast cancer test from research to real-world use. With Sonic Healthcare enabling local collection close to home, women can access testing without the travel and scheduling hurdles that often delay early screening. From there, we dive into ClearNote’s genomic technology, the high specificity and sensitivity thresholds guiding clinical confidence, and the significance of being selected for the US Vanguard Study—an indicator that the science stands on strong ground.

We also map the road to Q1 CY26: GP and specialist education, laboratory readiness in Sydney, efficient logistics to ClearNote’s California lab, and a results pipeline designed for speed and clarity. The stakes are high—ovarian cancer can reach about 90% five-year survival at stage one, yet overall survival lingers near 49%; pancreatic cancer shows a similar gap, with roughly 80% at stage 1A versus about 13% overall. By making testing accessible and reliable, BCAL aims to move more diagnoses into those early windows when treatment works best.

Finally, Shane shares the 12–18 month plan: accelerate breast test volumes, ramp ovarian and pancreatic launches, and build toward a one‑stop biomarker hub for clinicians, alongside preparation to enter the US breast cancer market. If early detection, practical access, and robust data matter to you or your patients, this conversation brings the strategy into focus. Subscribe, share with a colleague, and leave a quick review telling us which barrier to early screening you want solved next.

A near-forgotten gold mine with a modern decline, bought for under a million dollars, and already delivering drill grades that beat expectations—that’s the kind of edge we love to unpack. Steve Norregaard, Managing Director of WIN Metals, joins us to share how the team pivoted from nickel exploration to a high-grade gold strategy built around speed, grade, and smart capital use. We dig into the Radio Gold Mine acquisition, why the existing infrastructure matters, and how a “soft start” could put ounces back into production by mid next year.

We walk through the first 9,000 metres of drilling at Radio, the plan to recalculate resources early in the new year, and the path to a clear mine plan shortly after. Steve explains why Repeater could be a northeast extension of the main Radio structure and how deeper hits, including a metre at 14 g/t, support a bigger system than first thought. The conversation then shifts to the Kimberley, where the Butchers Creek scoping study outlines around 200,000 recoverable ounces from a 250,000-ounce resource, a C1 cost near A$2,500/oz, and strong project metrics at current Australian gold prices—all while funding a new A$70 million plant.

If you care about near-term production, margin resilience, and exploration that actually feeds a mine plan, this one’s for you. We cover the funding runway, upcoming drill news, a maiden resource at Radio, and the staged development that keeps dilution in check. Plus, we talk optionality: the nickel and lithium assets remain in the portfolio, ready for a price turn that could unlock value fast. Subscribe, share with a friend who follows ASX miners, and leave a quick review to tell us what you want us to analyse next.

The map is changing faster than most businesses can. We sit down with Aerometrex CEO Robert Veitch to unpack how a leaner operating model, smarter products, and disciplined sales are turning a complex geospatial portfolio into a growth engine with real operating leverage.

Robert breaks down the three pillars: MetroMap, a high‑resolution aerial imagery subscription updated up to six times a year in major cities; LIDAR, delivering precision terrain and asset intelligence for sectors like environment, energy, mining, and infrastructure; and hyper‑realistic 3D meshes that power digital twins and scenario planning. We explore why MetroMap’s ACV now has outsized margin impact, how oblique imagery, elevation profiles, contours, and hillshade reduce site visits and accelerate approvals, and what a cleaner interface means for enterprise adoption. On the LIDAR side, we go inside recent wins with the Queensland Government and Shell QGC, the 52% revenue lift, and the importance of asset utilisation without extra capex. For 3D, we dig into international momentum, practical use cases that justify spend, and the path to scale as digital twins move mainstream.

The strategy pivots on “One Aerometrex”: a unified organisation where product, production, PMO, and sales work as one, breaking silos so customers get solutions rather than isolated services. That shift, paired with more than $2 million in cost reductions and two quarters of zero cash burn, sets the stage for profitable growth. Robert also shares highlights from the Q1 trading update, the renewed Landchecker partnership with a multi‑year commitment, and a measured stance on M&A, partnerships, and licensing to maximise shareholder value.

If you care about spatial data that actually changes outcomes, this conversation delivers clarity and numbers you can trust. Subscribe, share with a colleague who lives in maps, and leave a quick review to tell us which feature you want to see next.

A quieter revolution is unfolding inside battery recycling: selective chemistry that finally makes economic and environmental sense. We sit down with Dr Ebbe Dommisse, CEO of Iondrive, to explore how deep eutectic solvents enable clean, closed-loop recovery of critical minerals from battery black mass, e-waste, magnets, and end-of-life solar panels—and why that unlocks real scale.

We trace the strategic entry into Europe through a €3.1 million German battery recycling consortium led by RWTH Aachen and Fraunhofer. With upstream partners supplying black mass and downstream partners preparing to validate cells, the project closes the loop from waste to new materials. Ebbe explains how DES separates nickel and cobalt with high selectivity, cuts the environmental footprint versus hydrometallurgy, and lines up with strict European regulations. Beyond chemistry, the win is commercial: secured feedstock, credible offtake, and performance validation that matters to OEMs.

Urban mining becomes the broader play. In North America, the focus is permanent magnets and rare earth recovery alongside partner Colt Recycling. In Europe, EV batteries still dominate, with solar waste rising fast. In Australia, a wave of retired solar panels brings silver and silicon recovery to the fore, supported by local partnerships and policy engagement. We break down why Iron Drive is pursuing two complementary deployment models—hub-and-spoke for Europe’s centralised processing, and modular, co-located units for the geographic sprawl of the US—so the same DES platform can flex across regions and feedstocks.

We also map the near-term milestones: commissioning an Australian pilot plant supported by a government grant, initial debugging, then shipping to Germany for consortium operations on a defined timeline. Expect announcements on technology expansion across e-waste verticals, plus additional supply and offtake agreements that firm up volume. If you care about battery recycling, rare earth supply chains, and the economics of circular materials, this conversation offers a clear view of where the market is going and how a chemistry-first approach can lead.

If you enjoyed this conversation, follow the show, share it with a colleague who tracks energy transition, and leave a quick review with the one insight you’re taking away.

A lab surprise turned frontline hope: we sit down with Dr Liz Dallimore, CEO of Argenica Therapeutics, to unpack a peptide drug designed to protect the brain during the chaotic minutes after stroke and other injuries. Built from a chain of arginines, the therapy targets the glutamate‑driven calcium surge that kills neurons, aiming to stabilise tissue while clot dissolvers or thrombectomy restore blood flow.

We trace Argenica’s journey from Perth lab benches to a multi‑centre Phase 2 trial across Australia, where the drug met its primary safety endpoint and showed encouraging trends in functional outcomes at day 30 and day 90, including a 23% improvement in cognitive impairment at day 90. Just as important, the 10‑minute IV infusion fits the reality of emergency care and did not interfere with the efficacy of standard clot‑busting drugs. That bedside practicality matters for hospitals and regulators alike, aligning neuroprotection with established stroke pathways.

The conversation digs into AI‑enabled imaging with Brainomix to better understand collateral flow, penumbra, and the fast‑progressor subgroup where an efficacy signal emerged. We also explore the broader pipeline: compelling ferret data in traumatic brain injury that supports a direct move into Phase 2, and an FDA‑orphan backed program in hypoxic ischaemic encephalopathy for newborns, now progressing through piglet studies and heading toward an IND and potential Fast Track. On capital, Liz outlines a pragmatic plan combining cash on hand, the R&D tax rebate, and non‑dilutive grants such as US Department of Defense funding to advance multiple trials without slowing the pivotal stroke study.

If you’re tracking innovations in stroke treatment, neuroprotective drugs, AI imaging in acute neurology, or the future of TBI and HIE care, this is a clear-eyed look at what’s working, what’s next, and how trial design is sharpening to benefit the right patients at the right time. Follow the show, share it with a colleague, and leave a review to tell us which milestone you’re watching next.

Heavy industry doesn’t need another moonshot. It needs a practical way to swap carbon-heavy hydrogen for a cleaner, cost-competitive alternative that slots into plants already running at scale. That’s where Hazer Group steps in: an iron ore–catalysed process that turns methane into clean hydrogen and high-purity graphite, delivered through a fluidised bed reactor built for industrial realities, not lab-bench hopes.

We sit down with Hazer CEO Glenn Corrie to unpack how the technology works, why lowering operating temperature and energy demand is the real unlock for cost, and how a “climate brick” design plugs into ammonia, methanol, refining, LNG, and even power assets as an over-the-fence hydrogen solution. Glenn breaks down the momentum behind the strategic alliance with KBR, including a 30–50 ktpa process design package on track for early next year and a global go-to-market push that targets KBR’s deep footprint across hundreds of ammonia plants. The goal is simple and bold: replace steam methane reforming’s ten tonnes of CO2 per tonne of hydrogen with a drop-in, cleaner pathway that competes on price.

The story doesn’t end with hydrogen. For every unit of hydrogen produced, Hazer outputs around three and a half units of graphite—now a designated critical mineral in many regions. We explore the strategy to capture value from graphite amid tightening global supply, including partnerships with First Graphene and Mitsui, new IP in Singapore, and progress on purification to battery-grade specs. Add a strengthened cash runway via a non-dilutive R&D refund, reduced burn, and early revenues from paid studies, and the path to 2026 commercialisation sharpens into view.

If you’re tracking decarbonisation of ammonia, methanol, and steel—or you’re weighing the economics of clean hydrogen at industrial scale—this conversation offers a grounded, data-rich view of what’s next. Subscribe, share with a colleague who runs projects or plants, and leave a review with the one question you want us to put to Glenn in the next update.

A reliable pay cheque from shares sounds like a dream, but it doesn’t have to be. We sit down with portfolio manager Phil Cornet from Atlas Funds Management to unpack a straightforward idea with powerful outcomes: hold quality Australian dividend payers and sell call options over them to target a 10% annual cash yield, paid quarterly. It’s a candid look at how buy-write strategies trade some upside for steadier income and lower volatility, and why that swap can make sense when multiples stretch and nerves fray.

Phil walks us through the mechanics of covered calls in plain English, the role of option premiums in smoothing returns, and the clear limitations when markets surge. We dig into their stock selection process across the ASX 200, blending a quantitative dividend-and-liquidity screen with qualitative checks on balance sheets, earnings durability, and industry structure. Instead of big sector bets, the portfolio spreads across GICS groups and stays underweight tech where dividends and liquidity are thin, aiming to deliver market-like breadth with a calmer ride.

We also talk practicalities: who uses a strategy like this, how advisers and institutions blend it with growth allocations, and what realistic distribution targets look like in shifting rate and volatility regimes. With a benchmark tied to RBA cash plus 3%, the fund sets a clear income bar above term deposits, while acknowledging the inevitable trade-offs in runaway bull markets. If you value dependable cash flow, franking potential, and measured risk-taking over chasing every last uptick, this conversation offers a grounded blueprint for income from Australian equities.

Enjoyed the conversation? Follow the show, share it with a friend, and leave a quick review so others can find it. Your feedback helps us bring you more clear, practical investing insights.

Prices are surging, supply is squeezed, and buyers are searching for reliable sources of tungsten outside China and Russia. We sit down with Gary Lyons, Non‑Executive Chair of Tungsten Mining, to unpack how Mt Mulgine in Western Australia could become a cornerstone supplier for hardmetals, aerospace, energy, and defence—while using near‑term gold to fund the path to scale.

Gary takes us inside the market fundamentals: China at roughly 80% of concentrate, Russia near 10%, export bans in place, and a demand profile that could double over the next eight years. Against this backdrop, Mt Mulgine stands out for its size, jurisdictional stability, and multi‑commodity upside—including molybdenum, copper, and silver. We explore the company’s $9.5m capital raise and why a staged, gold‑first approach—supported by strong metallurgical test work and conventional processing—can create early cash flow, reduce upfront capital intensity, and de‑risk the larger tungsten build.

We map the execution roadmap from studies to site: advancing engineering, environmental work, and permitting; fast‑tracking PFS and moving to DFS with a target to finalise by end‑2026 to early 2027; and aligning development with market and partnership conditions. Gary also reflects on portfolio strategy—how a years‑long acquisition program built one of the largest “tungsten warehouses” outside China, and why the focus now is on unlocking value rather than more deals. If you care about critical minerals security, supply diversification, and the practical steps to bring a world‑class tungsten project online, this conversation offers clarity, timelines, and a compelling plan.

Enjoyed the chat? Follow the show, share it with a colleague who tracks critical minerals, and leave a quick review to help others find us.

Australia’s Iron Corridor is one of the busiest shipping routes on earth—and one of the hardest to decarbonise. We sit down with NH3 Clean Energy chair Charles Whitfield to map a practical path forward: large-scale clean ammonia produced in the Pilbara, bunkered at Dampier, and burned by a new generation of ammonia-ready ships. Instead of chasing hype, we dig into the concrete pieces now falling into place: a 650,000 tpa phase one (scaling to 1.3 million), a 2029 first production target, and a landmark MOU with Mitsui O.S.K. Lines and Oceania Marine Energy to build a reliable bunkering ecosystem.

We unpack the demand flywheel driven by Japanese and Korean energy policies and the looming economics of the IMO’s carbon pricing from 2028. Charles explains why an end-to-end value chain matters—production at Maitland, near-port storage for fast turnarounds, refuelling tankers operated by Oceania, and MOL’s leadership on the Pilbara–Asia route—to make switching easy for iron ore exporters. A scarce 7.5-hectare site at the Port of Dampier emerges as a quiet game-changer, enabling storage buffers, efficient loading, and scalable capacity for both export cargoes and marine fuel, reducing bottlenecks and downtime.

We also talk investor milestones on the road to a 2026 final investment decision: approvals, detailed engineering, construction and operations agreements, and financing pathways. Whether via traditional project finance and an EPC partner or a build–own–operate collaboration, the team’s strategy is to de-risk delivery while aligning with Western Australia’s push to become a global renewable energy powerhouse. If you’re tracking clean shipping, hydrogen and ammonia markets, or ASX-listed energy transition plays, this conversation lays out the how, not just the why.

Enjoyed the chat? Follow the show, share this episode with a colleague in shipping or resources, and leave a short review to help more people find thoughtful conversations on clean energy and decarbonised trade.

What if the real competitive edge in enterprise transformation isn’t a new tool, but the ability to deliver at speed with trust? We sit down with StepChange Holdings’ managing director Shane Bransby to unpack how a fresh ASX listing became a lever for credibility, talent, and tier-one wins—especially across Western Australia’s resource-heavy economy where multi-year programs demand both governance and grit.

We explore why demand for ERP transformation keeps rising: capital projects in mining and energy, the urgency of cloud migration, and the push for measurable productivity gains in finance, HR, and supply chain. From SAP-led programs to pragmatic client-side integration, we share the playbook that’s helping StepChange beat prospectus forecasts and grow to 161 billable consultants. Being sovereign-based and on the ground in Perth matters here—shorter feedback loops, tighter security postures, and a delivery culture that prioritises outcomes over slideware.

You’ll hear how cloud is the true starting line for AI, not the finish, and why structured ERP data unlocks practical automation—from invoice coding and asset maintenance to demand planning and spend analytics. We also talk through the growth thesis for FY26: steady organic demand from tier-one clients, a measured M&A strategy to add specialisation and scale, and the operating discipline that turns programs into referenceable wins. If you care about SAP, cloud ERP, AI readiness, or the realities of building a credible consultancy on the ASX, this conversation offers a clear, actionable view of what creates value right now.

If this resonated, follow the show, share it with a colleague, and leave a quick review—your support helps more leaders find conversations like this.

Healthcare shouldn’t feel like a maze. In this candid talk with Global Health Managing Director Mathew Cherian, we unpack how a connected SaaS stack—MasterCare+ for clinicians, Lifecard for consumers, HotHealth as the digital front door, and ReferralNet for secure messaging—can turn fragmented journeys into coordinated care. The stakes are real: chronic mental health, diabetes, cardiovascular disease, and AOD services demand team-based workflows that stretch from hospital to home. With budgets tight across public and private sectors, the only path forward is smarter systems that do more with less.

Mathew explains the company’s heavy lift from legacy desktop to modern SaaS and AI, a three-year investment that’s now driving a 6% subscription revenue lift and a return to positive operating margins. We dig into practical AI: scribes that cut documentation time, triage avatars that route people to the right help, and clinical documentation support that raises quality and compliance. The vision is grounded—open integrations, best-of-breed components, and choice for customers—so organisations can adopt the right tools without lock-in.

We also explore growth levers: Lifecard’s refreshed UI/UX and new monetisation via direct-to-consumer and B2B2C models; a partnership with Best Practice that opens access to 6,000+ GP practices; and a measured international push into ASEAN markets where ageing populations and chronic disease trends mirror Australia’s. With R&D spend tapering and more than a dozen implementations underway, the team is shifting energy to sales, marketing, and repeatable migrations that compress delivery timelines and improve margins. The message to investors is clear: complete the SaaS transition in 12–18 months, grow ARR, and return to profitability by June 2026, with a portfolio that follows the patient from first consult to recovery across settings.

If you value thoughtful takes on digital health, AI in care delivery, and the hard work of turning platforms into outcomes, this conversation is for you. Subscribe, share with a colleague who’s wrestling with care coordination, and leave a review with your biggest question about patient-controlled records.

Rare earth elements are the unsung heroes powering everything from wind turbines to guided missiles, yet securing their supply remains one of the greatest challenges in the transition to clean energy and advanced technologies. In this revealing conversation with Andrew Reid, Managing Director of Brazilian Critical Minerals, we explore a breakthrough that could fundamentally alter the rare earth landscape.

The results from BCM's in-situ pilot trials at their Ema Project in Brazil have exceeded all expectations. Solution grades reaching nearly 8,000 ppm – far surpassing laboratory predictions – demonstrate the exceptional leaching characteristics of their ionic clay deposit. "Every time we ask it to perform, it's been able to deliver quite outstanding results," Reid explains. Perhaps most striking is how the mineralization, while not exceptionally high-grade in the ground, achieves remarkable recovery rates through their innovative extraction approach.

What truly sets the Ema Project apart is its economic profile. With a projected capital cost of just US$55 million – a fraction of what competitors require – BCM has positioned itself to potentially become the next commercial rare earth producer outside China. This capital efficiency isn't just good for investors; it dramatically accelerates the timeline to production at a moment when rare earth prices have surged 30% in recent months. The project's unique composition includes significant quantities of samarium and other middle rare earths crucial for defense and aerospace applications, making it exceptionally valuable for strategic industries.

As the company progresses toward completion of its feasibility study in early 2024, the Ema Project represents a potential turning point in Western efforts to secure critical mineral supply chains. For investors watching the critical minerals space, Brazilian Critical Minerals offers a compelling combination of technical innovation, capital efficiency, and strategic value that's worth following closely. Subscribe to hear more breakthrough stories from companies transforming the resources landscape.

A blocked artery isn’t the end of the story—what happens when blood rushes back can decide how much tissue survives. We sit down with Nyrada CEO James Bonner to unpack how Xolatryp, a small molecule TRPC channel blocker, aims to protect mitochondria, cut calcium overload, and reduce injury after heart attack, traumatic brain injury, and stroke. With Phase I safety in the bank and a Phase IIA study planned for PCI patients, we dig into the practical metrics that matter: MRI‑based infarct size, blood biomarkers, heart function, and arrhythmia rates.

James explains why mitochondrial stability is the hinge point in ischemia‑reperfusion injury and how preclinical work with the Walter Reed Army Institute of Research supports Xolatryp’s mechanism. We talk through the study design choices that bring the drug into the cath lab at the right moment, the potential to standardize dosing alongside angioplasty, and the broader clinical logic that could translate across cardiology and neurology. The conversation also explores Nyrada’s IP moat with a composition‑of‑matter patent, the company’s lean, virtual operating model, and a funding plan combining new equity and R&D rebates to carry the program through Phase IIA.

If you care about where the next leap in acute care may come from, this is a grounded look at a therapy built for minutes‑matter medicine. We share Nyrada’s two‑to‑three‑year outlook, including a licensing‑by‑indication strategy across key markets, and frame the market size anchored by roughly two million annual PCI procedures in developed regions. Subscribe for more ASX‑focused biotech briefings, share this with a colleague who tracks cardiovascular or neuro trauma innovations, and leave a review to tell us which endpoints you believe should define success.

Dive deep into Medallion Metals ambitious gold and copper development strategy with Managing Director Paul Bennett in this revealing conversation. Paul outlines how the company is revolutionising their approach by acquiring the Forrestania processing infrastructure from IGO, a move that dramatically reduces both time and capital requirements on their path to production.

With impressive mineral resources of 1.1 million ounces of gold and 40,000 tonnes of copper in Western Australia's southern goldfields, Medallion is strategically positioned for growth. Paul explains their calculated decision to secure a secondary ball mill ahead of final investment decision, keeping them on track for first metal production by late 2026 and commercial production in 2027.

The economics look compelling – their previous scoping study showed a $329 million NPV and 129% IRR, figures that are likely to improve substantially given rising gold prices and plans to increase mill throughput. Recent drilling at the Kundip Mining Centre has revealed exciting new loads that could extend mine life and increase production rates, while strong interest from offtake partners (with some offering funding solutions up to $85 million) validates the project's quality.

With $29 million in cash reserves and a clear development pathway, Medallion Metals stands at the threshold of transformation. Whether you're an investor seeking exposure to precious metals, a mining enthusiast tracking emerging producers, or simply curious about innovative approaches in the resources sector, this episode offers valuable insights into a company poised for significant growth. Subscribe to ASX Briefs for more conversations with the leaders shaping Australia's mining future.

The global logistics industry is long overdue for a technological revolution. With most systems still running on software developed 25-30 years ago, freight forwarders and customs brokers have been starved of innovation and choice. That's where Yojee Limited steps in.

Mark Connell, CEO of Yojee Limited, reveals how his company is disrupting traditional logistics models with their groundbreaking MOSAIC platform. Unlike competitors who simply build "better mousetraps," Yojee approaches longstanding industry problems from entirely fresh angles. Their single, seamless global platform unites supply chain participants in a community-driven ecosystem that simplifies cargo management while challenging entrenched incumbents.

The market response has been extraordinary. Following MOSAIC's unveiling at Australia's largest freight forwarding conference, Yojee saw their share price jump as industry insiders rushed to invest. A recent heavily oversubscribed capital raise will accelerate R&D at their Sydney headquarters and support expansion of their Transport Carrier Management System (TCMS) across Asia Pacific.

Perhaps most impressive is Yojee's strategic shortcutting of barriers that have kept others from challenging industry monopolies. Through their SmartYojee joint venture, they've secured critical customs technology—typically taking years to develop—reducing both time-to-market and costs by 2-5 years. Meanwhile, enterprise contracts with major players like APP Indonesia and Röhlig Logistics Singapore are providing immediate revenue streams.

What's next? Their beta program remains on track for completion this quarter, with revenue-generating contracts expected in early 2026. From there, expansion will continue across Australia, New Zealand, Southeast Asia and eventually into Africa and Latin America. Want to witness a logistics revolution in action? Yojee is definitely one to watch.

Discover how Critica Limited is positioning itself to become Australia's next rare earth developer through its flagship Jupiter project – the largest clay-hosted rare earth deposit in Australia with an impressive 1.8 billion tons of resource at 1,700 ppm TREO.

CEO Jacob Deysel, a mining engineer with nearly three decades of global experience, reveals the three key advantages setting Jupiter apart: scale, simplicity, and speed. The project's innovative beneficiation-first approach reduces mass by 95% while achieving an 800% upgrade in feed grade using conventional metallurgical equipment. This pathway delivers a high-grade mixed rare earth carbonate while keeping capital expenditure, operating costs, and environmental footprint exceptionally lean.

What makes Jupiter particularly valuable is its rich concentration of magnet rare earth elements – neodymium, praseodymium, terbium, and dysprosium – which represent 80-90% of the basket value and are essential for manufacturing permanent magnets that power future technologies. With China controlling approximately 70% of global mining and 90% of refining capacity, Western manufacturers are urgently seeking alternative, transparent, and ESG-compliant supplies of these critical minerals.

Jupiter's concentrate also features exceptionally low uranium and thorium levels, simplifying approvals, shipping logistics, and market access to sensitive regions including the US, Japan, Korea, and Europe. Beyond Jupiter, satellite discoveries at Aurora and Juno demonstrate the district-scale potential of the Brothers project, potentially transforming it from a single-deposit story into a multi-deposit rare earth district.

Listen as Jacob outlines Critica's ambitious development timeline, including partnerships with ANSTO, Minutech, and GAVAQ to advance their metallurgical program, a pilot plant to upscale beneficiation, and a comprehensive scoping study expected before mid-2024. Subscribe to ASX Briefs for ongoing updates as Critica works to transform Jupiter from a world-class resource into Australia's next rare earth development success story.

Ever wondered how a small Australian explorer becomes a key player in America's critical minerals strategy? Jindalee Lithium's story might just be the blueprint.

The race for battery metal security is reshaping global mining, and Jindalee has positioned itself at the center of America's lithium ambitions. In this compelling conversation with CEO Ian Rodger, we dive deep into the McDermitt Project – one of the largest lithium resources in the United States, strategically located on the Oregon-Nevada border.

What makes this discussion particularly timely is Jindalee's recently announced SPAC transaction that values McDermitt at a staggering US$500 million while allowing the company to retain approximately 80% ownership. This clever structure opens doors to deep US capital markets without surrendering control, creating a dedicated vehicle to advance the project toward production. As Ian explains, "The natural long-term owners of this project are US investors," highlighting the strategic wisdom behind this corporate maneuver.

The McDermitt Project's significance extends beyond its size. Its designation under FAST-41 (one of just ten projects nationwide) and collaborative agreements with the Department of Energy underscore its importance to American mineral security. 

After two challenging years for lithium markets, green shoots are emerging – perfect timing as Jindalee transitions from explorer to developer. For investors seeking exposure to the critical minerals space, this ASX-listed company offers a compelling entry point to America's lithium future. Subscribe now to stay updated on Jindalee's journey and discover more strategic opportunities reshaping global supply chains.

Water is our most precious resource, yet industries worldwide face increasingly complex challenges in using it efficiently and responsibly. In this fascinating conversation with Seán Halpin, Managing Director & CEO of SciDev Limited (ASX: SDV), we explore how this Australian company is revolutionising water treatment across multiple sectors with proprietary technologies that deliver both environmental and economic benefits.

Seán reveals SciDev's dual-focused business model spanning Chemical Services and Water Technologies, united by a compelling purpose: solving industry's most complex water problems. The company helps heavy industry reduce fresh water consumption, promote efficient water use, minimise contaminated water production, and repair legacy environmental damage across mining, energy, infrastructure, remediation and defence sectors.

Despite FY25 being what Seán describes as a "pivotal year" with strategic wins rather than dramatic financial growth, the future looks exceptionally bright. With FY26 revenue guidance of $120-140 million, improved gross margins of 28%, and significant contract wins in Q4, SciDev is positioned for substantial growth. Particularly exciting is their CatChek product for the oil and gas industry, which saw 46% year-on-year growth and secured a master services agreement in the Permian Basin.

Perhaps most intriguing is SciDev's FluorofIX technology tackling PFAS contamination—the "forever chemicals" creating environmental havoc worldwide. Seán reveals the European remediation market alone could be worth an astonishing 2-3 trillion USD. With contracts already secured across Australia, Europe and with the US Department of Defense, SciDev stands at the forefront of solving one of our era's most pressing environmental challenges.

Listen now to discover how SciDev is transforming industrial water challenges into opportunities and why this Australian innovator deserves a spot on your investment watchlist.

Revolutionary cancer therapies are no longer confined to science fiction. Dr. Michael Baker, CEO of Arovella Therapeutics (ASX: ALA), reveals how the company's groundbreaking work with invariant natural killer T-cells (iNKT cells) is transforming cancer treatment through truly off-the-shelf cell therapies.

Traditional cell therapies face significant hurdles – they're expensive, time-consuming to produce, and limited to treating the same patient they're derived from. Arovella's approach elegantly solves these problems. "iNKT cells can be given freely from one person to another," explains Dr. Baker, highlighting their unique ability to bypass rejection issues that plague other immune cell therapies. This revolutionary approach means potentially hundreds of doses can be manufactured in a single run, dramatically improving accessibility and reducing costs.

The clinical promise extends beyond manufacturing advantages. Early studies show iNKT-based therapies may offer improved safety profiles compared to traditional CAR-T, with reduced rates of serious side effects like cytokine release syndrome and neurotoxicity. Arovella's pipeline includes ALA-101 for blood cancers, advancing toward clinical trials in 2026, and ALA-105 targeting solid tumours like gastric and pancreatic cancers – areas with devastating mortality rates and few effective treatments. Their collaboration with the University of North Carolina on IL-12-TM "armoring" technology further enhances these cells' cancer-fighting abilities by increasing their persistence and tumour infiltration.

Ready to witness the next evolution in cancer treatment? Follow Arovella Therapeutics as they advance their pipeline toward clinical trials and potentially reshape how we approach cancer therapy. With recent funding secured and clear strategic direction, they're positioned at the forefront of a therapeutic revolution that could benefit countless cancer patients worldwide.

The future of education assessment is digital, and Janison Education Group is leading the global transformation. In this eye-opening conversation, CEO Sujata Stead reveals how this Australian tech pioneer has evolved from its humble beginnings in country NSW to delivering over 7 million assessments across 117 countries annually.

Janison's impressive growth trajectory continues with 9% revenue growth to $47 million in FY25, a healthy $11 million cash position, and zero debt. Their strategic focus balances foundational investments with disciplined execution, yielding both immediate returns and positioning for accelerated future growth. The company's $28.6 million pipeline spans government, professional accreditation, and higher education sectors, with significant concentration in the APAC and UK regions.

What truly sets Janison apart is their revolutionary AI-powered assessment authoring platform, Jai. This game-changing innovation has slashed item development costs by half while boosting productivity five-fold, with no compromise on quality. Early adopters report 70% faster development processes with over 90% acceptance rates of AI-generated items. As Stead explains, "Jai is a great example of how you keep humans still central to the assessment process... but you augment the process by using AI."

The company's credentials in large-scale assessment delivery are unmatched, from managing Australia's NAPLAN tests to their recent landmark contract with the New Zealand Ministry of Education. With a refreshed leadership team and board now in place, Janison is perfectly positioned to capture a significant share of the digital assessment market, projected to reach US$26 billion by 2032. For educators, institutions, and investors alike, Janison represents the cutting edge of how technology is revolutionizing how we measure and unlock human potential.

Curious about how AI and digital transformation might reshape assessment in your organization? Join the conversation and discover how Australian innovation is making global impacts in educational technology.

The merger of Prophecy International Holdings and Complexica represents a watershed moment in Australian enterprise technology. As artificial intelligence continues to transform business operations worldwide, this strategic combination creates something truly unique in the ASX landscape – a comprehensive, end-to-end AI technology company with deep expertise and global reach.

What makes this merger particularly compelling is how perfectly complementary these businesses are. Prophecy brings four decades of experience in enterprise data management, having evolved from an on-premise software provider into a sophisticated cloud-based data platform handling integration, security, and analytics. Complexica contributes cutting-edge AI optimization capabilities honed over twelve years as an "AI-first" company, long before the current wave of AI enthusiasm. Together, they address the complete technology stack required for successful enterprise AI implementation.

The practical impact of this combination becomes clear when examining Complexica's work in trade promotion optimization. By analyzing thousands of variables across product economics, pricing sensitivities, cross-product impacts, and external factors, their AI technology creates optimized promotional strategies that deliver measurable ROI. Now, with Prophecy's data orchestration capabilities integrated into the solution, customers gain a seamless path from raw data to actionable AI insights – solving one of the most significant challenges in enterprise AI adoption.

For investors seeking meaningful exposure to the AI revolution through an established, enterprise-grade vehicle, Complexica Group offers a differentiated opportunity. With over 500 major enterprise customers globally, proven AI technology, and the combined expertise of two highly specialized teams, this merger creates a platform for sustained innovation and growth in one of technology's most promising sectors. Subscribe to ASX Briefs for more insights into innovative Australian companies transforming global industries.

The sky above Australia's mining sector is changing dramatically as autonomous drones revolutionise how critical data is gathered, processed, and utilised. In this revealing conversation with Chris Clark, Managing Director of RocketDNA, we uncover the remarkable journey from conventional drone services to AI-powered autonomous aerial solutions that are now embedded in the daily operations of Australia's biggest miners.

What began as a response to nighttime security threats at an African mine has evolved into a sophisticated remote operation system that's transforming mining workflows across continents. Chris shares how RocketDNA's technology allows operators in Perth and Adelaide to safely manage drone flights at sites thousands of kilometres away, creating an "everyday accessible utility" for both on-site teams and corporate decision-makers. The proof is in the contracts – with Vault Minerals and Goldfields recently signing long-term agreements that signal a fundamental shift in how the industry views this technology.

The conversation reveals fascinating insights into how RocketDNA's "land and expand" strategy works in practice, with customers typically starting with one or two specific applications before quickly discovering additional uses across multiple departments. With flight activity up 97% quarter-on-quarter and deployments expanding to BHP's Prominent Hill, Bowen Basin coal operations, and international sites in Africa and Papua New Guinea, the company has clearly moved beyond proof-of-concept to what Chris calls "proof of contract." For investors watching the intersection of AI, mining technology and drones, this represents a compelling case study in how innovation becomes indispensable through demonstrable ROI. Want to understand how aerial data is becoming the next essential mining tool? Listen now to hear directly from the company at the forefront of this transformation.

Gold explorers often make big promises, but Great Boulder Resources is quietly delivering real results at its flagship Side Well Gold Project near Meekatharra in Western Australia's gold-rich Murchison region. Managing Director Andrew Paterson shares how they've built a substantial high-grade resource in just four years, with clear pathways to reach one million ounces this year and ambitious plans for 1.5 million ounces in the medium term.

The company's approach blends methodical resource definition with strategic exploration across multiple prospects. Already boasting two-thirds of a million ounces at an impressive 2.8 grams per tonne, Side Well's growth story continues with recent drilling success at Eagle Hawk and Side Well South. Patterson details how they've expanded the already profitable Ironbark deposit, where high-grade gold averaging 3.3g/t extends from surface and continues southward with impressive new intersections between six and nine grams per tonne.

What makes Side Well particularly compelling is how each technical hurdle has become an opportunity. When the Ironbark extension was discovered beneath the Goldfields Highway, Paterson's team developed multiple pathways forward – either realigning the road for an expanded open pit or considering underground mining to access the high-grade ore. Similarly, concerns about copper affecting gold recovery were comprehensively addressed through metallurgical testing, revealing ore characteristics that make Side Well's material attractive even as toll-treated feed.

Perhaps most exciting is the discovery of a previously unrecognized corridor between the main mineralised trends, identified through IP surveys and about to be drill-tested. With $12 million in the bank and a balanced approach to both resource growth and new discoveries, Great Boulder Resources represents that rare combination in junior exploration – a company with proven resources, clear development pathways, and substantial blue-sky potential still to be unlocked. Follow our journey as we continue transforming Side Well into Western Australia's next significant gold development.

Ever wondered how a small ASX-listed company could be sitting on one of South Africa's largest onshore gas discoveries? Kinetiko Energy (ASX: KKO) is redefining energy exploration with their breakthrough at Brackfontein, delivering an eye-popping 370,000 cubic feet per day peak gas flow from a well just 417 metres deep.

Executive Chairman Adam Sierakowski takes us behind the scenes of this remarkable achievement, revealing how 144 metres of gas pay zone (representing 35% of the well's depth) validates their newly optimised drilling strategy. After facing challenges as first movers in South Africa's onshore gas sector, Kinetiko leveraged global expertise to completely reimagine their approach – and the results speak for themselves.

The company's certified 6 trillion cubic feet contingent resource is just the beginning, with Adam confidently targeting resources beyond 10 TCF. Their strategic partnership with South African energy group FFS Refiners accelerates the path to commercialisation, co-funding development of production clusters that could see first gas sales within just 18 months. The partnership envisions scaling to hundreds of wells, positioning Kinetiko to deliver significant value in South Africa's energy-hungry market.

With drilling underway on their seventh well, a debt-free balance sheet, and consistent news flow expected throughout coming months, Kinetiko stands at the threshold of transforming from explorer to producer. Don't miss this deep dive into one of Australia's most promising energy plays that's unlocking South Africa's natural gas potential. Subscribe to ASX Briefs for more insights into innovative Australian listed companies making global impacts.

Copper exploration is heating up in one of the world's richest mining districts, and Solis Minerals is right in the thick of the action. CEO Mitch Thomas joins us to share the exciting developments at their flagship Ilo Este project in Southern Peru, where a 5,000-metre diamond drilling campaign is currently underway.

The timing couldn't be better for this ASX-listed explorer as they target what could potentially be the high-grade core of an extensive porphyry system. Drawing on nearly 10,000 metres of historical drilling data from previous campaigns by Rio Tinto and Latin Resources, Solis is employing cutting-edge geophysical and geochemical analysis to pinpoint targets that were previously overlooked. As Mitch explains, "We are, or the previous drill holes were, in the cloud of a porphyry and the objective of the current drilling program is to really find the high-grade source."

What sets Solis apart is their strategic position in Peru's Southern Copper Belt – a region described as "the dominant source of supply of copper globally." This isn't just about geological potential; it's about practical advantages too. The company benefits from existing infrastructure, including concentrators, a refinery, smelter, and port facilities, providing a clear pathway to market for any discovery. Their portfolio extends beyond Ilo Este to include the promising Cinto project (acquired from BHP) adjacent to the 60-year-old Toquepala mine, and Chancho Al Palo, where assay results are pending.

With drilling updates expected in the coming weeks, assay results in September, and plans to drill Cinto before year-end, Solis is entering what Mitch calls "a very exciting period for the company." For investors looking for exposure to copper – a metal essential to global electrification – this emerging explorer offers a compelling opportunity to get in on the ground floor of what could become Peru's next significant copper discovery. 

Subscribe now to stay updated on Solis Minerals' progress as they pursue their ambitious exploration strategy in one of the world's premier copper jurisdictions.

Ever wondered how a marketplace business can achieve profitability while simultaneously expanding globally? Tim Fung, co-founder and CEO of Airtasker Limited, reveals exactly how they're doing it.

With $1.2 million in positive free cash flow for FY25—their second consecutive year—Airtasker has proven they're not dependent on external capital even while aggressively expanding. The Australian marketplace continues to thrive with 20.7% revenue growth in Q4, driven by strategic media partnerships that boost brand awareness. As Tim explains, "Airtasker's got a long way to go in the Australian market. It's an absolutely huge total addressable market," with current penetration at just 1%.

What's truly fascinating is their international expansion strategy. The UK marketplace reached $21 million GMV annual run rate in June 2025, less than two years after launch. Meanwhile, US operations achieved a staggering 754% revenue growth in Q4. The secret? A refined "marketplace playbook" that turns the art of building marketplaces into a repeatable science, deployed city by city across new markets. Their partnerships with media giants like OohMedia, ARN, Channel 4 Ventures, and Sinclair Broadcast Group create what Tim calls an "asymmetric upside"—these companies share the risk of market entry while providing cultural insights through their local news and morning shows.

Looking ahead to FY26, Airtasker is focused on building Australian brand awareness, improving repeat booking functionality, and refining their city expansion strategy. For investors and business leaders alike, this episode offers valuable insights into how a marketplace can achieve that elusive combination of profitability and rapid growth. 

Subscribe to ASX Briefs for more conversations with innovative company leaders who are transforming their industries.

Ever wondered what powers cutting-edge wound healing technology that's transforming patient outcomes while delivering consistent financial growth? Our conversation with Brian Ward, CEO of Aroa Biosurgery, provides remarkable insights into this innovative ASX-listed company.

Aroa has emerged as a high-growth soft tissue reconstruction powerhouse leveraging proprietary ECM technology across four product families. With over 7 million patient treatments to date, they're targeting a $3 billion market opportunity primarily in the US. What makes their approach particularly compelling is the dual benefit they offer – superior clinical outcomes alongside significant cost reductions for healthcare providers.

The numbers tell a compelling story: three consecutive quarters of positive cash flow, NZD$22 million in the bank, and ambitious FY26 targets of up to $100 million in revenue. But it's the clinical evidence that truly sets Aroa apart. Their recent study involving 830 patients showed Endoform Natural heals venous leg ulcers up to eight weeks faster than leading competitors – a life-changing difference for patients at risk of amputation. With a 40% increase in healing probability for difficult cases, it's clear why healthcare professionals are taking notice.

As Brian explains, upcoming clinical studies, expanding sales productivity, and strategic market engagement through major industry conferences are positioning Aroa for continued growth. Whether you're an investor looking for healthcare innovation or a medical professional interested in next-generation healing technologies, this episode offers valuable insights into a company transforming soft tissue regeneration. 

Subscribe to ASX Briefs for more conversations with leaders of Australia's most exciting companies.

Phil Russo, Managing Director of Toubani Resources, returns to ASX Briefs to share the remarkable progress of the company's flagship Kobada Gold Project in Southern Mali. At the heart of this exciting development is a 2.2 million ounce resource with game-changing characteristics that set it apart from typical gold projects.

What makes Kobada truly special is its oxide-dominated profile – "free-dig, free-milling soft rock ore" that permeates every aspect of the project. This distinctive feature dramatically impacts the technical approach, economic projections, and capital requirements, creating what Russo describes as a project that can produce 162,000 ounces annually for nearly a decade at exceptionally competitive costs.

The company is advancing at full speed toward a final investment decision later this year, with multiple workstreams running concurrently. Two drilling rigs are actively exploring fresh and oxide rock to expand the resource, while permitting and government negotiations progress steadily. The project's exploration upside is substantial – with only 11 kilometres of their 50-kilometre shear zone drilled to date, and current drilling averaging just 130 metres deep across a 5-kilometre strike length. As Russo notes, "the more you drill, the more gold you find here."

Financially, Toubani has significantly strengthened its position, securing a $29 million placement that includes strategic investment from A2MP Investments, plus a non-binding debt commitment letter for at least US$160 million. This robust financial backing, combined with the project's favourable economics, puts Toubani "in control of our own destiny" according to Russo.

Subscribe to ASX Briefs for continuing coverage of this developing story and more conversations with leaders of ASX-listed companies.

The future of data infrastructure is modular, scalable, and rapidly deployable – and DXN Limited is leading the transformation. In this revealing conversation with CEO and Managing Director Shalini Lagrutta, we explore how this Australian company has achieved remarkable 48% revenue growth by revolutionising critical infrastructure deployment across telecommunications, satellite communications, defence, and AI sectors.

Shalini breaks down DXN's three-part business model: their core prefabricated modular data centres (approaching their 100th global deployment), owned edge data centres providing recurring revenue, and their newest strategic pivot – Data Centre as a Service. This innovative approach has secured contracts with major players like Globalstar for satellite ground infrastructure in Hawaii and a US-based satellite operator in Northern Territory, demonstrating their global capabilities and trusted reputation for quality builds in remote locations.

What makes DXN stand out in competitive global tenders? Their nimble approach to customisation and ability to integrate emerging technologies gives them an edge that larger competitors can't match. The StructCore indoor solution opens new markets for brownfield telco exchange upgrades, while their hyperscale prefabrication capabilities address the Asia-Pacific region's resource constraints. Perhaps most exciting is their move into AI-enabled high-density computing environments supporting up to 120kW per rack – positioning them perfectly for the GPU-as-a-service revolution.

Discover how DXN's prefabricated approach is reshaping critical infrastructure deployment worldwide and why their strategic expansion into recurring revenue models signals a promising future. Subscribe now to stay updated on the companies building tomorrow's digital backbone.

The defence industry is experiencing a technological revolution, and Australian company HighCom Limited is positioning itself at the cutting edge. When HighCom CEO Todd Ashurst explains their proprietary XTclave™ technology, he doesn't mince words: "While ovens and autoclaves operate at 1 to 15 bar pressure, our technology goes to 300 bar pressure, which is like diving on the Titanic."

This remarkable pressure system represents a quantum leap in ballistic protection manufacturing. Unlike conventional methods, HighCom's approach allows for creating complex geometries impossible with standard technology – including anatomically correct female body armour and ultra-lightweight plates that maintain superior protection. The strategic relocation of this system from Adelaide to Ohio wasn't just about doubling production capacity; it was a calculated move to overcome the "Buy America Act" restrictions that had previously limited HighCom's access to the world's largest body armour market.

What makes HighCom particularly fascinating is how they're diversifying beyond traditional ballistic protection. Their recent $2.6 million contract with the Australian Department of Defence for counter-drone systems showcases their adaptability. Ashurst, drawing from his personal experience as a NATO counter-UAS officer in Afghanistan, sees this as a natural extension of their expertise. With over 160,000 armour plates already supplied to Ukraine and ten new XTclave™ manufactured products scheduled for release between September and January, HighCom exemplifies how Australian defence innovation is making global impact. Their unique approach combines technological superiority with strategic market positioning – creating lighter, stronger protection systems that both military personnel and shareholders can appreciate.

Ready to learn how Australian defence technology is revolutionising battlefield protection? Subscribe to ASX Briefs for more exclusive conversations with the executives reshaping crucial industries.

Gold exploration in West Africa is heating up, and African Gold Limited is at the forefront with their flagship Didievi project in Côte d'Ivoire. CEO Adam Oehlman joins us to unveil a story of remarkable resource growth, strategic partnerships, and multiple pathways to development.

The numbers speak for themselves: a high-grade resource approaching 1 million ounces at an impressive 2.5 grams per tonne from surface. But what's truly exciting is that this is just the beginning. The deposit remains open in all directions – along strike, at depth, and to the east – with Adam emphasizing their commitment to maintaining the high-grade, open-pit nature of the project while aggressively expanding the resource footprint.

A game-changing $12 million strategic partnership with Montage Gold has transformed operations, bringing big-company technical expertise and in-country support to accelerate development. With Montage now operating the project under a joint technical committee, African Gold has the perfect blend of major company capabilities and junior explorer agility. The strategic location of Didievi, sitting within 60 kilometres of three major gold mills, creates compelling development options including potential satellite mining arrangements.

Beyond the main Blaffo Guetto resource, promising discoveries at Poku and Pranoi demonstrate the broader potential of the land package, with eight additional drill-ready targets waiting to be tested. With plans to scale up from one to four drill rigs before year-end, the company is positioned for a steady stream of results and potential catalysts.

Ready to follow African Gold's journey from exploration to development? Subscribe to ASX Briefs for ongoing updates as this dynamic company unlocks the multi-million ounce potential of their West African gold assets.

The security landscape is rapidly evolving, and at the forefront of this transformation stands Intelligent Monitoring Group. Returning to our podcast, Managing Director Dennison Hambling reveals how this ASX-listed company has positioned itself as Australasia's largest security monitoring business, serving 200,000 customers through its renowned ADT brand and technical services division.

What truly captivates in this conversation is the company's remarkable financial turnaround. After completing what Dennison calls "the complete financial cleanup," the company delivered an eye-opening $17 million in net operating cash flow in Q4. This impressive figure finally makes visible what management has long promised – that beneath the transitional costs and acquisitions lies a business with powerful cash-generating capabilities and solid recurring revenue.

The technological evolution of security monitoring takes center stage with their ADT Guard service. Moving beyond traditional alarm systems that merely alert after a breach, this AI-powered video surveillance allows operators to actively monitor situations, speak directly to intruders, and make real-time threat assessments. With over 300 sites protected and 30+ criminal apprehensions directly attributed to the system, IMG isn't just monitoring security – they're actively deterring crime and reshaping what's possible in the industry.

Strategic acquisitions have consistently performed "to the upside", while the company's new market segmentation into direct, partnership, and wholesale channels brings clarity to their business model. Now entering a growth phase with strong financial foundations, IMG has launched a share buyback program while maintaining flexibility for future opportunities in this fragmented industry.

For anyone interested in security technology innovations or ASX investment opportunities with recurring revenue profiles, this conversation provides valuable insights into a company transforming its sector.

Financial management shouldn't be complicated. That's the driving philosophy behind One Click Group's rapid ascent in Australia's fintech landscape, as revealed in my latest conversation with Managing Director Mark Waller.

One Click has transformed financial services through simplicity. Their mobile-first tax platform pulls information directly from the ATO, allowing users to lodge returns with unprecedented ease—particularly valuable considering recent research showing 45% of Australian adults are financially illiterate. This approach has fueled remarkable growth: revenues have jumped from $1 million to nearly $5 million since listing in 2022, with this year's figures already shattering records. Most tellingly, their returning customer rate has surged to 72%, a powerful testament to their service quality and user satisfaction.

What began as a tax-focused service has evolved into a comprehensive financial ecosystem spanning tax, wills, lending, insurance, and mortgages. Their newest offering, the "Little Money" cash advance product, strategically extends their value proposition beyond the seasonal tax period. Next on their roadmap is superannuation services, targeting their predominantly younger customer base of transient workers who often accumulate multiple super accounts as they job-hop. By simplifying super management and encouraging early engagement, One Click aims to significantly improve long-term financial outcomes for Australians.

Ready to simplify your financial life? Discover how One Click is revolutionizing personal finance management for everyday Australians through innovative technology and user-first design. Listen to the full conversation now and see why they're outperforming the market while maintaining their commitment to simplicity and accessibility.

The global bauxite landscape is shifting dramatically, and ASX newcomer VBX Limited is positioning itself at the forefront of this transformation. Fresh from completing a $10 million IPO that was oversubscribed with strong institutional support, Managing Director Ryan de Franck reveals why this Northern Australian bauxite developer has captured investor attention at such a critical market juncture.

With Chinese bauxite demand surging 33% year-to-date and Guinea now supplying a precarious 80% of that market, VBX's advanced Wuudagu project in Western Australia's far north emerges as a compelling alternative. The project's Guinea-equivalent low-silica product, combined with efficient logistics from a stable jurisdiction, addresses growing concerns about supply chain security. What makes this opportunity particularly intriguing is that the current 96 million tonne resource has been defined from just 48% of the plateau target areas, suggesting significant exploration upside still to be captured.

Ryan outlines an ambitious timeline that would see VBX complete its Definitive Feasibility Study by year-end, secure project financing and offtake agreements in early 2026, and achieve first production by the close of next year. The company's tight capital structure and high management ownership levels ensure strong alignment with shareholders throughout this journey. As Australia's share of Chinese bauxite imports has slipped from 25% to just 16%, VBX appears perfectly positioned to capitalize on emerging market gaps while offering refiners a product that maintains the low silica content they require to control processing costs.

Subscribe to ASX Briefs for more conversations with the innovators and leaders transforming Australian industry and creating tomorrow's market opportunities.

Dive deep into the lithium frontier with Matt Hartmann, President of US Operations at IRIS Metals Limited, as he unveils the company's ambitious strategy in South Dakota's mineral-rich Black Hills.

Matt reveals how this ASX-listed company has quietly amassed an impressive 170-square-kilometer portfolio of mining claims since pivoting to US lithium in 2022. What makes their approach particularly compelling is the speed at which they're advancing—already boasting 20,000 meters of drilling, multiple permitted pegmatites, and the recent completion of test mining at their flagship Longview deposit.

The conversation explores their initial resource of 2.2 million tons at just over 1% Li2O at Longview, but perhaps most fascinating is the detailed look at Tin Mountain – a unique pegmatite containing spodumene crystals "the size of tree trunks" alongside a treasure trove of other critical minerals including cesium, tantalum, and beryllium.

At the heart of IRIS Metals' strategy is their hub-and-spoke model, designed to maximize efficiency by operating multiple high-grade mine sites simultaneously to feed a centralized processing facility. Matt explains how this approach capitalizes on the outcropping nature of the pegmatites and the region's excellent infrastructure, enabling a development that harmonizes with local communities.

Subscribe to ASX Briefs for more exclusive conversations with the executives driving Australia's most dynamic companies – and discover your next investment opportunity before the market catches on.

Striking gold on your first drill hole is the stuff of mining dreams, and that's exactly what happened for Olympio Metals (ASX: OLY). Managing Director Sean Delaney joins us to share this exciting development from their Paquin prospect within the Bousquet Gold Project in Quebec, Canada.

The story gets even more compelling when you understand the location. Situated along the legendary Cadillac Break—a geological feature responsible for over 100 million ounces of historical gold production—Olympio's projects benefit from both world-class mineral potential and exceptional infrastructure. With the Trans-Canada Highway running through the property and proximity to operating mines and processing facilities, they're strategically positioned in what Delaney describes as "absolutely brilliant" real estate.

Beyond their golden aspirations, Olympio has made significant copper discoveries at their Dufay Project. Recent drilling revealed multiple thick mineralized zones extending across 850 meters of strike length, with indications that grades improve at depth. This unusual find has geologists working to understand its full potential, adding another dimension to Olympio's exploration portfolio. With strong financial support following a recent capital raise and the advantages of operating in mining-friendly Quebec, Olympio Metals represents a compelling exploration story where geology, geography, and timing have aligned favorably. Whether you're a resource investor or simply fascinated by discovery stories, this conversation offers valuable insights into the modern mineral exploration landscape.

Subscribe to hear more stories of innovation and opportunity across Australia's listed companies as we continue to bring you compelling conversations from the frontlines of resource development.

Unlocking the riches beneath Australia's historic goldfields takes vision, expertise, and careful strategy. In this revealing conversation, Jonathan Downes, Managing Director of Kaiser Reef Limited, takes us deep into the company's transformation from small player to emerging force in high-grade gold production.

Kaiser Reef now controls three underground gold mines across Australia's eastern states, with two currently producing and a third poised for reactivation. The recent acquisition of the Henty gold mine marks a watershed moment, bringing substantial immediate cash flow that could generate over $50 million annually at current gold prices. The impact was immediate – a record 1,200+ ounce gold pour within just ten days of taking ownership, as the operation processes higher-grade ore than its historical average.

What makes Kaiser's story particularly compelling is their multipronged growth strategy. At the A1 mine, Australia's longest-running gold operation, the company has invested over $25 million to reach virgin territory below historical workings. This transitions them from "remnant mining" leftover material to accessing untouched high-grade deposits with greater tonnage potential. Meanwhile, the historic Maldon mine stands ready for reactivation, representing another significant production opportunity. With strategic partner Catalyst Metal maintaining a 19.99% stake, Kaiser gains valuable alignment with a major Victorian goldfields player.

Having secured $40 million in recent funding, Kaiser is well-positioned to execute their expansion plans at a time when gold prices are setting records. For investors seeking exposure to producing gold assets with clear growth pathways, Kaiser Reef offers an intriguing opportunity to participate in the renaissance of Australia's storied gold mining districts. Follow their journey as they unlock the potential of these historic but still richly endowed underground operations.

The social drinking landscape is on the verge of a revolution, and Althea Group Holdings Limited (AGH) is positioning itself at the forefront of this transformation. Joining us on ASX Briefs, CEO Josh Fegan reveals how the company has evolved from its medical cannabis origins to become a focused manufacturer of THC-infused beverages across North America.

What makes Althea's approach unique is their proprietary Envision technology - a patent-pending emulsion platform that creates superior THC beverages ranging from seltzers and sodas to waters and mocktails. As Josh explains, "We believe in liquid on the lips," emphasizing that taste experience is crucial for attracting traditional alcohol consumers. This philosophy has already led to impressive results, with over 14 million cans produced in Canada since 2021 and a strong US launch delivering 550,000 units within weeks of operations beginning.

The timing couldn't be better for this strategic shift. Modern consumers are increasingly seeking alcohol alternatives that provide similar social experiences without the negative health impacts. "THC beverages are definitely going to be the future of social drinking," Josh confidently states, highlighting that these products offer intoxication without hangovers, organ damage, or high addiction potential. This positioning has attracted attention from major alcohol companies who recognize both the competitive threat and enormous market potential of cannabis-infused drinks.

With a strengthened balance sheet following a recent capital raise and a clear vision for growth across North America, Althea represents an intriguing case study in how cannabis companies are evolving to meet changing consumer preferences. 

Subscribe to ASX Briefs for more conversations with leaders of innovative companies shaping the future of their industries and creating new growth opportunities on the ASX.

Looking for Australian resource companies positioned to capitalize on the global energy transition? New Frontier Minerals represents a compelling opportunity with its strategic focus on critical minerals essential to clean energy technologies.

Kevin Das, Senior Consultant at New Frontier Minerals, joins ASX Briefs to unveil the company's dual-commodity strategy across two high-potential Australian projects. At Hart's Range in the Northern Territory, they're targeting something truly special – high-value heavy rare earth elements, particularly dysprosium and terbium, which currently command prices of $250/kg and $840/kg respectively. What makes this pursuit particularly significant is that these critical elements are predominantly sourced from China, creating a strategic opportunity for Australian suppliers in global supply chains.

Meanwhile, in what Kevin describes as the "Beverly Hills of Mount Isa," their Northwest Queensland copper project demonstrates a pragmatic approach to resource development. With a current resource of 2.1 million tons at 1.1% copper and a strategic alliance with Austral Resources providing access to the Mount Kelly processing facility, New Frontier has created a potential pathway to production without the massive capital expenditure typically required. This innovative approach, combined with nearly 1,000 square kilometers of highly prospective ground containing 20 additional targets, positions the company for significant exploration upside in one of Australia's premier copper regions.

For those seeking exposure to critical minerals in tier-one jurisdictions with excellent infrastructure, New Frontier Minerals warrants close attention.

A remarkable transformation is underway at Yari Minerals, where their Rolleston South Coal Project has just received a massive boost. The company reports a 91% increase in their JORC inferred resource, bringing the total to 151 million tonnes of thermal coal with significant potential to be upgraded to more valuable metallurgical semi-soft coal.

This Queensland-based project sits in the premier Bowen Basin, a Tier 1 mining jurisdiction with exceptional infrastructure advantages. As MD Anthony Italiano explains, their strategic location just 40 kilometres from the Blackwater Rail System via sealed highway gives them a crucial edge in bringing this bulk commodity to market efficiently. "Infrastructure is key in bulk commodity projects," he emphasizes, and Yari benefits tremendously from existing rail loop loading facilities that could accelerate potential development timelines.

The technical breakthrough came through clever acquisition of two open source coal seam gas wells and subsequent resource model remodeling. This not only expanded the current resource but creates a pathway for future expansion with less drilling required. Looking ahead, Yari plans a drilling program in the second half of 2025 aimed at both extending the resource footprint and upgrading from inferred to indicated status. With $1.7 million cash on hand and no debt, the company is prioritizing its coal assets while maintaining lithium exploration interests in the Pilbara using innovative, low-cost remote sensing techniques. 

Subscribe to ASX Briefs for more insights into emerging resource companies and their potential.

The mining landscape is evolving rapidly as Australia positions itself as a critical minerals powerhouse, and Cobalt Blue Holdings stands at the forefront of this transformation. In this revealing conversation, newly appointed CEO Andrew Tong charts a bold new direction for the company that extends well beyond its namesake mineral.

After nine years with the company, Andrew has stepped into the leadership role with a clear mission: transitioning Cobalt Blue from a development company into a cash-generating business. At the heart of this strategy are two complementary projects poised to capitalize on the growing demand for energy transition minerals.

The Kwinana Cobalt Refinery represents the company's nearest-term opportunity, with a Final Investment Decision targeted for late 2025. Having secured a binding framework agreement with Japanese trading house Iwatani and a crucial feedstock supply deal with mining giant Glencore, the refinery project has gained significant momentum. The facility will process cobalt hydroxide from the Congo into high-value cobalt sulphate and cobalt metal products for the battery and aerospace industries, potentially generating approximately $20 million in annual free cash flow.

Complementing this is the recently acquired Halls Creek copper-zinc project in Western Australia's Kimberley region. The clever two-stage development approach begins with a low-capital oxide heap leach operation to produce copper metal, followed by an underground sulphide mine producing copper and zinc concentrates. This sequential approach minimizes upfront capital while establishing early revenue streams that can fund future development.

Want to stay ahead of Australia's evolving critical minerals sector? Subscribe to ASX Briefs for exclusive insights from the executives leading the energy transition.

Quantum computing breakthroughs and revolutionary medical diagnostics might sound like distant future technologies, but Archer Materials is bringing them to life right now. Our fascinating conversation with Dr Simon Ruffell, recently promoted from CTO to CEO, reveals how this Australian semiconductor company is simultaneously advancing two groundbreaking technologies with global implications.

Archer's quantum computing program has reached several crucial technical milestones, including extended spin lifetimes in carbon-based quantum films and successful coupling to superconducting resonators. These achievements might sound complex, but they represent fundamental building blocks toward creating functional qubits - the essential components of quantum computers.

Meanwhile, Archer's biochip program is moving rapidly toward practical applications. Their breakthrough technology can detect potassium levels in blood samples - crucial for monitoring chronic kidney disease. Recent achievements include integrating sophisticated graphene sensors with silicon circuitry and dramatically improving measurement consistency from 15% variability down to just 1.5%. By the end of 2024, they aim to demonstrate a prototype that can analyse blood samples in minutes, transitioning from laboratory demonstrations to tangible, functional hardware.

With $15 million in cash reserves, strong technical progress on both fronts, and a leadership team bringing experience from technology giants like Microsoft and Applied Materials, Archer Materials represents a fascinating intersection of cutting-edge science and commercial potential. Subscribe now to hear more stories of Australian innovation making global impacts!

Discover the untapped mineral potential of Northern Canada with Troy Whittaker, Managing Director of White Cliff Minerals (ASX: WCN), as he unveils the company's remarkable exploration success at their Rae Copper Project.

What makes this story particularly compelling is White Cliff's strategic advantage - positioning themselves near Yellowknife provides exceptional infrastructure access that dramatically reduces operational costs. With an all-weather airstrip directly on their licence and proximity to an existing port, the company enjoys logistical benefits that many remote exploration projects can only dream of.

The results speak volumes about the potential scale of their discovery. Recent assays revealed an astounding 90 meters of 4% copper from surface at the Rae Copper Project, while deeper drilling intercepted 175 meters at 2.5% copper - with mineralization actually strengthening at depth. This suggests we're just scratching the surface of what could be a world-class copper deposit.

Equally impressive is White Cliff's financial strategy, having secured over $14 million at nearly a 40% premium through Canadian flow-through share provisions. This innovative funding approach minimizes dilution while providing ample capital for their ambitious exploration program set to launch in July. Using both diamond and RC drilling, they'll simultaneously target the deep Hulk prospect and extend along the 10-kilometre structure at Danvers.

With assay results expected from mid-August onward and money in the bank, White Cliff Minerals stands at an exciting inflection point. The combination of high-grade copper discoveries, strategic location, and innovative exploration techniques positions them as one of the most compelling emerging stories in the resources sector. Follow their journey as they continue to unearth the mineral riches of Northern Canada.

Healthcare systems worldwide face unprecedented challenges: aging populations, staffing shortages, and the need for greater efficiency without compromising care quality. Kate Quirke, CEO and Managing Director of Alcidion Group Limited, offers a vision of how intelligent technology is meeting these challenges head-on.

In this revealing conversation, Kate introduces us to Miya Precision, Alcidion's flagship platform that's transforming healthcare delivery across Australia, the UK, and New Zealand. At its core, this solution integrates disparate healthcare systems and data, giving clinicians critical information "in the moments that matter" – whether at the patient bedside or when making operational decisions.

What makes Alcidion's approach unique is their commitment to simplicity and mobility. As Kate explains, today's healthcare professionals expect solutions that are intuitive and accessible anywhere, requiring minimal training while delivering maximum impact. This philosophy has propelled Alcidion to significant milestones, including a landmark £40 million contract with North Cumbria NHS Trust and their first expansion into Wales.

Looking toward the future, we explore Alcidion's careful approach to AI integration, balancing innovation with regulatory compliance and patient safety. With upgraded financial guidance showing EBITDA expected to exceed $3 million in FY25 and positive cash flow, this self-described "sleeping giant" in health tech demonstrates how technological innovation can address healthcare's most pressing challenges while building a sustainable business.

Subscribe to ASX Briefs for more conversations with leaders reshaping Australia's innovation landscape and discover how technology is transforming our most essential industries.

Breathing new life into Australia's forgotten gold mines is exactly what Great Divide Mining is mastering. CEO Justin Haines joins us to reveal the company's remarkable journey from IPO to imminent gold producer in under two years – a timeline that defies the industry's typical seven-year development cycle.

At the heart of Great Divide's strategy is a refreshingly practical approach: why spend millions searching for gold in untouched areas when you can revitalise sites where gold has already been discovered? Their flagship Challenger Gold Mine exemplifies this philosophy perfectly. With existing infrastructure, environmental approvals, and community relationships already in place, the team has fast-tracked the restart process and stands on the cusp of their first gold pour – a milestone that will automatically increase their stake from 15% to 51%.

The conversation takes us deep into the company's exploration successes at Devil's Mountain, where cutting-edge LiDAR technology has revealed over 480 historical workings spanning several kilometres. Rather than viewing these old diggings as depleted resources, Justin explains how the limitations of early miners – who could only extract shallow deposits – have left behind significant untapped potential perfect for modern mining methods.

Whether you're an investor interested in emerging producers or simply fascinated by innovative approaches to resource development, this episode offers valuable insights into how brownfield mining is changing the game. Subscribe to ASX Briefs for more conversations with the leaders transforming Australia's resource landscape.

Gold exploration is taking centre stage at Premier1 Lithium as Managing Director Jason Froud reveals the company's strategic pivot towards promising gold targets within their Western Australian portfolio. Demerged from SensOre last year with an initial lithium focus, Premier1 has adapted to challenging market conditions by unlocking the substantial gold potential hiding within their tenements.

The spotlight falls on their Yalgoo project, where recent drilling has delivered remarkable results. A 3,000-metre RC program uncovered significant intercepts including 7 metres at 4.3 g/t gold at Carlisle and an impressive 3 metres at 30 g/t gold at Crescent South. What makes these discoveries particularly exciting is that they represent mineralisation in areas largely untouched since limited drilling in the late 1980s. The Crescent shear zone alone offers kilometres of untested strike length with proven high-grade potential.

Premier1's disciplined exploration approach combines thorough historical data analysis with modern techniques—high-resolution drone magnetics, detailed geochemical sampling, and litho-structural studies—maximising their chances of success while carefully managing capital. This methodology has already yielded dividends with the discovery of a previously unrecognised mineralised system west of Olive Queen, confirming the gold-rich nature of the broader Yalgoo area.

Looking ahead, Premier1 has secured a $180,000 co-funded drilling grant under WA's Exploration Incentive Scheme for their Mount Kersey and Central Block targets, where rock chips have returned values up to 26 g/t gold along a 2-kilometre geochemical anomaly. Their Abbots North project is also showing early promise with rock chips up to 7 g/t gold. With results pending from Abbots North, imminent drilling at Carlisle, and the EIS-supported program at Mount Kersey commencing in August, Premier1 is poised for a catalyst-rich period that could significantly enhance their growing reputation as a focused gold explorer in prime Western Australian terrains.

Stem cell therapeutics represent one of medicine's most promising frontiers, and Australian biotech Cynata Therapeutics stands at the cutting edge with breakthrough treatments poised to transform patient care across multiple diseases.

Dr. Kilian Kelly, CEO and Managing Director of Cynata Therapeutics, reveals how their proprietary manufacturing process creates mesenchymal stromal cells (MSCs) with consistent quality and potency—solving a fundamental challenge that has limited stem cell therapy development. This technological advantage underpins their impressive clinical pipeline targeting conditions with significant unmet needs.

Their graft-versus-host disease treatment has already demonstrated remarkable efficacy, boosting two-year survival rates from a typical 20% to 60% in early trials. With Phase 2 enrollment nearing completion and results expected by year-end, this therapy could soon offer hope to patients facing this devastating transplant complication. Meanwhile, their kidney transplant program aims to eliminate the toxic immunosuppressants that paradoxically damage the very organs patients are trying to preserve.

Perhaps most revolutionary is Cynata's approach to osteoarthritis, which focuses not just on managing pain but actually halting the disease's progression—something no current treatment achieves. With 321 patients treated and final results expected within months, this therapy could fundamentally change how we approach a condition affecting millions worldwide, potentially eliminating countless knee replacements and transforming patient outcomes.

The next 9-12 months represent the most significant period in Cynata's history, with multiple trial readouts potentially triggering pharmaceutical partnerships and reshaping treatment landscapes. For investors and patients alike, Cynata Therapeutics represents a compelling opportunity at the intersection of innovation, medical need, and commercial potential.

Memory technology might seem mundane, but it's actually at the heart of the most exciting technology revolution we're experiencing today. In this fascinating conversation with Coby Hanoch, CEO of Weebit Nano Limited, we explore how this Australian-listed semiconductor company is pioneering the next generation of non-volatile memory.

Traditional Flash memory simply can't keep up with the demands of modern AI applications, especially at the edge where devices need to process information locally rather than sending everything to the cloud. Weebit's resistive RAM (ReRAM) technology solves this problem by enabling smaller, more efficient, and more secure memory solutions. As Coby explains, their recent automotive qualification (AEC Q100) proves their technology can withstand extreme conditions—operating at 150°C for 10 years—making it suitable for virtually any application worldwide.

What makes Weebit's story particularly compelling is their emerging position as the only independent supplier of ReRAM technology. While competitors have fallen by the wayside, Weebit has secured partnerships with semiconductor powerhouses like OnSemi (a NASDAQ 100 company) and DB HiTek. With over $90 million in cash, they're poised for significant growth as the industry increasingly recognizes ReRAM as Flash memory's successor. If you're curious about the technologies that will power everything from your smartphone to autonomous vehicles in the coming years, this episode provides a rare glimpse into a critical but often overlooked sector of the tech industry.

The vulnerability of global rare earth supply chains has just moved from theoretical to tangible with China's new export restrictions. This couldn't make Australian Strategic Materials' strategy more relevant – or more urgent.

When Rowena Smith, CEO and Managing Director of ASM, explains their mine-to-metal capability, what stands out is how few companies globally can do what they do. As the only ASX-listed company with established metallisation capability outside China, ASM offers something increasingly precious: supply chain security for critical minerals essential to clean energy, defence, and emerging technologies.

The company's Korean metals plant is already shipping products to customers, with validation processes completed for multiple magnet producers across several jurisdictions. What's particularly exciting is their breakthrough in heavy rare earth metallisation – they're on the verge of commercial dysprosium production, with terbium to follow. Smith notes that only two other companies outside China have similar capabilities, positioning ASM at the forefront of this critical technology.

ASM's two-pronged strategy combines the shovel-ready Dubbo project in NSW with global metals plants. Their expansion plans include replicating their Korean facility in the US, with strong interest from the Department of Defense seeking domestic manufacturing capability through allied nations. The company is also exploring a phased approach to the Dubbo project, potentially targeting the rare earths portion first to reduce initial capital requirements below $1 billion.

Gold is commanding over $5,000 per ounce in the Australian market, and Astral Resources is poised to capitalize on this opportunity with their growing portfolio of gold assets in Western Australia's renowned Kalgoorlie region. Managing Director Marc Ducler pulls back the curtain on how this emerging producer is methodically advancing toward development with a remarkable discovery cost of just $20 per ounce.

The conversation centers on Astral's flagship Mandilla Gold Project, which already boasts a 1.43 million ounce resource that could support up to 20 years of processing. With the Pre-Feasibility Study nearing completion and scheduled for release before the end of June, Marc reveals they've already secured the essential technical inputs needed to generate "very, very good financials." The company isn't stopping there – they're immediately transitioning to a Definitive Feasibility Study targeting completion in mid-2025, maintaining momentum toward a production decision.

What sets Astral apart is their strategic approach to resource growth and project optimization. Rather than simply accumulating ounces, their recent acquisition of Maximus Resources provides both the physical space needed for infrastructure and additional exploration upside at the Spargoville project. Meanwhile, drilling at both Spargoville and Feysville specifically targets higher-grade material that could displace lower-grade Mandilla ore, potentially boosting the project's net present value significantly. With $22 million in the bank and additional funding possible from in-the-money options, Astral is fully funded to execute this strategy while maintaining continuous exploration across their expanded land package.

Ready to discover more about the companies shaping Australia's future? Subscribe to ASX Briefs for direct conversations with the leaders driving innovation and growth in the market.

Discover the untapped potential of Australia's forgotten gold districts as Cosmo Metals makes a strategic leap into New South Wales. Managing Director Ian Prentice reveals how the company's acquisition of the Bingara and Nundle projects could transform their prospects in the precious and base metals space.

The conversation takes us deep into the geological significance of these newly acquired assets, situated within the New England Orogen – a vast mineral province that has historically yielded 35 million ounces of gold but remains surprisingly underexplored. What makes this opportunity particularly compelling is the scale: with nearly 500 square kilometres at Bingara and 260 square kilometres at Nundle, these truly represent district-scale exploration plays that haven't seen modern exploration techniques applied in over three decades.

Ian's excitement is palpable as he describes the commodity mix of gold, copper, and antimony across these projects, highlighting historical drill results like six metres at six grams per tonne gold from surface that have never been properly followed up. The comparison to world-class deposits like Mount Morgan (multi-million ounces gold plus 360,000 tonnes copper) demonstrates the scale of targets Cosmo is pursuing. Through cutting-edge exploration techniques including LiDAR and Sub-Audio Magnetics surveys, the company is rapidly building a modern understanding of these forgotten mineral districts.

The mining services landscape in Australia is evolving rapidly, and few companies exemplify this transformation better than MLG Oz Limited. Murray Leahy, Managing Director and founder, joins us to unpack how this Kalgoorlie-based company has grown from identifying a market gap to becoming an integrated powerhouse delivering critical services to Australia's most prominent mining operations.

At the heart of MLG's success is their pioneering hub-and-spoke model, connecting remote mining sites to centralized processing facilities through an intricate network of logistics, crushing, screening, and civil services. What once existed as fragmented offerings from multiple small providers has been reimagined as a seamless, integrated solution driving efficiency across the mining value chain. Murray explains how this approach has secured major contracts with gold producers like Westgold Resources, Northern Star, and Evolution Mining—partnerships characterized by longevity and mutual growth.

Despite posting impressive 20% revenue growth in the first half of FY25, MLG has faced challenges including project delays affecting short-term margins. However, Murray confidently outlines how strategic capital investments in fleet expansion and dedicated Kalgoorlie accommodation facilities are now bearing fruit, positioning the company for stronger profitability in the coming months. Perhaps most fascinating is MLG's innovative approach to the industry-wide skills shortage—their new-to-industry training program has brought 350-400 workers into specialized mining roles over just two and a half years, creating pathways for non-traditional workers while building their workforce capacity. As gold prices reach historic highs and Australia's mining sector continues its expansion, MLG's selective approach to quality partnerships and operational excellence offers valuable insights for anyone interested in the future of mining services.

The ophthalmology world is taking notice as Nova Eye Medical achieves its strongest US sales quarter ever. In this fascinating conversation with Managing Director Tom Spurling, we unpack the remarkable growth trajectory of their minimally invasive glaucoma treatment technology that's winning over doctors and patients alike.

Spurling reveals the powerful simplicity behind their success: "We have a really good product and a driven sales team. The more doctors that try our product, the more take it up." With approximately 1,300 monthly procedures already and an estimated 20,000-30,000 minimally invasive glaucoma procedures occurring monthly in the US market, Nova Eye's runway for growth appears substantial and sustainable.

The financial transformation is equally impressive, with the glaucoma segment nearly achieving break-even in Q3 – posting just a $30,000 EBITDA loss compared to a $1.8 million loss in the first half. This dramatic improvement stems from enhanced manufacturing processes, resolved supply chain issues, and accelerating sales. Perhaps most exciting is the forecast of break-even performance for the glaucoma segment by second half FY25, with group-wide profitability following shortly thereafter.

Beyond the core glaucoma application, Nova Eye has identified a potentially transformative opportunity in ocular drug delivery. Pharmaceutical companies have approached them about leveraging their iTrack technology for targeted medication delivery within the eye – potentially opening an entirely new revenue stream. With minimal exposure to international trade uncertainties and clear catalysts on the horizon, Nova Eye Medical demonstrates why they're positioning themselves at the forefront of ophthalmic innovation. Listen now to understand how this Australian company is revolutionizing glaucoma treatment globally!

Alexander Scanlon takes us deep into Barton Gold's ambitious plans to transform South Australia's central Gawler Craton into a major gold producing region. As Managing Director and CEO, Alex outlines how the company has meticulously built a 1.7 million ounce resource platform and secured the region's only processing mill to create a compelling two-stage development strategy.

The conversation reveals the remarkable economics behind their flagship Tunkillia project, where recent optimization work has delivered stunning financial projections. With projected operating free cash flow of $2.7 billion over eight years and an incredibly fast payback period, Alex explains how they've engineered a project that generates approximately $1.3 billion in just the first two years of operation. This front-loaded cash flow profile creates exceptional financing flexibility and dramatically reduces development risk.

What distinguishes Barton's approach is their commitment to innovation and sustainability with detailed plans for implementing a renewables-powered microgrid that simultaneously reduces costs, lowers carbon footprint, and hedges against energy price volatility - potentially making Barton the first mining operation in South Australia to employ this technology at scale. The discussion also explores their unexpected ultra-high-grade silver discovery at Tolmer, where intersections reaching 17,600 grams per ton hint at significant additional upside beyond their established gold resources.

Listen now to understand why this emerging Australian gold developer presents one of the most compelling growth stories in the precious metals sector today.

Jamie Twiss, CEO of Beforepay Group Limited, takes us deep into the world of ethical fintech that's reshaping how Australians access funds when they need it most. With their Pay Advance product issuing 40,000 loans weekly at an average of just under $400, Beforepay has built a reputation for responsible lending with no hidden fees, late charges, or penalties.

The conversation reveals the sophisticated technology powering Beforepay's impressive sub-2% default rate - their 12th generation risk model that analyzes over 400 separate attributes from transaction data. This isn't just about measuring income or expenses; it's about understanding customer behavior and financial mindsets at a granular level. As Jamie explains, "Just as important is how the customer thinks about their financial obligations and their desire to repay the loan."

What truly sets Beforepay apart is their three-pronged growth strategy: expanding their core Pay Advance business, scaling their recently launched personal loan product offering up to $3,000 over three months, and growing Carrington Labs - their enterprise software arm that provides credit risk analytics to overseas lenders. With over $28 million in cash reserves, 250,000+ active users, and selection for MasterCard's Start Path Accelerator program, Beforepay demonstrates how fintech innovation can deliver both strong financial results and responsible consumer outcomes. Whether you're interested in financial technology, ethical lending, or ASX investment opportunities, this conversation offers valuable insights into a company transforming access to credit for working Australians.

Privacy concerns have never been more pressing for parents sharing family photos online. Enter Tinybeans, the trusted platform helping millions of families safely capture life's precious moments without the risks associated with mainstream social media.

In this revealing conversation with Managing Director and CEO Zsofi Paterson, we explore the remarkable journey of this Australian-founded, ASX-listed company that's now making major waves in the US market. With one million monthly active users and 50,000 paid subscribers, Tinybeans has successfully navigated the challenging path from startup to sustainable business.

The discussion dives into Tinybeans' recent financial milestone—achieving positive operating cashflow for the first time—through a strategic reset of their operating model. Paterson shares candidly about reducing their team by 70% while improving performance and strengthening subscription retention rates. This rare glimpse into the company's internal transformation reveals valuable lessons for businesses balancing growth with capital efficiency.

We explore innovative product developments like gift cards and upcoming physical photo products that aim to increase customer lifetime value. Patterson also unpacks their marketing strategy, including strategic partnerships with BabyList in the US and Bounty Bags in Australia that place Tinybeans directly in front of new parents at the perfect moment. The conversation concludes with a look toward FY25 priorities: accelerating paid subscriber growth, better monetizing their substantial free user base, and carefully managing the path to profitability.

Whether you're a parent concerned about online privacy, an investor interested in subscription business models, or an entrepreneur navigating the balance between growth and sustainability, this episode offers valuable insights into building a purpose-driven tech company in today's challenging market. Subscribe to ASX Briefs for more conversations with the leaders shaping Australia's business landscape.

The urgency of South Africa's energy crisis takes center stage as Adam Sierakowski, Executive Chairman of Kinetiko Energy Limited, reveals how his company is positioned to transform the nation's energy security. Sitting on a mammoth 6 trillion cubic feet of 2C contingent gas resources—equivalent to 1 billion barrels of oil—Kinetiko has made what could be South Africa's most significant energy discovery in decades.

What makes this story particularly compelling is the technical breakthrough recently achieved. After initial test wells delivered disappointing flow rates, world-class experts identified that high-pressure drilling methods had caused formation damage, reducing gas permeability by up to 85%. This wasn't a geological problem but a fixable technical issue. The rocks themselves contain excellent gas potential, and with straightforward drilling optimization, Kinetiko can now unlock flows that could supply clean energy to South Africa for half a century.

The timing couldn't be more critical. South Africa's coal-dominated energy grid faces "effective decay and decline" while its imported gas from Mozambique is projected to cease within 3-5 years. Kinetiko's discovery, strategically located just 180km southeast of Johannesburg amidst existing energy infrastructure, represents a "multi-generational opportunity." 

Subscribe to ASX Briefs for more exclusive conversations with executives driving the next wave of resource and energy opportunities. Leave us a review if you found this discussion valuable—we're dedicated to bringing you insights into companies addressing the world's most pressing challenges.

Discover how Helios Energy is poised to reshape the Texas oil landscape with Managing Director Philipp Kin at the helm. Having joined in November 2023, Phil reveals how this ASX-listed company has secured a first-mover advantage in an unexplored basin in West Texas that shows remarkable similarities to one of America's most prolific oil-producing regions.

The conversation takes us deep into the technical aspects of Helios's flagship Presidio Oil and Gas Project, where four successful wildcat drill sites have already demonstrated production potential. Most compelling is the project's comparison to the legendary Austin Chalk formation, which has yielded over 600 million barrels of oil since the 1920s. This analogy isn't just impressive—it's a roadmap for investors to understand the massive potential that lies beneath Helios's 85,000+ acres.

What sets this story apart is the strategic approach Phil outlines for Helios's future. The company has attracted elite engineering talent from W.D. Von Gonten, secured financial backing from respected investment firms like Thorney Investments, and mapped a clear path toward becoming a dividend-returning producer by 2026. 

Whether you're an existing shareholder or considering energy investments in your portfolio, this episode offers valuable perspective on how technical expertise, strategic partnerships, and targeted land acquisition combine to create exceptional shareholder value in the oil and gas sector. Subscribe to ASX Briefs for more exclusive conversations with the leadership teams driving Australia's most promising listed companies.

Artificial intelligence is transforming how we communicate across languages and borders. In this fascinating conversation, Tony Abrahams, co-founder and CEO of AI-Media Technologies Limited, shares the remarkable journey of how a company that began by providing captions for Australian pay TV and has evolved into a global leader in AI-powered media solutions.

Tony reveals how a project to help deaf students access classroom education in real-time became the catalyst for AI-Media's growth. That initiative, launched in 2007, helped increase high school completion rates for deaf students from just 10% to an impressive 90% today. It's this foundation of purpose-driven innovation that has guided the company through partnerships with Facebook and their acquisition of US-based EEG in 2021—a move that helped transition their services from human-assisted to fully automated AI solutions.

The conversation dives deep into AI-Media's ambitious growth strategy targeting $60 million EBITDA by FY29. Central to this plan is their LEXI product family: LEXI Text for captioning, the newly launched LEXI Voice that provides real-time translation across 100+ languages, and LEXI AI that synthesizes organizational knowledge. Tony explains how their unique encoder technology functions as a "fly screen" to filter massive data streams down to essential components, enabling response times of just 33 milliseconds—creating a significant competitive advantage in live media applications where every second counts. 

Discover the untapped potential of Australian mining with Terrain Minerals Executive Director Justin Virgin as he reveals game-changing discoveries that could reshape the company's future.

The conversation begins with explosive news from the Smokebush project, where recent drilling has delivered spectacular results of 11 metres at 6g gold and 43.5g silver. Justin explains how these findings have completely transformed their understanding of the project, uncovering parallel structures at the Lightning and Monza prospects that suggest different mineralisation events. With characteristics resembling Volcanic Massive Sulphide deposits similar to major nearby operations, this breakthrough could signal the emergence of a significant new gold district in Western Australia.

Beyond precious metals, Justin illuminates Terrain's strategic position in the critical minerals space through their Larins Lane Gallium project. With China controlling 98% of global gallium production and prices reportedly around US$1 million per tonne, Terrain's discovery of substantial surface gallium mineralisation couldn't be more timely. This "magical glue" powers everything from AI and quantum computing to LED lighting and electric vehicles, making it an essential component of modern technology with rapidly growing demand.

Ever wonder how massive infrastructure projects manage their complex network of suppliers, contractors, and compliance requirements? Mike Davis, co-founder and CEO of Felix Group Holdings Limited, pulls back the curtain on this fascinating world in our latest conversation.

Felix has carved out a powerful niche providing cloud-based procurement management solutions for capital-intensive industries. Rather than competing head-on with global procurement giants, they've focused on becoming the specialist platform of choice for infrastructure, property, and mining sectors – a strategy that's paying off handsomely with three consecutive cash-positive quarters and 27% year-on-year growth in enterprise customer revenue.

What makes Felix stick? Their platform becomes deeply embedded within customer operations, integrating with finance systems and standardising how these huge enterprises engage with third parties. With modern slavery legislation, carbon accounting, and sustainability metrics now non-negotiable for major projects, Felix has transformed from a "nice-to-have" into essential business infrastructure.

The company's international expansion is gathering momentum through strategic relationships with industry giants. A renewed contract with CIMIC Group (Australia's largest contractor) potentially opens doors to CIMIC's global parent company, while their agreement with PCL Construction establishes a foothold in Canada and the US. Looking ahead, Felix aims to monetise both sides of its marketplace – a move that could dramatically accelerate growth. 

Imagine transforming a days-long pathology process into minutes while maintaining or improving diagnostic accuracy. That's exactly what Optiscan Imaging is accomplishing with their groundbreaking miniaturised confocal end microscopy technology.

Dr Camile Farah, CEO and Managing Director of Optiscan, returns to the podcast to unveil Inform – their revolutionary digital pathology device designed specifically for pathologists and pathology labs. This innovative technology captures microscopic-grade images in real-time at 1,000 times the resolution of standard medical imaging, dramatically streamlining workflows between surgeons and pathologists while slashing diagnostic waiting times from days to minutes.

What truly sets Optiscan's approach apart is their comprehensive cloud-based telepathology platform. This system enables surgeons in Melbourne to collaborate instantly with pathologists in Arizona while the patient remains on the operating table. For rural and remote areas, this technology eliminates the need for on-site specialists, democratising access to world-class pathology services regardless of location.

Ready to explore the future of medical imaging? Listen now and discover how Australian innovation is transforming global healthcare one microscopic image at a time.

Fascinating breakthroughs in sustainable construction and climate technology take centre stage as James Marsh, CEO of Zeotech Limited, unveils the company's game-changing innovations. The conversation explores how Zeotech's AusPozz™ product is redefining possibilities in low-carbon concrete, with commercial demonstrations confirming its ability to replace up to 40% of cement while delivering superior strength and dramatically reduced shrinkage.

What makes this technology truly revolutionary is its versatility and comprehensive performance profile. Beyond simple cement replacement, AusPozz™ outperforms expensive additives like silica fume while eliminating the need for various chemical additives that typically address concrete issues like cracking and bleeding. This exceptional value proposition has attracted partnerships with construction giants including Holcim, with strategic agreements positioning Zeotech for seaborne distribution to Sydney and Melbourne concrete markets, as well as global opportunities through Gladstone Ports Corporation's deepwater facilities.

The conversation takes an exciting turn as Marsh details their second horizon: zeolite-based methane remediation technology showing 70-85% efficiency in capturing this potent greenhouse gas. With their pre-feasibility study nearing completion and their current resource representing just 5% of available exploration area, Zeotech stands at the threshold of significant growth. Dive into this episode to discover how Australian innovation is tackling two of our most pressing environmental challenges – carbon-intensive construction and methane emissions – with solutions that don't just match industry standards but dramatically exceed them. Ready to understand the future of sustainable materials? Listen now and gain insights into technology that leading industry experts are calling "a genuine game-changer."

Steve Lydeamore, CEO of Immuron Limited, takes us behind the scenes of one of Australia's most innovative biopharmaceutical companies. What makes this Melbourne-based biotech unique is their dual focus—a thriving commercial product alongside a promising technology platform targeting infectious diseases.

The spotlight falls on Travelan, Immuron's preventative treatment for traveller's diarrhoea that has experienced phenomenal growth. After sales plummeted to near-zero during the pandemic, the company has ssen a remarkable turnaround from $145,000 to over $5.3 million in less than a year. This success story involved strengthening pharmacy distribution networks across Australia and Canada while leveraging Amazon as their primary channel in the US market. As international travel rebounds, particularly to high-risk regions like Bali and Vietnam, Travelan's unique preventative approach—"nobody wants to get it"—positions it perfectly for continued growth.

Critical minerals lie at the heart of the green energy transition, yet many remain under-appreciated by investors. Tin - essential for electronics, solar panels, and batteries - stands out as particularly vulnerable with looming supply shortages and concentrated production far from end users.

Joe David, Managing Director of Elementos Limited, reveals how their company is positioning to address this critical gap through two strategic projects. Their flagship Oropesa project in Spain's Andalusia region recently completed a Definitive Feasibility Study showing remarkable economics: $270 million NPV and 26% IRR using conservative pricing assumptions. For a company valued at just $20 million, this represents substantial potential upside.

What makes Oropesa truly strategic is its position as Europe's only vertically integrated tin mine and smelter. David explains the startling reality that neither Europe nor North America currently have any domestic tin mines, despite being major consumers. By establishing a complete mine-to-metal operation within European borders, Elementos not only addresses geopolitical supply risks but also captures the $1,000 premium that tin commands in European markets compared to standard prices.

Renewable energy and waste transformation converge powerfully in this illuminating conversation with Joe Oliver, Managing Director of Delorean Corporation Limited (ASX:DEL). We explore how this innovative company is revolutionizing Australia's approach to organic waste by converting it into valuable renewable energy through advanced anaerobic digestion technology.

The spotlight shines on Delorean's recent $6 million ARENA grant success, which powerfully validates their business model and accelerates the development of the groundbreaking SA1 facility – Australia's first project injecting biomethane from organic waste into the gas network. Joe reveals the facility's unique dual revenue model that combines renewable gas with food-grade liquid CO2 production, creating diversified cash flow and enhanced returns on capital.

Ready to discover how waste transformation is powering Australia's clean energy revolution? Listen now and see why Delorean Corporation represents one of the most compelling opportunities in the renewable energy sector today. Subscribe to ASX Briefs for more innovative company spotlights and investment insights!

Ever wondered how scientists accurately measure brain health across thousands of patients in dozens of countries speaking 30 different languages? That's exactly what Cogstate has mastered over its 25-year journey to become a leader in neuroscience technology.

Brad O'Connor, CEO of Cogstate Limited, takes us behind the scenes of this fascinating ASX-listed company that's quietly revolutionizing how brain health is measured globally. What began as a digital disruptor creating computerized cognitive assessments has evolved into an essential partner for pharmaceutical companies developing new treatments for conditions like Alzheimer's disease, depression, and rare neurological disorders.

The numbers tell a compelling story of innovation driving efficiency. While many companies struggled during the pandemic, Cogstate found ways to do more with less—reducing their workforce by 25% while simultaneously achieving record revenue growth. Their secret? Strategic implementation of AI and advanced analytics that allow them to manage clinical trial endpoints with unprecedented accuracy and at global scale.

Beyond impressive financials—60% gross margins, 20% EBIT margins, and US$34 million in cash with no debt—it's Cogstate's vision for the future that captivates. O'Connor shares how their technology might soon help everyday people assess their cognitive health from home, similar to using a thermometer before deciding whether to see a doctor. With pharmaceutical spending on central nervous system diseases projected to approach oncology levels within a decade, Cogstate stands at the forefront of a massive market opportunity.

Ready to explore how brain health technology is creating both better patient outcomes and compelling investment opportunities? Listen now to discover why Cogstate's digital cognitive tools are becoming indispensable in both clinical research and healthcare settings worldwide.

Shane Hartwig, Managing Director and CEO of Northern Minerals, reveals how the company is positioning itself at the forefront of Australia's heavy rare earth sector through its flagship Browns Range project. Located in the remote Kimberley region of Western Australia, this strategic asset represents a significant opportunity to develop an Australian-based rare earths supply chain.

The conversation navigates through Northern Minerals' evolution from uranium explorer to rare earth developer, showcasing how the company plans to produce heavy rare earth-rich concentrate for partner Iluka Resources. This strategic partnership creates a powerful alternative to Chinese-dominated supply chains, with Iluka set to process Northern Minerals' concentrate into separated rare earth oxides essential for permanent magnets used in electric vehicles, wind turbines, defense applications, and even emerging humanoid robotics.

Shane details the company's methodical approach to project development, highlighting recent exploration programs at deposits like Dazzler and Gambit while explaining how their systematic review has identified a strong pipeline of prospects to potentially expand their mineral resources. The discussion provides valuable insights into their optimization efforts around CAPEX and OPEX for the feasibility study expected to be completed by the second quarter's end – a critical milestone that will drive funding discussions with government agencies like NAIF and EFA.

Step into the world of one of Australia's most promising precious metals discoveries with Glen Diemar, Managing Director of Australian Gold and Copper (AGC). The company's Achilles discovery in New South Wales is turning heads across the mining sector with extraordinary polymetallic grades—including a jaw-dropping discovery hole featuring 5 meters at nearly 17 g/t gold, 1700 g/t silver, and 15% combined lead and zinc.

What separates AGC from the typical junior explorer is its remarkable financial strength. With $16 million in cash and strong backing from major shareholders GeoZen and New South Resources, the company is executing an exploration program more akin to what you'd expect from a major mining house. This financial firepower enables a comprehensive, multi-discipline approach across an 8-kilometer shear zone that has barely seen modern exploration.

The timing couldn't be better for AGC's silver-dominant system, with precious metals prices reaching record highs week after week. But this story extends far beyond Achilles itself. Glen reveals how the company's systematic exploration could uncover multiple deposits along the shear zone, following the pattern seen throughout the prolific Cobar Basin. Just 130 kilometers north lies the world's third-highest grade copper mine—a tantalizing reminder of the potential prize awaiting successful explorers in this region.

Gold has touched an unprecedented AU$5,000 per ounce, and Adelong Gold Limited (ASX:ADG) is strategically positioned to capitalize on this remarkable market. Managing Director Ian Holland joins us to reveal the company's ambitious dual-strategy approach that sets it apart in Australia's competitive mining landscape.

At the core of Adelong's near-term value proposition is a clever joint venture with Great Divide Mining for the Adelong Gold Project in New South Wales. This partnership aims to fast-track production without diluting shareholders, targeting first gold within just 12 months. The economics are compelling – 15,000-20,000 ounces annually at costs below AU$2,000 per ounce, potentially generating hundreds of millions in free cash flow at current gold prices. Shareholders maintain 49% project interest while enjoying significant downside protection.

Meanwhile, the company's recently acquired Apollo Gold Project in Victoria has delivered exceptional exploration results. Multiple drill intercepts exceeding 100 gram-metres indicate substantial economic potential, but the real surprise came from Hayfield Reef, where high-grade antimony-gold mineralization (exceeding 3% antimony) was discovered. This epizonal deposit shares characteristics with economically significant regional projects like Fosterville and Sunday Creek. With China dominating the antimony supply chain and the mineral's critical status in Western economies, this discovery adds strategic value beyond gold alone.

Despite these compelling assets and near-term production potential, Adelong trades at a modest $7-8 million market capitalization. For investors seeking exposure to gold's strength while gaining leverage to critical minerals, Adelong offers a unique opportunity that warrants close attention as both projects advance toward their respective milestones. Follow their progress as they work to create substantial shareholder value through the coming year.

Imagine buildings that don't just consume energy but actually generate it. That's the revolutionary vision Martin Deil and his team at ClearVue Technologies are bringing to life through Building Integrated Photovoltaics (BIPV). 

In this fascinating conversation, Martin explains how ClearVue transforms entire building facades into energy-generating assets while maintaining transparency and aesthetics. Unlike traditional solar panels mounted on rooftops, their technology integrates directly into windows, skylights, and vertical structures, helping buildings achieve net-zero energy targets without sacrificing design. 

The discussion takes an unexpected turn toward food security when we discuss how ClearVue's solar greenhouse technology has demonstrated remarkable results: 25% water savings, over 40% energy generation for the building, and crop yield improvements exceeding 100% for certain plants. 

Whether you're interested in clean energy innovations, sustainable agriculture, or smart investment opportunities in the green technology sector, this episode offers valuable insights into how Australian innovation is addressing global challenges. Subscribe now and discover more forward-thinking companies reshaping our sustainable future.

Dive deep into the world of nutritional innovation as Peter Davey, CEO of Clover Corporation Limited, reveals how this Australian company has become a global leader in microencapsulation technology. With manufacturing facilities spanning Australia, New Zealand, and Ecuador, Clover has positioned itself as an essential supplier to the world's infant formula manufacturers – with an impressive 98% of their production exported globally.

The conversation unpacks Clover's remarkable financial rebound, achieving 38% revenue growth despite challenging global market conditions. Peter explains their dual-strategy approach: vertical integration into their supply chain (including their strategic Ecuador fish oil extraction facility) and horizontal expansion into new products and markets. This approach has not only improved margins by 270 basis points but has opened exciting new market opportunities beyond traditional infant formula.

Most fascinating is Clover's innovation pipeline, including their patented Gelphorm technology that achieves what was previously considered impossible – incorporating omega-3 into UHT products. This breakthrough has already gained traction in North America and is poised for expansion into Europe and Asia. As global birth rates decline (China's has halved in six years), Peter shares how Clover is pivoting with their customers to adult nutrition, sports formulas, and even pet food applications, demonstrating remarkable adaptability.

The gold exploration landscape in Western Australia is heating up as Asra Minerals undergoes a dramatic transformation. CEO Paul Stephen reveals how this ASX-listed explorer is pivoting sharply from diversified metals to become a laser-focused gold company with ambitious resource targets in the legendary Leonora goldfields.

With fresh leadership and a renewed strategy, Asra has already delivered compelling high-grade intercepts at their Sapphire and Orion prospects—part of the highly prospective Kookynie area in their Leonora South project. These narrow but exceptionally rich quartz veins echo the million-ounce Raleigh deposit successfully mined by Evolution Mining.

What sets Asra apart is their strategic consolidation of previously fragmented tenements, creating the first unified exploration approach across this promising gold system in decades. The recent $3 million sale of their Tarmoola Pastoral Lease has strengthened their financial position without shareholder dilution, while removing operational distractions. With drilling set to commence by April 2025 and ambitious plans to grow resources beyond 500,000 ounces, Paul's focused approach promises to deliver substantial shareholder value through the drill bit.

The global race for clean energy solutions is heating up, and NH3 Clean Energy is positioning itself as a frontrunner with its innovative approach to low-emission ammonia production. CEO Stephen Hall takes us deep into the company's flagship WAH2 project in Western Australia's Pilbara region, revealing how they've doubled their NPV to $493 million through strategic infrastructure partnerships and operational efficiencies.

What sets NH3 apart from competitors is their practical, cost-effective approach. While electrolysis-based projects struggle with production costs around $900-1000 per ton, NH3's gas reforming with carbon capture strategy delivers clean ammonia at just $600 per ton. This stark differential explains why many high-profile investors are walking away from alternative technologies that remain unproven at scale. Hall outlines how agreements with Chevron for gas supply, AGIG for CO2 transportation, and Water Corporation for water have streamlined the project's scope and approval process.

Join us for an engaging episode with Andrew Booth, CEO of Advanced Braking Technology, as we explore the groundbreaking innovations in braking systems tailored for the mining industry. With a relentless focus on safety and sustainability, ABT is leading the charge in developing world-class solutions that enhance operational efficiency and compliance with evolving regulatory landscapes.

Andrew shares the story of ABT's remarkable journey, highlighting a strong 25% profit increase and the company's strategic move into international markets. With 56% of revenue now stemming from overseas sales, ABT is pushing boundaries in regions like Africa and North America, addressing the unique challenges posed by ageing machinery in the mining sector.

Dive deeper into their revolutionary product, BrakeIQ, a comprehensive braking system designed to enhance safety without disrupting existing equipment. As the industry adapts to new technologies and safety regulations, Andrew discusses how ABT’s commitment to R&D will pave the way for future innovations.

As listeners, you’ll gain insight into how ABT combines technology and safety to meet the demands of the modern mining landscape. Join us in shaping the conversation around safety and effectiveness in heavy industries. Subscribe, share your thoughts, and let us know what you think about the advances in braking technology!

The digital transformation of utilities is no longer a distant future – it's happening right now, and X2M Connect is at the forefront of this revolution. Our conversation with CEO Mohan Jesudason reveals how this Australian technology company has evolved from a patent-based startup to an international player with 80 enterprise customers across Australia, Taiwan, Japan, South Korea, and now the Middle East.

Mohan walks us through X2M's three-phase strategic transformation, culminating in their current shift toward profitability through high-margin SaaS and AI-driven solutions. What sets their platform apart? The ability to connect diverse devices – from water meters to solar panels – onto a single integrated platform, making even "dumb" devices smart in minutes. This technology works across any telecommunications network, functions during power outages, and can be deployed in new markets within days rather than months.

Join us as we dive deep into the world of rare earths with Philippa Leggat, the Managing Director of Critica Limited. This episode explores Critica's groundbreaking achievements, including the discovery of Australia’s largest clay-hosted rare earth resource at the Jupiter project. Philippa shares the exciting journey of how Critica has utilized innovative exploration methods to uncover this significant resource, highlighting the remarkable scale of 1.8 billion tonnes and a high-grade component that positions them uniquely in the global market.

We discuss the impressive technological advancements in metallurgy that have enabled an astonishing upgrade in rare earth concentration while simultaneously lowering overall processing costs. The pressing need for sustainable and efficient rare earth sourcing is underscored, particularly in light of increasing global demand for technology and renewable energy shifts. With a vision set on international partnerships and strategic funding, Critica is not just a participant in the rare earths market; it's poised to lead.

Mark Miocevich, Managing Director of Veem Limited, takes us behind the scenes of what he calls "a rare beast in Australia" – a high-technology marine products manufacturer dominating global markets through innovation and precision engineering.

Veem specializes in three critical marine technologies: advanced propulsion systems, revolutionary gyrostabilizers, and specialized defence applications. Despite the cyclical nature of defence contracts, the company recently posted $33.6 million in first-half revenue for FY25 and is on track for continued growth following last year's record $80+ million performance.

The conversation reveals Veem's remarkable global expansion, securing contracts with major Italian super yacht builders while simultaneously entering Asian markets where demand for high-performance marine technology is surging. Most exciting is their exclusive 17-year partnership with Sharrow to manufacture what Mark describes as "the biggest step forward in probably a hundred years in propellers" – innovative toroidal-based designs that significantly increase efficiency.

Dive into the fascinating world of carbon capture with Dotz Nano, a trailblazer in the fight against climate change. In this episode, we chat with Sharon Malka, the CEO of Dotz Nano, who shares invaluable insights into how the company is revolutionising carbon management through cutting-edge nanotechnology. As the urgency to tackle global carbon emissions rises, Dotz Nano is not just imagining solutions but actively implementing innovative strategies that set new standards for environmental responsibility.

Learn about their advanced sorbent technology that enables both direct air capture and point source carbon capture. These solutions are not only designed to enhance efficiency but also to deliver substantial cost reductions—potentially by as much as 85%—which could transform the industry landscape. Sharon also discusses the critical importance of strategic partnerships in scaling their revolutionary technology, shedding light on how collaboration with key industry players can accelerate market penetration.

The landscape of connectivity is rapidly evolving, particularly within the domains of defence and unmanned systems. In this episode, we gain valuable insights from Yoav Amitai, the CEO of Elsight Limited, a trailblazer in AI-powered connectivity solutions. As Elsight embarks on a phenomenal journey of transformation, we explore the company's flagship product, Halo, which has significantly enhanced drone operations by leveraging advanced multi-link bonding technologies. 

A staggering 32% increase in annual revenue evidences Elsight's strategic pivot towards defence, where demand for reliable communication is at an all-time high. As geopolitical tensions escalate, we discuss how Elsight is navigating these waters with meaningful partnerships with renowned contractors like Lockheed Martin, ensuring sustainable success through their innovative design-win strategy. The episode also delves into key product developments, such as DroneCommX, an aftermarket solution tailored for DJI drones, aimed to strengthen security protocols amid growing concerns over data protection.

Step into the world of family technology as we chat with Simon Crowther, the CEO of Spacetalk Limited. Sparked by their remarkable 12% revenue growth, Simon shares how Spacetalk is redefining safe communications for families. By pivoting from hardware towards a subscription-based model, the company has unlocked new avenues for growth while reinforcing its commitment to providing valuable tech solutions for families of all ages. With significant improvements in annual recurring revenue and a focus on leveraging digital retail spaces like Shopify and Amazon, Spacetalk is poised to make waves in the tech market. 

Notably, Simon discusses their strong focus on the seniors market, capturing insights on how their forthcoming software upgrade will enhance user engagement and elevate service offerings. Join us as we dive into the strategies that are not only driving current growth but also paving the way for future innovations in family-centric technology. Don’t miss this opportunity to learn about the evolving landscape of family tech and how SpaceTalk plans to revolutionise it—tune in, subscribe, and keep pace with one of the industry's most exciting journeys!

Dive into the world of rare earth elements with our engaging discussion featuring Andrew Reid, Managing Director of Brazilian Critical Minerals. This episode delves into the remarkable 97% increase in indicated mineral resources at the Ema Rare Earth Elements project in Brazil, one of the most exciting developments in the sector. Join us as Andrew walks us through the significance of this achievement and its positive implications for the company and its investors. 

Discover how BCM's innovative in-situ recovery method is not only transforming traditional mining practices but also ensuring an environmentally sustainable approach. With the use of eco-friendly magnesium sulfate, Andrew introduces us to the future of green mining that promises minimal environmental impact and high recovery rates. We'll also explore how the Ema project mirrors successful rare earth deposits from global market leaders, giving BCM a competitive edge amid growing demand. 

Effective logistics play a crucial role in BCM’s strategy, and Andrew provides insights into their streamlined processes from the mine site to processing facilities. This operational efficiency is pivotal for maintaining cost competitiveness within the global rare earth supply chain.

Are you curious about how technology is changing the way homeowners find tradies? In this engaging episode of ASX Briefs, Roby Sharon-Zipser, CEO and co-founder of hipages, unveils the innovative strategies behind Australia’s leading online platform connecting tradies with homeowners. hipages stands at the forefront of digital transformation. Roby explains the powerful shift towards a unified platform that helps trades manage their businesses efficiently, combining job leads and management into a single application.

Roby discusses some of the significant growth metrics, including a 10% increase in operating revenue and a leap in monthly recurring revenue (MRR). These results highlight the successful transition from a traditional commission model to a subscription-based approach, establishing a more predictable revenue stream while providing greater value to trades. By enhancing the user experience and ensuring that trades receive tailored support, hipages has captured the attention of the market.

Tune in to gain a deeper understanding of this thriving marketplace and discover how technology is making home renovations easier and more accessible. Join us and don’t forget to subscribe, share, and leave your thoughts!

Paul McDonald, the dynamic CEO of IDT Australia Limited, shares the game-changing strategies that have skyrocketed the company’s revenue by over 1,700% in the advanced therapies sector. Discover how IDT's transformative approach, initiated just two and a half years ago, has harnessed existing products and introduced groundbreaking innovations like mRNA and complex lipid nanoparticles. Paul dives into the future of antibody drug conjugates, offering a targeted approach to chemotherapy that minimizes side effects, and reveals how strategic pivots into advanced therapies have revolutionized IDT's market potential.

Get an insider's look at how IDT's newly secured $20 million asset-backed loan facility from ScotPac is paving the way for future growth. Paul outlines the strategic deployment of this capital to seize new opportunities and invest in state-of-the-art technology. Learn about the company’s calculated steps, from utilizing the R&D expertise brought in from Pfizer to pushing the boundaries of pharmaceutical innovation. This episode is a treasure trove of insights for anyone keen on understanding the intersection of strategic planning and pharmaceutical advancement.

Unlock the future of green hydrogen and advanced materials with Nick O'Loughlin, Managing Director of Sparc Technologies, as he returns to ASX Briefs. We're diving deep into the company's groundbreaking foray into photocatalytic water splitting—a revolutionary technology poised to upend traditional electrolysis and redefine cost-efficiency in the green hydrogen market. Supported by heavyweights like Fortescue and the University of Adelaide, Sparc is set to pioneer a new path in sustainable energy. Nick offers a strategic glimpse into why Morocco was the strategic choice for their first patent and how it aligns with the country's robust solar and fertilizer industries.

But that's not all—Nick also unveils the significance of the ecosparc® trial with BHP Mitsubishi Alliance at the Goonyella Riverside Mine. This venture tests graphene-based coatings in harsh conditions, showcasing Sparc's dual focus on innovation and practical application. Get ready to hear how these advances are not just spearheading change but also opening new frontiers in sustainable technology, setting Sparc Technologies at the forefront of innovation. Don't miss this episode brimming with insights and forward-thinking strategies from one of the industry's visionaries.

Discover how Findi Limited is reshaping the digital payments landscape in India as we welcome Nicholas Smedley, the Executive Chairman, to ASX Briefs. Ever wondered how a company can expand its reach to over 200,000 locations in a single financial year? Nicholas shares the exciting journey of Findi's strategic acquisitions, including Tata Communications' white-label ATM business and BankIT, and how these moves are set to redefine financial accessibility across India. Get an insider look at the company's approach to financial inclusion and the transformative steps they're taking to educate millions about digital transactions.

Join us as Nicholas delves into Findi's ambitious plans and the impact of their Union Bank of India contract on the company's future growth. Understand how FindiPay is gaining momentum with thousands of new merchants each month and what this means for the company's trajectory. Nicholas also provides his expert insights into the rapidly evolving digital payment ecosystem in India and how Findi is strategically positioning itself to capitalize on these changes. Don't miss this opportunity to grasp the future of fintech in one of the world's most dynamic markets through the lens of a true industry leader.

What if your next investment could be the key to unlocking critical defense resources? Join us on ASX Briefs as we sit down with Rob Kirtlan, Chairman of Renegade Exploration Limited, to uncover the electrifying developments in their exploration ventures. Renegade is not just another player in the mining sector; they're making significant strides with their projects in Northwest Queensland and the Yukon Territory, focusing on copper, gold, and rare earth elements. Rob reveals the intriguing story behind the recent discovery of germanium and gallium in their Yukon zinc deposit, a revelation that has piqued the interest of major defense and infrastructure entities in North America.

Discover how these findings are reshaping Renegade's strategic outlook and what steps they're taking to verify these valuable resources. Rob shares candid insights into the company's plans to resample drill cores amidst challenging conditions, as well as the gold and antimony discoveries that present further exciting opportunities. With potential collaborations on the horizon and an eye on neighboring success stories, this episode paints a vivid picture of the dynamic landscape of mineral exploration and the high-stakes decisions that could alter the future of the industry. Tune in for a riveting conversation that promises to be as informative as it is inspiring.

Unlock the secrets to maximizing income with Don Hamson, the Managing Director of Plato Investment Management, as he shares the innovative strategies behind the Plato Income Maximizer. Promising a blend of income generation and robust total returns, this fund stands out with its fully-franked monthly dividends, specifically designed for retirees and income-focused investors. Discover how Plato's active trading approach ensures optimal performance, setting it apart from traditional buy-and-hold strategies and competitors who rely on derivatives or options.

Join us on ASX Briefs to explore the insights on navigating current market dynamics and what to watch for as we approach 2025. Learn about the dual objectives of the Plato Income Maximizer and how its strategic management of Australian and global equities consistently aligns with benchmark performances. Whether you're a seasoned investor or new to the market, this episode is a valuable resource for anyone looking to grow their income and deepen their understanding of the Australian equity landscape.

Unlock the strategies behind Reckon Limited's growth with insights from CEO Sam Allert on ASX Briefs. Discover how Reckon, a leading Australian software company, is tackling the business software landscape with innovative solutions for SMEs and legal firms. Sam Allert shares the secret sauce behind Reckon's 5% increase in annual recurring revenue and 7% surge in cloud revenue, fueled by their successful US legal group business and the growing Reckon One accounting and payroll software in the SME market. Learn about the promising prospects arising from their strategic acquisition of Cashflow Manager, introducing 20,000 new SME clients to the Reckon family, and how this move aligns with their ambitious growth plans.

Sam delves into Reckon's strategic manoeuvers to capture new opportunities in the US and UK legal markets, particularly through their investment in NQ ZebraWorks and the BillingQ product. With a keen focus on enhancing sales and marketing efforts, Reckon's commitment to delivering EBITDA and fostering profitability is set to propel them towards double-digit ARR growth. Tune in to gain a deeper understanding of how Reckon is poised to transform the business software sector and what this means for the future of SMEs and legal firms worldwide.

Discover why Helium-3 could be the key to the future of nuclear fusion and advanced technologies as we chat with Neil McDonald, Managing Director of Gold Hydrogen Limited. With helium becoming increasingly scarce, Neil sheds light on their groundbreaking discovery in South Australia’s Ramsey Project and the untapped commercial possibilities it presents. As Gold Hydrogen expands its exploration footprint to an impressive 77,000 square kilometers, we explore how this positions them as leaders in the pursuit of natural hydrogen and helium—two elements crucial for our technological and environmental future.

Explore the strategic plans driving Gold Hydrogen’s operations, and hear how they’re optimizing well design and equipment to revolutionize the extraction rates of natural hydrogen and helium. With a focus on maximizing shareholder value, Neil offers a glimpse into the meticulous preparation behind their enhanced drilling operations set for later this year. We wrap up with an optimistic view of what’s on the horizon for Gold Hydrogen and the broader hydrogen and helium markets, highlighting their vital roles in achieving net zero emissions and advancing technologies like quantum computing. Join us for this deep dive into the exciting future of energy and technology.

Discover how PARKD Limited is setting new benchmarks in the construction world with its revolutionary modular car park solutions. In our latest episode, we sit down with Peter McUtchen, the Managing Director at PARKD Limited, who shares the company's journey from its inception in 2018 to becoming a leading specialist contractor and technical advisor. Learn how their innovative pre-fabricated systems are shaking up the industry by focusing on efficiency, sustainability, and adaptability. Peter also unveils the details behind their exciting licensing agreement with Fielders, which combines their renowned slab product with PARKD's patented beam technology, unlocking new potentials in the market.

Explore the fascinating proof of concept projects: The Quattro Automotive Myaree and John Hughes Forward Street, which showcased the effectiveness of PARKD's Metal Deck Support System (MDSS). Peter offers insights into how these initiatives validated their technology's performance and underscored their competitive edge. Uncover the unique benefits of PARKD's lightweight concrete modular car park systems, which drastically cut down on-site labor and time while maintaining high performance standards. This episode promises a wealth of insights into how PARKD Limited is poised to transform construction with its forward-thinking approach.

Curious about how the Mackay Potash Project is set to revolutionize global food security? Join us on ASX Briefs as we sit down with Debbie Morrow, the dynamic CEO and Managing Director of Agrimin Limited, to explore this groundbreaking initiative. Positioned on the world’s largest undeveloped potash-bearing salt lake in Western Australia, the Mackay Potash Project is strategically poised to meet the surging global food demand projected to increase by 50% by 2050. Debbie shares the intricacies of Agrimin's journey, including the recent triumph of securing state environmental approval. This approval not only represents a critical milestone in the project's development timeline but also marks a pivotal step towards enhancing Agrimin's export capabilities.

Discover how this ambitious project is set to transform remote communities across Western Australia. With plans for a fully sealed transport corridor stretching to the Port of Wyndham, the Mackay Potash Project promises significant job creation and regional development. Debbie delves into the socio-economic benefits poised to uplift some of Australia's most underserved communities, highlighting the opportunities for improved education, job readiness, and economic betterment. Tune in to gain insights into how these initiatives are designed to de-risk the project and pave the way for sustainable growth, both locally and globally.

Get ready to uncover the secrets behind Magnetic Resources NL's impressive growth in the gold sector with our special guest, George Sakalidis, Managing Director of the company. Join us as George shares the journey of their Laverton project, showcasing a remarkable increase in gold reserves, particularly at the Lady Julie North 4 deposit. With an ambitious plan combining both open pit and underground mining, George highlights the strategic partnership with Blue Cap Mining and the critical milestones that lie ahead. Whether you're an investor seeking insights or simply curious about the dynamics of gold mining, this episode is brimming with valuable information and future prospects for Magnetic Resources.

We'll also explore the geographical advantage of the Laverton project, nestled among major gold systems, and discuss plans to leverage this proximity to enhance exploration efforts along the Chatterbox Shear Zone. George enlightens us with the significance of deep drilling efforts and the potential for expanding their resource base. As assays for Lady Julie North 4 are eagerly awaited, George provides a glimpse into how these results could shape the next phase of exploration. Dive into this compelling conversation to understand the bold steps Magnetic Resources is taking to establish itself as a formidable player in the gold mining industry.

Could Hazer Group's methane pyrolysis technology be the game-changer the world needs for decarbonization? Join us as we chat with Glenn Corrie, CEO of Hazer Group Limited, who walks us through the company's meteoric rise from a university project to a global leader in clean hydrogen production. With a recent $6.2 million boost from the Lower Carbon Grants Program, Hazer is set to scale its reactor technology, filling the void left by major companies scaling back their green hydrogen efforts. Glenn shares insights into how Hazer's innovative approach offers a cost-effective and sustainable alternative to traditional practices, setting the stage for a cleaner future in industries like steelmaking and concrete.

In our discussion, Glenn underscores the competitive edge given by Hazer's robust intellectual property strategy, boasting an impressive 70 patents across 35 jurisdictions. We also explore the promising horizon with the upcoming integration of their next-generation reactor in 2025, which holds potential not just for industry transformation but also for investors looking to be part of this revolution. Supported by strategic partnerships and solid funding, Hazer is not just innovating—they're paving a path for a low-emission future. Tune in and discover how Hazer is poised to redefine the landscape of sustainable industrial practices.

Discover the cutting-edge advancements in rare earth element development with Rafael Moreno, CEO of Viridis Mining and Minerals, as he returns to ASX Briefs. With industry-leading results from their Colossus project, Rafael shares why this venture is setting new standards in recovery rates and environmental sustainability. Get an insider's look at how the maiden mixed rare earth carbonate results are redefining the value proposition for Viridis and how recent high-grade drilling in the Cuban south promises a significant resource upgrade. Learn how these breakthroughs are not just numbers on paper but are poised to transform the economic outlook for the project, making it a beacon in the rare earth industry.

Join us as Rafael explores the strategic partnership between Viridis and Ionic Rare Earths, highlighting the development of Viridion Rare Earths Technologies. This collaboration is set to revolutionize the rare earth supply chain in South America, bolstering their downstream capabilities with innovative and sustainable practices. Understand the implications of these strategic advancements and how they position Viridis Mining and Minerals at the forefront of the mining and minerals sector. Don’t miss this opportunity to hear firsthand how they plan to shape the future of rare earth supply chains with world-class efficiencies and eco-friendly methodologies.

What if you could revolutionize the entire microbiology laboratory industry with the power of AI? Join us as Brent Barnes, CEO and Managing Director of Clever Culture Systems Limited, shares the journey behind their groundbreaking product, APAS Independence. Once known as LBT Innovations, Brent discusses the strategic rebranding to streamline communication with investors and customers alike. Gain insights into how their cutting-edge machine vision technology is setting a new standard in the pharmaceutical manufacturing sector, with significant clients like AstraZeneca and Bristol-Myers Squibb already on board. Learn about their path toward potential cash flow positivity by the financial year 2025 and how they’re leading the charge with the only FDA-cleared AI technology for automated plate reading.

Listen in as Brent explains the transformative advantages of APAS Independence, from improved traceability and quality to increased speed in environmental monitoring. Discover what it means to see AstraZeneca, a global pharmaceutical giant, standardize on this innovative technology across its major manufacturing sites. With repeat orders reflecting strong market acceptance, Clever Culture Systems is poised for global impact. Brent’s insights offer a comprehensive look into how intelligent automation in microbiology is not just enhancing traditional methods but reshaping the future of laboratory workflows.

Join us to hear how Jason Weate, a Fund Manager from Dexus Convenience Retail REIT, is reshaping the landscape of real estate investment trusts (REITs) in Australia. With a portfolio worth $741 million, DXC stands out with its strategic investments in high-quality service stations and convenience retail assets. Jason highlights the REIT’s old-school approach to generating secure income and the successful partnerships with top brands like 7-Eleven, Chevron, and McDonald's, offering investors a tantalizing distribution yield of around 7%. He shares insights into the recent divestment of seven assets as part of DXC's innovative capital recycling strategy and the exciting Glasshouse Mountains redevelopment project, which promises to revolutionize service centers with premium dining options and state-of-the-art EV charging facilities.

Join us as Jason unveils the factors driving DXC's decisions and the REIT’s commitment to enhancing its portfolio's value. He explains how core locations in major cities are key to capturing growth opportunities, particularly with the upcoming Brisbane Olympics. Get a sneak peek into the future of service centers with DXC’s flagship Glasshouse Mountains project, set to feature a stellar lineup of quick-service restaurants and modern amenities like EV chargers. Discover how DXC fosters long-term partnerships with national and international tenants, ensuring tenant satisfaction and stability in a competitive retail environment. This episode is a must-listen for anyone interested in the evolving dynamics of real estate investments.

Unlock the secrets of sustainable growth in the oil and gas industry with Andrew Knox, Managing Director of Red Sky Energy Limited, as he reveals the strategic maneuvers propelling this dynamic company. Discover how Red Sky is transforming proven assets in South Australia's Innamincka and Killanoola oil field into lucrative opportunities, with Yarrow 1 and Yarrow 3 leading the charge towards a promising future. Learn how international expansion efforts in Southeast Asia and Sub-Saharan Africa could diversify their portfolio and amplify their impact on the global energy sector.

Join us in this insightful episode of ASX Briefs where Andrew provides a comprehensive update on the re-entry process for Yarrow 1, the impressive revenue figures from Yarrow 3, and the game-changing 3D seismic interpretations at Innamincka Dome. Gain valuable insights into the operational efficiencies driving success and the revised strategies for the Killanoola oil field, all while exploring the potential for expanded cash flows and enhanced production efficiency. Whether you're an investor or an energy enthusiast, this episode is packed with actionable insights and forward-looking strategies that should not be missed.

Unlock the secrets behind Nova Eye Medical's remarkable 44% global sales growth as we sit down with Tom Spurling, the visionary Managing Director who’s leading a revolution in glaucoma treatment. Tom shares how their innovative iTrack™  Advanced Canaloplasty device is changing the game, offering a stent-free, minimally invasive solution that’s capturing the attention of ophthalmic surgeons worldwide. Discover how Nova Eye is making strategic moves in the US, China, and Europe despite facing supply chain challenges, and learn how they’re setting the stage for future success in the global medical technology landscape.

Join us as we explore Nova Eye Medical's ambitious plans for the financial year 2025, focusing on growth in key markets and achieving financial break-even in their glaucoma division. Tom gives us a closer look at the company’s strategic priorities and the growing adoption of their cutting-edge technology. Whether you’re intrigued by the future of glaucoma care or curious about the dynamics of scaling a medical tech company, this episode is brimming with insights and strategies from a leader who’s at the forefront of ophthalmic innovation.

Unlock the secrets of the diamond industry with Kim Truter, CEO and MD of Burgundy Diamond Mines, as he shares the groundbreaking approaches reshaping this sparkling sector. Imagine knowing exactly where your diamond comes from — that's what Burgundy promises with its vertically integrated model that guarantees ethical sourcing and transparency from mine to market. This episode uncovers the strategic advantages that Burgundy Diamond Mines holds, especially with its operations at the renowned Ekati mine in Canada. Kim enlightens us on the impressive recovery of their hundred millionth carat and the vital infrastructure legacy inherited from BHP, which sets the stage for future triumphs.

Kim also reveals how the Misery Main ore body extension is poised to redefine Burgundy's production outlook, offering a promising horizon with minimal additional costs. Get a front-row seat to understand the factors that are shaping the company's revised revenue forecast for 2024 amidst aspirations for market recovery. With insights into the company's ambitious five-year plan and the role of its cutting and polishing facility in Perth, this episode is a must-listen for anyone curious about the evolving landscape of the diamond business. Tune in to discover how Burgundy Diamond Mines is setting new standards in the industry.

Discover how Jessie Glew, the innovative CEO of WOTSO Property, transformed the company into a powerhouse in the flexible workspace sector building an impressive network across Australia and New Zealand, achieving a record-breaking $49.7 million in revenue for FY24. Jessie shares the secrets behind the strategic focus on suburban and regional locations and how they balance growth with high occupancy rates amidst the rising demand for flexible leases. Tune in to find out how WOTSO's ancillary services, like virtual offices and meeting room hires, are enhancing their value proposition and opening doors to future opportunities.

We're thrilled to bring you an engaging update on WOTSO Property's current status and future direction. Jessie sheds light on the company's recent expansions and the strategies fueling this growth. Learn how flexible lease options help WOTSO navigate today's volatile financial climate while positioning the company for continued success. With 28 locations, including new expansions in New Zealand, WOTSO is at the forefront of meeting the evolving needs of businesses seeking flexible workspace solutions. Join us for this insightful episode filled with exciting possibilities and innovative approaches to the future of office spaces.

Discover the ambitious exploration journey of Western Mines Group with our guest, Dr. Caedmon Marriott, the company's Managing Director, as he unveils the strategic vision propelling their Mulga Tank Project towards potential new nickel sulfide discoveries. We promise an inside look at how the team’s personal investment is driving innovative exploration efforts, with recent drilling results hinting at a system that could rival the region’s most notable deposits. Caedmon shares his expertise on how Western Mines Group plans to consistently reveal higher-grade intervals, underscoring their commitment to value creation through cutting-edge exploration methods.

As we continue the conversation, the focus shifts to the promising future of nickel mining and the broader industry landscape. Recent successes at Mulga Tank, supported by the EIS grant, highlight the discovery of ultramafic komatiite channels, opening doors to untouched deposits and belt-scale potential. Join us in exploring how the global nickel market could stabilize in the wake of Indonesia’s market influence and dwindling reserves. Looking ahead, Caedmon outlines key milestones for shareholders, emphasizing aggressive exploration plans and resource development at Mulga Tank, alongside metallurgical testing aimed at maximizing economic returns for the company and its investors.

Discover the future of clean technology with Dr. Ebbe Dommisse, CEO of IonDrive Limited, as he reveals how the company is revolutionizing lithium-ion battery recycling. Our conversation uncovers the secrets behind their groundbreaking Deep Eutectic Solvent (DES) process, which promises an eco-friendly, cost-effective alternative to conventional recycling methods. Iondrive's innovative approaches are not only making waves in the industry but are also gaining international attention through strategic partnerships and collaborations, particularly in Europe. With Ebbe's insider perspective, listeners will gain a comprehensive understanding of the technical, commercial, and market advantages of Iondrive's pioneering solutions.

Join us as we explore the impressive results of Iondrive's pre-feasibility study, which highlights their significant edge over traditional methods in terms of cost, environmental impact, and scalability. Ebbe discusses how their sustainable process aligns with the company's mission to reshape the battery recycling landscape and establish a strong presence in key global markets. Don't miss this insightful episode that sheds light on the strategic moves being made to create a robust and environmentally conscious recycling industry, paving the way for a cleaner, more sustainable future.

Get ready to meet Martin Deil, the visionary CEO of ClearVue Technologies, as he unveils the future of architectural design with building-integrated photovoltaics. Mark shares how his groundbreaking technology transforms ordinary glass windows into transparent solar power generators, maintaining aesthetics while slashing energy costs. Discover how ClearVue's innovation not only generates renewable energy but also curtails solar heat gain, lessening the reliance on air conditioning in modern buildings. If you've ever wondered how buildings could serve as their own power stations, this episode offers a glimpse into a sustainable future.

Gain insights into ClearVue's strategic expansion into lucrative markets such as the Middle East, India, and South Africa, highlighting their collaboration with Alutec in Qatar. Mark discusses the pivotal role of their strategic partners in scaling operations and integrating the technology across new markets. Plus, learn about the transformative $7.5 million institutional placement that is propelling ClearVue from a research-focused entity into a project execution powerhouse. Mark's revelations promise to leave you with a richer understanding of how smart building technology is reshaping the energy landscape and boosting shareholder value.

Join us for an engaging discussion with Jane Lowe, the trailblazing founder and managing director of IR Department, as she unravels the intricate world of investor relations. From her start in the diagnostics and tech sectors to steering through the Global Financial Crisis, Jane’s story is a testament to strategic resilience and innovation. She shares her journey of establishing IR Department, a firm dedicated to supporting companies in healthcare, tech, and industrial sectors with a foundation built on integrity and value creation. Jane sheds light on the pivotal role of Annual General Meetings (AGMs) in fostering shareholder engagement and ensuring successful business decisions through impactful voting.

In this episode, listeners will uncover practical strategies for maximizing AGM outcomes, making them not just a procedural obligation but a valuable opportunity for engagement. Jane offers insightful tips on creating an inviting and informative AGM atmosphere, emphasizing the roles of the chair and CEO. The conversation also touches on the future landscape of investor relations as we move towards 2025.

Discover how pioneering strategies and cutting-edge technology are setting the stage for Resouro Strategic Metals' success as CEO Alistair Stephens joins us on ASX Briefs. Our conversation unveils Alistair's journey from the goldfields of Western Australia to spearheading the company's ambitious projects in Brazil. Alistair paints a vivid picture of the company's flagship Tiros project, where recent mineral resource estimates and metallurgical breakthroughs promise a bright future. He also reveals how Resouro's partnership with Altilium Projects and their innovative nitric acid digest technology is a game-changer in the competitive rare earths market.

The episode further explores the company's strategic expansion with the acquisition of additional mineral rights in Brazil, enhancing long-term growth prospects. Alistair shares insights into how the company's dual listing on the ASX not only boosts visibility but also fortifies its financial strategy, drawing parallels with industry giants like BHP. With a focus on strategic positioning, innovation, and shareholder value, this episode offers a captivating glimpse into the dynamic evolution of Resouro Strategic Metals and the broader rare earths industry landscape.

Discover how Simon Henry, the dynamic Founder, Executive Director and CEO of DGL Group Limited, transformed a single chemical logistics site into a chemical industry powerhouse across Australia and New Zealand. Simon shares his journey and reveals the key strategies that have enabled DGL to sustain growth despite facing challenges like falling commodity prices and geopolitical tensions. Learn how DGL leverages unit cost production and economies of scale to maintain profitability and explore how their recent acquisition of Australian Petrochemical Storage aligns with their long-term vision for expansion and innovation.

Get an insider's look at DGL's commitment to organic growth through strategic investments in new plants and expanded warehousing, alongside an ambitious M&A strategy. Simon discusses the criteria for future acquisition targets, focusing on businesses with valuable chemical formulation and storage capabilities that complement DGL's strengths. With an impressive track record of over 20% CAGR growth for 23 years, Simon lays out the milestones shareholders can anticipate in the upcoming months, underscoring DGL’s unwavering pursuit of excellence and growth. Join us for this engaging conversation that sheds light on the dynamic steps DGL is taking to ensure continued success in the chemical industry.

Could a pioneering exploration project in Argentina hold the key to the future of clean energy? Join us as Arvind Misra, Managing Director of Belararox Limited, unveils their groundbreaking 6,000-meter diamond drilling campaign at the TMT project. Discover how this ambitious venture targets the Tambo and Malambo prospects within a promising copper-gold porphyry system, setting the stage for significant advancements in the battery and renewable energy markets. Arvind gives us an exclusive look into their strategic partnership with Conosur Drilling SA, highlighting how this collaboration boosts the efficiency and potential success of their exploration efforts.

With expert insights from Belararox Limited’s experienced technical team, led by the talented Jason Ward, this episode is a treasure trove of information for anyone intrigued by mineral exploration and clean energy solutions. Arvind shares stories of past achievements, and introduces us to the skilled geologists shaping their current endeavors in Argentina. Prepare to be inspired by the expertise and dedication fueling the company's mission to become a driving force in the clean energy revolution.

Ignacio Salazar, the dynamic CEO and Managing Director of Highfield Resources, joins us in an episode bubbling with excitement and opportunity. Ever wondered what it takes to transform a company into a global contender? Ignacio shares how Highfield Resources is stepping up its game with groundbreaking developments at the Muga potash project in Spain and an ambitious leap into the Canadian market. You'll uncover the backstory of securing vital investments that not only fully fund Muga's construction but also bring new assets into play, setting the stage for Highfield's ascent in the potash industry.

Ignacio opens up about the strategic alliance with Yankuang Energy and the acquisition of the Southey Potash project, revealing how these moves align with Highfield's vision of global leadership in the potash sector. With assets spanning Europe and North America, Highfield Resources is poised to compete on a worldwide scale. Tune in to discover the synergies between their Spanish and Canadian projects and learn how experience and foresight are propelling them to new heights. From funding breakthroughs to future roadmaps, this conversation is packed with insights for anyone eyeing the global potash market.

Unlock the secrets of clean energy innovation with Neil McDonald, Managing Director of Gold Hydrogen Limited, as he joins us to discuss the company’s groundbreaking journey in South Australia's York Peninsula. With helium purity levels reaching an unprecedented 36.9%, Gold Hydrogen is not just making discoveries; they're setting new standards in natural hydrogen and helium exploration. Get ready to explore how these extraordinary results position the company as a leader in clean energy solutions at a time when global demand has never been higher.

Neil walks us through the strategic steps Gold Hydrogen is taking to transition the Ramsey project from exploration to commercial success. Discover their cutting-edge plans for drilling and resource optimization, and hear about their exciting collaboration with Mizuho, a Japanese banking giant, which could accelerate their entry into international markets. With Japan's strong commitment to a hydrogen economy, this partnership could be a game-changer. Tune in to understand how Gold Hydrogen is poised to revolutionize the energy sector and what their advancements mean for the future of sustainable energy.

What if the shift from lithium to copper exploration could redefine the future of a resource company? Glenn Poole, CEO and MD of Firetail Resources Limited, joins us to peel back the layers of this strategic transition. As Firetail pivots its focus to copper across Canada, Peru, and Australia, Glenn reveals the exciting opportunities and challenges that lie ahead. From the recent land expansion at the Skyline Copper Project in Canada to the exploration of overlooked sulfide zones, listeners will gain a comprehensive understanding of the company's next steps and the potential growth in untapped areas.

Join us as Glenn takes us through Firetail's ambitions to unlock a larger mineralized system with a holistic approach and strategic drilling campaigns. Discover how Firetail plans to capitalize on its contiguous land package and what the Helii EM survey could mean for their exploration timeline. Glenn also shares key milestones and future opportunities that could significantly impact Firetail's trajectory and offer new prospects for investors. This episode is packed with insights that highlight Firetail's commitment to innovation and strategic growth in the copper exploration landscape.

Get ready to explore the cutting-edge world of cancer treatment with Dr. Chris Burns, CEO & MD of Amplia Therapeutics Limited and co-recipient of the 2024 Prime Minister's Prize for Innovation. Our latest episode of ASX Briefs takes you inside Amplia's groundbreaking work with Focal Adhesion Kinase (FAK) inhibitors, specifically their promising small molecule inhibitor, designed to tackle pancreatic cancer head-on. Dr. Burns shares the significant milestones in their ACCENT trial, including the recruitment of the first 26 patients and the remarkable achievement of six confirmed partial responses, which may signal a new frontier in cancer therapy.

Join us as Dr. Burns uncovers the science behind Amplia's innovative approach and how their treatment aims to enhance the effectiveness of existing therapies. He discusses the trial's progress, the potential for improved patient outcomes, and the exciting path forward with further recruitment underway. This episode is a compelling listen for anyone passionate about the future of oncology and the relentless pursuit of breakthroughs in cancer treatment. Don't miss the chance to hear firsthand from a leader at the forefront of medical innovation.

What if a single strategic move could redefine the music and media industries? Join us on ASX Briefs as we uncover the secret sauce behind Vinyl Group Limited's trailblazing success with their CEO, Josh Simons. Josh returns to share how the company, which boasts the world's only official music credit database, is pushing boundaries with innovative strategies and smart acquisitions. Discover the seamless integration of platforms like Jaxsta and Vampr, and learn how their revamped interfaces promise an even more dynamic user experience. Explore how their acquisition spree, including Jaxsta, Vampr, and Media Week, is positioning Vinyl Group at the forefront of the creator economy and media landscape.

But that's not all—Josh delves into Vinyl Group's strategic expansion into the realm of collectibles with the London-based Web3 pioneer, Serenade. This move aligns with their ambitious Vinylcom initiative and is set to boost cash flow significantly. Hear firsthand about the impact of acquiring Funkified Entertainment and how bringing event management in-house is a game-changer for improving margins. As the company targets a break-even point by FY26, Josh shares insights on the art of identifying promising acquisition targets that fuel growth. Don't miss out as we explore how Vinyl Group is reshaping the future of music and media with visionary leadership and strategic foresight!

Explore the transformative journey of Percheron Therapeutics with Dr. James Garner at the helm, as he shares the company's pioneering efforts in the field of rare disease therapies. Discover how their strategic evolution from Antisense Therapeutics to Percheron Therapeutics has positioned them at the forefront of developing groundbreaking treatments for Duchenne muscular dystrophy (DMD). As we delve into the intricacies of their phase 2b trial of avicursen for non-ambulant boys, Dr. Garner reveals the innovative use of the Performance in the Upper Limb (PUL2.0) endpoint and the promising results from their essential non-human primate toxicology study, aligning with FDA requirements for future clinical trials.

Uncover the strategic blueprint Percheron employs to bring their therapies to market, leveraging Ionis Pharmaceuticals expertise and carefully outsourcing critical tasks, allowing them to concentrate on clinical development. Dr. Garner outlines their ambitious commercialization plans, aiming to partner with larger entities for broader market reach. With pivotal data readouts expected soon and ongoing conversations with the FDA, Percheron is on a mission to de-risk their drugs and attract strong partners. Listen in to understand how these innovative therapies could significantly impact the lives of patients with rare diseases, paving the way for a brighter future.

Unlock the secrets of the helium supply chain with Shaun Scott, the dynamic Managing Director and CEO of Noble Helium. Discover how the company is setting a new course in helium exploration with cutting-edge projects in Tanzania. Shaun shines a light on a staggering 67% boost in the P50 helium prospective resource at the North Rukwa Basin, sharing the innovative strategies that made this achievement possible. As we venture into the prospects on the eastern side of the basin, Shaun reveals Noble Helium's strategic plans to navigate the challenges of deep exploration and the potential partnerships on the horizon.

Get an insider's perspective on the pivotal role of helium in powering high-tech industries and the nuanced geopolitical factors reshaping its global supply chain. Shaun discusses the advantages of primary helium production over byproduct extraction and outlines Noble Helium's vision for the next 12 to 18 months. From shallow drilling revelations to the quest for farm-in partners for deeper targets, this episode is packed with critical insights and future-focused strategies that underscore helium's vital importance in our technological future.

Discover the strategic insights of Ed Ainscough, Managing Director of Lunnon Metals Limited, as he reveals the company's bold transition from nickel to gold exploration amidst challenging market conditions. With a storied history in the Kambalda Nickel District, Lunnon Metals has strategically pivoted to capitalize on their promising gold assets, particularly at the Lady Herial Prospect. Ed shares how this shift was not only a response to external challenges but also a calculated move to leverage the soaring gold prices, ensuring value creation for shareholders while maintaining a strong cash position.

Join us as Ed uncovers the impressive recent findings at the Lady Herial Prospect and discusses the exciting opportunities they present for Lunnon Metals. Learn how the company's reassessment of its gold portfolio, backed by a solid legacy and strategic foresight, positions it to navigate the evolving commodity landscape. This episode is a must-listen for anyone interested in the mining and exploration sector, offering a deep dive into how strategic decisions can drive growth and resilience in a volatile market.

What if turning trash into treasure could be the key to decarbonizing entire nations? Join us for an insightful conversation with Joe Oliver, the visionary CEO of Delorean Corporation, as he shares his compelling journey in the bioenergy sector. Discover how Delorean is pioneering advancements in organic waste conversion, positioning themselves at the forefront of renewable energy solutions in Australia and New Zealand. Joe reveals the details behind Delorean's recent $30 million funding success for the ambitious SA1 project and how this strategic move is transforming their operational model to build-own-operate, setting the stage for impressive growth and infrastructure ownership.

In our latest episode, Joe offers a glimpse into the dynamic future of Delorean with updates on the VIC-1 project, aligning with the company's long-term vision of green gas production. As we explore the robust project pipeline and strong financial performance in FY 2024, you'll gain valuable insights into Delorean's role in reducing emissions and supporting third-party clients. This conversation is not just about numbers but about the vital steps being taken to reshape the renewable energy landscape, showcasing Delorean's commitment to sustainability and innovation. Tune in to understand the transformative strides this leader in the bioenergy market is making and what it means for the future of renewable energy.

What if controlling a single hormone in your brain could revolutionize the treatment of Alzheimer's and depression? On this episode of ASX Briefs, we're joined by Steve Gourlay, CEO of Actinogen Medical, a trailblazer in biotechnology, to unveil how their groundbreaking drug, Xanamem, could be a game-changer for mental health therapies. Steve takes us through Actinogen's fascinating journey from their 2014 merger with a University of Edinburgh startup to the promising Phase 2 depression trial results, where 167 patients showed significant improvement with minimal side effects.

Steve demystifies the complex science behind Xanamem, explaining how it targets brain cortisol, a hormone infamous for its role in stress and cognitive decline. With a deep dive into the biology of the brain, Steve enlightens us on how selectively reducing cortisol in regions like the hippocampus and frontal cortex can prevent the detrimental effects of chronic stress on nerve cells. This episode is a must-listen for anyone interested in the future of mental health treatment and how innovative therapies are set to change the landscape.

What if you could file your taxes from your phone in just five minutes? Join us on ASX Briefs as we chat with Mark Waller, the Managing Director of One Click Group Limited, a fintech disruptor making waves in Australia. Mark shares the incredible journey of transforming a room in a house into a thriving company that simplifies tax returns through its One Click Life platform. From a groundbreaking partnership with the ATO to mastering digital marketing, Mark provides a behind-the-scenes look at how they made tax time a breeze for over 160,000 Australians.

But that's not all—Mark also dives into the company’s impressive growth metrics, having smashed their 2023 revenue targets well before 2024 even wrapped up. Learn how user acquisition strategies and innovative services like the next-day refund product are meeting the rising demand for instant financial solutions. This episode is a treasure trove of insights into the fintech landscape in Australia and how One Click Group is perfectly positioned to lead the charge in digital financial services. Don't miss out on this engaging conversation packed with valuable takeaways!

What if a hidden treasure could reshape Australia's mining future? Join us on ASX Briefs as we sit down with Simon Noon, Managing Director of Boab Metals Limited, to uncover the groundbreaking developments at Sorby Hills in Western Australia's Kimberley region. With its proximity to Kununurra and robust local infrastructure, Sorby Hills is poised to be a game-changer. Simon reveals the details behind the recently completed front-end engineering design study, which has significantly enhanced the project's feasibility and economic potential. Learn how strategic adjustments to the mining schedule and the adoption of a traditional tailings facility have set the stage for success.

In this episode, Simon also shares the extraordinary discovery of zinc at Sorby Hills, unlocking new dimensions for future drilling programs. We discuss Boab Metals' strategic acquisition of Henan Yuguang's 25% stake, streamlining ownership and easing financing, and the exciting potential of Sorby Hills' silver deposits to position it as a leading silver producer in Australia. Listen as Simon outlines the key milestones for the next 12 to 18 months, from finalizing approvals to securing offtake agreements, and advancing towards the pivotal Final Investment Decision (FID). With its low-risk, high-reward profile, Sorby Hills is set to make waves in the metals market.

How can a single well power 100,000 homes? Join us in this captivating episode of ASX Briefs as we sit down with Richard Wolanski, Corporate Finance Director of Kinetiko Energy Limited. Richard shares the exciting achievements from the 2024 Core Hole Exploration Program, revealing a 100% success rate in intersecting gas pay zones. With an ambitious exploration program kicking off, Kinetiko is set to transform the energy landscape in South Africa. Discover how this success is propelling their rapid LNG production plans and learn about their groundbreaking gas-to-power demonstration at the Amersfoort site.

Richard also dives into the significance of Kinetiko's collaboration with FFS Refiners and the Industrial Development Corporation of South Africa. These partnerships are crucial in advancing their gas field development and establishing multiple development sites across their extensive South African tenements. Additionally, Richard explains how a recent capital raise has provided the financial stability needed to embark on one of their most important exploration programs to date. This episode is a treasure trove of insights for anyone keen on the future of energy innovation in South Africa.

Discover the latest breakthroughs in rare earth exploration as CEO Zac Komur of Equinox Resources takes us inside their pioneering projects in Brazil. Uncover the exceptional oxide and titanium dioxide grades from the Mata da Corda project and learn about the strategic plans for upcoming drilling campaigns. Zac shares insights on the recent expansion of their exploration team and the promising early results already in analysis, all aimed at pushing the boundaries of what's possible in mineral exploration.

But that's not all—Zac also unveils Equinox's strategic diversification with the acquisition of the high-grade Alturas Antimony project in British Columbia. Find out how this acquisition aligns with the company's broader goals and the initial findings that are setting new benchmarks. If you're keen on staying ahead in the rare earth and critical mineral sectors, this episode is packed with invaluable insights and updates that you won't want to miss.

Can drones truly transform emergency response and security operations? Join us as we welcome Chris Clark, CEO of RocketDNA Limited, a trailblazer in drone-based data services and AI technology. Chris gives us an inside look at how Rocket DNA's xBot and PatrolBot systems are setting new standards in public safety and industrial security. Discover how drones are providing critical situational awareness for the Western Australian Police Force and revolutionizing emergency responses by acting as first responders.

With a newly secured $1 million debt facility, RocketDNA has ambitious plans to further integrate their innovative solutions across various sectors. Chris elaborates on the strategic initiatives and the impact of these funds on the company’s expansion plans. From automating hazardous patrol tasks in the mining and energy industries to enhancing safety through AI-enabled surveillance, this episode offers a comprehensive overview of how RocketDNA is shaping the future of automated data services. Tune in to learn how AI and drone technology are making dangerous, dull, and dirty tasks a thing of the past.

Unlock the future of business communication with digital human technology in this enlightening episode of ASX Briefs! Join us for a captivating conversation with Idan Schmorak, CEO of Unith Limited, as he shares the revolutionary journey from CrowdMedia to Unith—a company at the forefront of generative AI. Idan walks us through how Unith’s blend of deep learning, conversational AI, and machine learning crafts interactive avatars that are indistinguishable from real humans, transforming sectors from healthcare to social work.

Get the inside scoop on Unith's anticipated platform, interFace, set to launch on September 23, 2024. Discover how this self-service system will empower businesses worldwide to create and deploy their own digital humans effortlessly. With over 600 B2B leads eagerly awaiting, Idan discusses the platform’s scalability features, advanced conversational AI technologies, and the democratization of digital human technology. This episode is a must-listen for anyone keen on the future of AI-driven customer interactions.

Curious about how a small company can shake up global markets? Discover how Larvotto Resources is positioning itself at the forefront of the critical minerals industry with CEO Ron Heeks. This episode of ASX Briefs pulls back the curtain on Larvotto's journey from its 2021 IPO to becoming a key player in Australia's mineral exploration scene. Ron dives into their major projects, including the Mount Isa copper venture and the rare earth prospects in Western Australia. However, it's their Hillgrove gold-antimony project that's turning heads, especially in light of China's recent antimony export ban. We unpack the implications for modern tech and defense sectors, and how Larvotto plans to meet soaring global demand.

But that's not all. Ron provides an insider's look at the extensive RC drilling program at Hillgrove, revealing some tantalizing high-grade gold finds and the depth potential at Baker's Creek. With the largest antimony deposit in Australia and eighth globally, Larvotto is gearing up for significant growth. We also get a preview of what's next for their robust project portfolio, including future exploration plans for Mount Isa and Eyre. If you're an investor or just fascinated by the evolving landscape of critical minerals, this episode is a must-listen packed with actionable insights and forward-looking statements.

Discover how Aroa Biosurgery Limited is revolutionizing healthcare with regenerative tissue technology in our latest episode of ASX Briefs. Join us for an inspiring conversation with Dr. Brian Ward, CEO of Aroa Biosurgery Limited, as he shares the remarkable journey of his company from its humble beginnings in 2008 to becoming a leader in wound and soft tissue reconstruction. You'll gain exclusive insights into Aroa's innovative Myriad product family and their strategic transition to direct sales in the US market. 

Dr. Ward also breaks down the science behind the company's groundbreaking ECM platform technology, which is changing the landscape of tissue regeneration and infection prevention. Learn how Aroa sets itself apart in the competitive global wound care market by offering high-quality, affordable solutions that increase patient access. This episode is packed with valuable information that highlights how Aroa's advancements are making a significant impact on patient outcomes and transforming the future of healthcare. Don’t miss this deep dive into the cutting-edge world of regenerative medicine!

What if you could revolutionize the mining industry with a single technology? Join us as we sit down with Dirk Treasure, the Managing Director and CEO of Chrysos Corporation, to uncover the game-changing impact of PhotonAssay™ technology. Developed by CSIRO and commercialized by Chrysos since 2017, this innovative method offers faster, more accurate, and eco-friendly gold analysis, setting a new standard in an industry that hasn't seen such a shift in millennia. Dirk sheds light on how PhotonAssay™ simplifies sample preparation, reduces labor, and enhances ESG metrics, making it a must-have for modern mining operations.

In this episode, Dirk also shares the strategic partnerships and global expansion strategies that have fueled Chrysos Corporation's impressive growth. Discover how collaborations with major gold miners like Barrick, Goldfields, and Agnico Eagle, along with alliances with leading laboratories such as ALS, Intertek, and SGS, have driven rapid adoption of PhotonAssay™ technology. Hear firsthand how Chrysos has built strong relationships with clients and received glowing feedback on the transformative impact of their technology. Don't miss this insightful conversation that promises to redefine the future of mining.

Unlock the secrets behind Orcoda Limited's game-changing technology in our latest episode of ASX Briefs. We sit down with Geoff Jamieson, Managing Director of Orcoda, to explore how his company is transforming transport logistics with cutting-edge smart solutions. Geoff walks us through Orcoda's journey from its name's origin, "organized connected data," to its remarkable impact on the industry, boasting 280 active customers and a 64% surge in annual recurring revenue. You'll gain an insider's perspective on their standout financial performance for FY24, marked by a stunning 396% boost in free cash flow and a 23% rise in total income.

Geoff also dives into the innovative applications of Orcoda’s transport optimization software, which is making waves in sectors such as community transport and agriculture. Learn about the strategic acquisition of Future Fleet and how it’s supercharging Orcoda’s fleet management capabilities. With proprietary algorithms and a focus on digital transformation, Orcoda is poised for even greater success in FY25. Don’t miss this chance to glean invaluable insights from a leader at the forefront of smart transport management.

Curious about how clinical research can revolutionize the complementary medicine industry? On this episode of ASX Briefs, we sit down with Blair Vega Norfolk, the visionary Founder and Managing Director of Biome Australia. Blair's inspiring journey from struggling with autoimmune diseases to establishing Biome in 2018 underscores his commitment to science-driven product development over fleeting industry trends. Learn how Biome has rapidly ascended to success with their ambitious Vision 27 strategic plan, aiming for substantial revenue growth through innovative distribution and educational initiatives. Blair also unveils their groundbreaking Biome Cholesterol Probiotic, emphasizing the critical role of clinical data in maintaining their competitive edge.

Discover how Biome Australia is setting its sights on the global stage, with promising ventures in the UK, Ireland, Europe, and North America. Blair offers valuable insights into their lean and cost-effective approach to international expansion. Additionally, get a sneak peek into the promising results from clinical trials for products like Biome Lift, Biome Osteo, and Biome Kids. With potential benefits ranging from improved mood to reduced bone density loss, these innovations are poised to bolster Biome's credibility and market presence. Tune in for an in-depth look at how Biome Australia aims to revolutionize the complementary medicine industry through clinically proven products and strategic growth initiatives.

Discover how Credit Clear Limited is revolutionizing the debt collection industry with cutting-edge AI technology in this episode of ASX Briefs. Join us as we chat with Andrew Smith, Credit Clear's CEO, who provides an insider's perspective on the transformative shift from traditional debt collection to innovative digital communications. See how this shift is not only boosting engagement rates but also elevating customer satisfaction across sectors like banking, telecommunications, and insurance. Andrew dives into the strategies that have helped onboard major clients like ANZ and Suncorp, emphasizing the pivotal role of performance and customer experience in driving impressive growth.

In our comprehensive update, Andrew sheds light on Credit Clear's current standing and future outlook. From recent progress and strategic initiatives to key developments that are paving the way for continued innovation, discover what stakeholders can expect in the coming months. Learn about the significant metrics that showcase the effectiveness of Credit Clear's digital approach, with an impressive majority of payments now processed through digital workflows. Don't miss this engaging conversation that highlights the ongoing success and future potential of a leading technology company in the debt resolution space.

What are the secrets behind a 71% sales surge in the ultra-competitive US ophthalmic market? Get ready to uncover the strategies that propelled Nova Eye Medical Limited to new heights as we chat with their Managing Director, Tom Spurling. You'll learn how effective treatment technologies, strategic marketing, and an expanded sales team have pushed the company to achieve record-breaking sales of $23.3 million dollars. 

Tom also discusses the anticipated impact of the proposed 30% reimbursement rate increase by CMS and changes from MACs on their iTrack Advance and Molteno 3 devices. Discover how positive feedback from US surgeons is setting the stage for expansion into Western Europe and Asia and why the upcoming European Society of Cataract and Refractive Surgeons conference is a game-changer for Nova Eye's future. Tune in for insights on financial health, improvements in EBITDA, and the road ahead for sustained success.

Ready to hear the remarkable evolution of a pioneering tech company? Join us as we sit down with Simon Crowther, the visionary CEO and MD of SpaceTalk Limited, to uncover how a firm that started with SMS-based school alerts has transformed into a leader in kids' wearables and family safety technology. Simon takes us through the strategic shifts since February 2023, aimed at broadening market reach to include not just children but also seniors. We’ll unpack the secrets behind SpaceTalk's financial resurgence in Q4 FY24 and how disciplined execution and operational focus have driven this turnaround.

Get excited for an exclusive look into SpaceTalk's future growth and expansion strategies. Learn about a groundbreaking deal with a leading telco partner and ambitious plans to enter the North American market. Simon also teases upcoming innovations, from the launch of the Adventurer 2 to the integration of AI in wearables, enhancing user engagement and brand appeal. Stay tuned for insights into their marketing strategies and future product developments that are sure to catch the attention of investors and tech enthusiasts alike.

Curious about the latest breakthroughs in mineral exploration? This episode of ASX Briefs has you covered as we sit down with Matthew Pustahya, the Managing Director of Litchfield Minerals, for an in-depth update on their ambitious exploration projects in the Northern Territory. Matthew shares the triumphs and trials from recent drilling activities at Silver King, Copper Flats, and Mount Irene, and reveals the promising finds of lead, zinc, and silver at Silver King. Discover what technical successes they achieved and the challenges that remain, all while gaining a deeper understanding of how their geological insights are shaping future endeavors.

Get ready for some exciting news as Matthew pulls back the curtain on Litchfield Minerals' upcoming tenement-wide VTEM survey, set to kick off in August. This cutting-edge electromagnetic survey aims to detect massive sulfides down to 200 meters, potentially unearthing significant mineral deposits. Learn about the fertile sulfide systems identified through their diamond drilling campaign and how these findings are steering their exploration strategy. Whether you're an industry veteran or just curious about the world of mineral exploration, this episode is packed with valuable insights and future plans that underscore Litchfield Minerals' dedication to uncovering critical resources.

Ready to uncover the latest breakthroughs in mineral exploration? Listen as we chat with George Ventouras, the Executive Director of Artemis Resources, who shares some riveting updates from their multi-faceted projects across Western Australia. Get an exclusive look into the Karratha Lithium Project, where George reveals the impressive high-grade lithium assays and the significance of coarse spodumene crystals found at the Mount Marie prospect. Discover why these findings are generating excitement and what the next exploration steps entail. 

But that's not all. George also delves into Artemis Resources' ongoing gold exploration within the Pilbara tenements, particularly at the Nickol River Hill South and Orpheus prospects. Learn about the remarkable rock chip sample results that have surfaced and how they align with the company's historic focus on gold. Plus, George discusses Artemis' 49% stake in the Osborne Lithium Project through a strategic joint venture with GreenTech Metals. Don't miss out on George's insights into the future of Artemis Resources and how their diverse mineral projects are shaping up.

What if a simple biological trick could revolutionize wound healing for the first time in 25 years? In our latest episode of ASX Briefs, we sit down with Tony Charara, the visionary co-founder and CEO of Tissue Repair Limited, to discuss this groundbreaking innovation. Tony introduces their lead drug candidate, TR987® , which is poised to transform the treatment of chronic wounds as it enters phase three clinical trials in the US and Australia. He explains how decoy yeast cells can accelerate the body’s natural healing processes, potentially making TR987®  the first approved drug in its category in a quarter-century.

But that's not all—Tony also sheds light on the recent TGA approval of TR Pro+™, , a post-procedure topical gel that's already creating buzz in over 200 clinics. Initially launched as a cosmetic, TR Pro+™,  has shown remarkable results in enhancing skin quality and speeding up recovery post-aesthetic procedures. With its new TGA listing, this product's potential applications have expanded dramatically, from treating acute wounds to addressing conditions like solar keratosis. Tune in to discover the innovative path Tissue Repair Limited is forging and the significant impact their solutions could have on healthcare.

Curious about the future of topical pharmaceuticals? Michael Kotsanis, CEO of Acrux Limited, joins us to uncover the company's strategic endeavors and recent successes. With over 25 years of industry experience, Michael offers valuable insights into Acrux’s focus on developing and commercializing topical generic products for the lucrative US market, valued at $16 billion. He also shares the exciting news of their recent launch of Dapsone 5% Gel and the promising market response, along with updates on three other products currently under FDA review.

Get a behind-the-scenes look at Acrux’s robust research and development efforts, supported by their GMP-licensed facility and collaborations with contract manufacturers worldwide. Learn about the intricate process of drug approval and how Acrux aims to build a sustainable revenue stream through consistent product submissions and launches. This episode is packed with fascinating details about the competitive pharmaceutical landscape and Acrux's future prospects. Don't miss this in-depth conversation with one of the industry's key players!

What if the future of energy relied on turning yesterday's waste into tomorrow's power? In our latest episode, we welcome Simon Linge, CEO and Managing Director of Lithium Australia Limited, who shares the company's remarkable journey from mining exploration to a pioneering force in lithium processing and battery recycling. You'll hear how strategic partnerships with industry giants like LG Energy Solution, Volvo, and Hyundai Glovis have not only strengthened their business model but also underscored the critical role of sustainability in today's economy. Discover the transformative technologies driving their recent cash profit and the key milestones that lie ahead.

Simon dives deep into the operational strides Lithium Australia has made, such as increased battery collection volumes and the lucrative sale of mixed metal dust. Long-term exclusive agreements with major OEMs and battery producers have been game-changers, propelling collection volumes to new heights. We also touch on their latest investment in safety and sustainability, which has significantly improved their processing capabilities. Learn about the exciting placement agreement and share purchase plan with The Lind Group, which aims to fuel future growth and drive their ambitious goals for FY25. Tune in to get the full scoop on the advancements in battery materials technology and lithium chemicals that could redefine the industry.

How does a company turn a promising mining project into a major production powerhouse? Find out as Colin Moorhead, Executive Chairman and Managing Director of Xanadu Mines Limited, takes us through Xanadu's exciting journey in Mongolia. This episode of ASX Briefs promises an insider’s view of the transformative developments at the Kharmagtai Copper Gold Project, including a groundbreaking 50-50 joint venture with Zijin Mining Group and a comprehensive pre-feasibility study that could position Kharmagtai as the next big player in the copper mining industry.

But that's not all—Colin also sheds light on the promising Red Mountain Copper Gold Project, drawing intriguing comparisons to renowned mining regions like the Lachlan Fold Belt. Learn about the innovative metallurgical and extensional drilling work that is pushing the boundaries of what these projects can achieve. If you’re passionate about mining, exploration, and the future of resource development, this episode is packed with valuable insights and strategic advancements that you won’t want to miss.

Ever wondered how some airports manage to maintain seamless passenger flow even during peak travel times? Join us as Billy Tucker, CEO of Beonic Limited, unveils the innovative techniques his company uses to transform physical spaces into highly efficient, data-driven environments. From leveraging LiDAR sensors to creating digital twins of retail and airport spaces, Billy shares how Beonic Limited helps businesses worldwide optimize their operations in real-time, enhancing customer experiences and boosting profitability.

Throughout this episode, you'll hear fascinating insights into how Beonic's cloud-based platform integrates historical and real-time data, weather forecasts, and AI-powered analytics to predict and manage space occupancy and staffing needs. With over 11,000 venues across 35 countries utilizing their technology, Beonic Limited is revolutionizing sectors like airports, retail, and education. Don't miss this captivating discussion on the cutting-edge technology that's redefining operational strategies and setting new standards for efficiency and customer satisfaction.

Unlock the secrets to effortless wealth-building with insights from Brendan Malone, CEO and Managing Director of Raiz Invest Limited. Discover how Raiz Invest has revolutionized the way Australians approach investing, starting with just $5 and expanding into diversified portfolios that even include Bitcoin and property. Brendan shares the company's innovative journey, highlighting how features like the Roundup concept have removed barriers to entry, making investing accessible to everyone. Tune in to learn how Raiz Invest is not just a savings tool but a comprehensive platform that includes superannuation options, cashback rewards, and specialized portfolios tailored to customer feedback.

Join us as Brendan dives into the strategies that have driven Raiz Invest’s impressive revenue growth and increased funds under management. From the highly requested Raiz Plus, offering 150 investment choices, to the phenomenal success of Raiz Kids, designed to secure the financial future of the younger generation, Brendan reveals how customer engagement and feedback have been pivotal. Hear firsthand about the development of new products and enhancements, and get inspired by the powerful story of a company that continues to innovate and meet the evolving needs of its customers.